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High explosives are highly sensitive to accidental detonation by impact, fire, shrapnel 
and small arms fire. This sensitivity can be reduced by storing the energetic material 
within a rubbery polymer matrix and are known as plastic bonded explosives (PBX). 
The current procedure used to manufacture PBX involves mixing the energetic 
material with a hydroxy-functionalised aliphatic polymer. Upon the addition of an 
isocyanate crosslinker an immediate polymerisation occurs and thus the rapidly curing 
mixture must be used to fill the missile or shells, referred to as ‘stores’. This process 
can lead to poor distribution of the crosslinker resulting in the formation of an 
inhomogeneously crosslinked matrix and the formation of voids. One solution to this 
problem involves containing the crosslinker within polyurethane microcapsules that are 
uniformly dispersed in the explosive-polymer mixture. Upon the application of a 
stimulus the crosslinker can be released from the microcapsules and the formation of 
a uniformly crosslinked PBX achieved. Herein is reported the design and synthesis of 
polyurethane microcapsules that release isocyanate crosslinkers when desired using a 
thermal stimulus. This has been achieved by exploiting the thermally-reversible nature 
of oxime-urethane and Diels-Alder adducts that have been incorporated into the shell 
wall of the microcapsules. An alternative approach to controlling the polymerisation of 
PBX materials has also been achieved using thermally-reversible blocked isocyanates 













Chapter 1 describes the current procedures used to bind high explosives within 
polyurethane rubber matrices. The problems and limitations of this procedure are 
outlined and a potential solution utilising microencapsulation technology is proposed. 
The first section of this chapter reviews the literature surrounding the applications, 
synthesis and controlled release of microencapsulated active liquid agents. The 
second section of this chapter investigates potential thermally-labile bonds that could 
be incorporated into the shell wall of microcapsules in order to generate 
microencapsulated crosslinkers that are released upon exposure to the application of 
heat. 
Chapter 2 describes how thermally-labile oxime-urethane bonds can be incorporated 
into the shell wall of microcapsules by first synthesising an isocyanate-terminated shell 
wall precursor. A library of shell wall precursors that possess varying degrees of steric 
hindrance around the thermally-labile bond have been generated. Methods for 
observing the dissociation of the shell wall precursor have been investigated including 
variable temperature infra-red spectroscopy (VTIR), differential scanning calorimetry 
(DSC) and thermogravimetric analysis. VTIR spectroscopic methods were 
demonstrated to provide the most reliable data and results revealed that increasing the 
steric hindrance around the oxime-urethane reduced the temperature at which 
dissociation occurred. 
Chapter 3 reports the synthesis of microcapsules using an interfacial polymerisation 
technique employing the shell wall precursors described in Chapter 2 in order to 
incorporate a thermally-labile oxime-urethane within the shell walls. The release of the 
core contents from these microcapsules using an application of a heat stimulus was 
investigated and the capability of these microcapsules to cure hydroxy-functionalised 
aliphatic polymers was demonstrated. Many reaction parameters are associated with 
the interfacial polymerisation approach to microcapsule synthesis and the second 
section of this chapter describes how modification of these parameters can be used to 
control the physical properties of microcapsules - microcapsule diameter, shell wall 
thickness and core loading. In addition, the microencapsulation of a dye, -carotene, is 
described and how UV-visible spectroscopy can be used to quantify the release of the 
core contents from microcapsules. 
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Chapter 4 reports the design and synthesis of microcapsules that contain a thermally-
reversible Diels-Alder adduct within the shell wall. This chapter first describes the 
design and synthesis of an isocyanate-terminated shell wall precursor that contains 
the Diels-Alder adduct and is capable of further chain extension to form 
microcapsules. The second part of this chapter describes the synthesis and 
characterisation of microcapsules synthesised using an interfacial polymerisation 
technique employing the generated shell wall precursor. The potential of these 
microcapsules to release their core contents upon exposure to a heat stimulus is 
reported. In addition, a method to increase the mechanical strength of the 
microcapsules is described. 
Chapter 5 describes how thermally-labile blocked isocyanates can be employed to 
generate active isocyanate crosslinkers when desired using an application of heat. A 
range of blocking groups - amines, amides, oximes, aromatic heterocycles and 
phenols were used to block isophorone diisocyanate. The potential of these molecules 
to regenerate the active isocyanate moiety and thus cure hydroxy-functionalised 
polymers at elevated temperatures is reported. Of these blocking groups, oximes were 
demonstrated to possess the most ideal solubility and curing characteristics. The 
second section of this chapter focuses how the dissociation temperature of oxime-
blocked isocyanates - designated herein as oxime-urethanes - can be controlled by 
modification of the steric and electronic properties of the oxime. The final section 
reports the potential of these oxime-urethanes to cure hydroxy-functionalised polymers 
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Modern high explosives consist of an energetic material bound within a rigid polymer 
matrix and are thus known as plastic or polymer bonded explosives (PBX). The current 
method for the manufacture of such materials involves addition of a diisocyanate 
crosslinker to multi-component formulation featuring the explosive and a hydroxy-
functionalised elastomeric polymer in order to generate a stable polymer network post 
cure. This chapter first describes this process and highlights the drawbacks resulting 
from the immediate polymerisation reaction between the isocyanate and polymer that 
ensues. The use of microencapsulation technologies to deliver the crosslinker in PBX 
systems is postulated as a potential solution in order to yield a more desirable end 
product. The second part of this chapter reviews state-of-the-art microencapsulation 
technologies describing how microcapsules can be designed with specific properties in 
order to achieve the release of the diisocyanate crosslinker when desired using an 
external application of heat. 
1.1. High Explosives 
An explosive is defined as a substance that upon ignition undergoes rapid chemical 
reactions, releasing large quantities of heat and causing a massive increase to the 
surrounding pressure.1 Explosives first appeared in Europe as early as 13th century, 
known as black powder, the crude mixture comprised charcoal, potassium nitrate and 
sulfur. In 1846, Italian chemist Ascanio Sobrero successfully nitrated glycerol to form 
the highly sensitive explosive nitroglycerine. The subsequent dangers associated with 
the poor stability of nitroglycerine prevented its extensive use in military applications 
and lead to the development of more stable high explosives such as trinitrotoluene 
(TNT) which saw large-scale employment in the First World War. Further research in 
the field has seen modern munitions replacing TNT with the more powerful high 
explosive cyclotrimethylenetrinitramine Research Department Explosive (RDX, Type 1) 
(Figure 1.1).1 The development of high explosives evolved conjointly with their 
methods of deployment. Two decades after the synthesis of nitroglycerine, Alfred 
Nobel observed the explosive could be desensitized by dispersing it in clay. Nobel 
patented his invention as ‘dynamite’ in 1867. The concept of desensitization by 
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dispersing in a matrix has not changed since this time. Since the Second World War 
high explosives have been desensitised using polymer matrices, commonly referred to 
as ‘Plastic or Polymer Bonded Explosives’ (PBX).2 
 
Figure 1.1. The structures of high explosives - nitroglycerine, trinitrotoluene (TNT) and 
Research Department Explosive (RDX). 
1.2. Design of Explosive Shells 
The earliest bombs consisted of a black powder packed into cases of canvas, wood or 
iron, detonated by a slow burning fuse. By the early 20th century high explosives were 
contained in steel case projectiles, referred to as ‘stores’. The bulk explosive payload 
is relatively insensitive, requiring a fuse to detonate the explosive (Figure 1.2). 
 
Figure 1.2. Simple design of an explosive shell, highlighting the propulsion charge, explosive 
payload, shell and fuse. 
In the early years of the 20th century, explosives were introduced to the store by a 
melt-cast process. The explosive formulation was melted and poured into the store. 
However, during the cooling and resolidification process adverse conditions could lead 
to cracking and formation of voids. Upon firing, these voids experience an increase in 
G-force to an excess of 13,000 G, a change that causes an extreme adiabatic 
compression process, sufficiently increasing the temperature above the explosives 
ignition point, thus posing a potentially fatal hazard to the gun operative. In addition, 
high explosives are susceptible to small arms fire, shrapnel and external fire. 
 





This sensitiveness to impact can be avoided by incorporating PBX within the stores, 
effectively desensitising the explosive material. The current process used to 
incorporate PBX within explosive stores involves mixing the explosive with a hydroxyl-
functionalised aliphatic polymer to form a pre-cure, the form in which the mixture is 
stored in. Curing is initiated by addition of a crosslinker plus a catalyst and the 
resultant mixture is then warmed to 55 - 70 °C. Upon the addition of the crosslinker, an 
instantaneous crosslinking reaction occurs and thus filling of the stores must 
commence immediately before extensive crosslinking can occur. The filled stores are 
cured in an oven at 60 °C for a period of 120 hours to ensure exhaustive crosslinking 
occurs (Scheme 1.1). 
 
Scheme 1.1. Scheme illustrating the current method involved in casting PBX in stores, 
highlighting a) the addition of a crosslinker and catalyst, b) introduction to the explosive store 
and c) the formation of an inhomogeneous crosslinked PBX. 
However, the manufacturing process can prove to be unreliable. The dispersion of the 
crosslinker in the mixture is not always even, leading to regions of low crosslinking 
density and the presence of voids. In addition, as a result of the ongoing crosslinking 
reaction, consecutively filled stores possess an increasingly inhomogeneous 
crosslinked PBX. The process also imposes restrictions on the catalyst concentration. 
In order to reduce the rate of crosslinking reaction the catalyst is in very low 
Pre-cure formulation 
HTPB and explosive 








Presence of voids 
60 °C  
120 hours 
a) b) c) 
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concentration levels (0.01 wt %), which in turn, contributes to poor crosslinking density 
and a product of variable quality. 
1.3. Rowanex 1100 1A 
One PBX formulation developed for use in explosive stores is Rowanex 1100 1A. It is 
comprised primarily of RDX and is bound in a rubbery polyurethane matrix prepared 
from hydroxy-terminated polybutadiene (HTPB) plus a crosslinker, isophorone 
diisocyanate (IPDI). The crosslinking reaction is catalysed by dibutyltin dilaurate 
(DBTDL) (Scheme 1.2). The hydroxyl moiety of HTPB reacts with the electrophilic 
carbon of the isocyanate units of IPDI to form urethane linkages. Furthermore, within 
the polymerisation matrix, reaction of isocyanate and the urethane nitrogen leads to 
the formation of allophonate crosslinks. 
 
Scheme 1.2. Scheme representing the crosslinking of HTPB with IPDI when catalysed with 
DBTDL. 
The components of Rowanex 1100 are listed in Table 1.1. It consists of RDX, HTPB 
pre-polymer, a plasticiser, an antioxidant to inhibit oxidation of material, a surfactant, 








Table 1.1. Rowanex 1100 1A explosive formulation. 
Constituent  Composition (wt %) 
RDX   > 80 
HTPB R45HT  
Plasticiser  
Antioxidant   
Surfactant  < 20 
IPDI    
DBTDL  
Antifoaming Agent  
1.4. The Microencapsulation Approach to Controlled Delivery of Crosslinkers 
Within the context of this investigation, it is proposed that microencapsulation 
technology will allow the uniform delivery of the crosslinker IPDI, thus achieving a 
homogeneously crosslinked rubber matrix. In addition, microencapsulation of the 
crosslinker may have several other benefits - control of the crosslinking reaction until 
desired can be achieved; thus filling of the stores does not need to occur immediately, 
the catalyst concentration can be increased; further contributing to the formation of a 
more uniform matrix and prevention of the exposure of toxic isocyanates to the 
process engineers. 
1.4.1. Microcapsules 
Microencapsulation involves the envelopment of a core substance within a protective 
shell which is typically composed of either - gel, surfactant, electrolyte3  or polymer.4  
Polymer microcapsules can be classified into three types - mononuclear,5 polynuclear6 
and matrix.7,8  
 
Figure 1.3. Design of mononuclear, polynuclear and matrix microcapsules. 
Mononuclear Polynuclear Matrix 
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Mononuclear microcapsules consist of a solid shell that surrounds a central core and 
polynuclear microcapsules are comprised of many cores within the solid shell. In 
contrast, matrix-type microcapsules do not possess a core - rather, the active 
substance is bound within the polymer matrix (Figure 1.3).5 Mononuclear 
microcapsules are typically spherical, between 1 - 1000 m in diameter and deliver the 
highest payload of encapsulated core.9 
1.5. Microcapsule Applications 
The intrinsic microcapsule core encompasses the active agent which may be solid, 
liquid or gas depending on its ultimate application.9  A range of liquid active agents 
have been enclosed in microcapsules, including - fragrances, 10  11  pesticides and 
agrochemicals, 12  food additives 13  pharmaceuticals and industrial chemicals, 14  The 
following section reviews the literature surrounding the uses of microencapsulated 
liquid agents. 
1.5.1. Microencapsulation of Fragrances 
Fragrances and perfumes are used extensively in textiles, cosmetics, deodorants and 
scented household items. However, the high volatility of fragrant molecules restricts 
the active lifetime of the scent.15 Microencapsulation technologies prolong the lifetime 
of fragrances by allowing a sustained release of the active agent,16,17 retaining up to 
90% of the fragrance after a period of 100 days. 18  Release mechanisms of 
microencapsulated fragrances have been developed19 by exploiting the degradation of 
encapsulated α-ketoesters. Exposure of such moieties to UV-light generates gaseous 
CO2, causing an increase in the internal pressure of the microcapsules sufficient to 
rupture the microcapsules and releasing the fragrance. Further to this, microcapsules 
that release fragrances upon exposure to acidic environments such as sweat have 
been reported.20,21 
1.5.2. Microencapsulation of Agrochemicals 
Pesticides and other agrochemicals exhibit high volatility and toxicity, reducing their 
activity and posing a health exposure risk. Microencapsulation offers a method of 
gradually releasing the active agent, thus prolonging the activity of these expensive 
chemicals and preventing exposure.22,23,24 In conjunction with the microencapsulation 
of conventional chemical pesticides, the encapsulation of insect pheromones have 
been investigated.25 The release of the pheromone around crops disrupts the insects 
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mating process, resulting in the reduction of the insect population and in turn 
increasing the crop yield.26 
1.5.3. Microencapsulation of Food Additives 
Recently, there has been a growing interest in microencapsulation of active agents 
used specifically in the food industry. 27  Many food additives exhibit poor stability 
towards oxidation, high reactivity to other components present in food and indeed 
certain additives are irritant in high concentrations preventing their extensive use in 
food products.28,29 Microencapsulation offers a route to overcome these problems and 
many food additives have now been stored in microcapsules, including - vitamins, fatty 
acids, minerals and antioxidants.27 
1.5.4. Microencapsulation of Pharmaceuticals 
Microencapsulation is being employed increasingly in drug delivery vehicles. Many 
drugs are susceptible to chemical and enzymatic degradation - insulin for example is 
degraded by the acidic conditions of the stomach and as such must be administered 
intravenously. Microencapsulated insulin prevents drug degradation and can be 
released from the microcapsules in the circulatory system.30 Many anticancer drugs 
exhibit high toxicity, attacking cancerous and healthy tissue indiscriminately. 
Employing microcapsules as drug carriers allows release of the drug to the targeted 
site, preventing exposure to healthy cells whilst simultaneously achieving an increased 
payload.31,32 Microencapsulated drug delivery was further developed33 by incorporating 
magnetic nanoparticles into the microcapsules, allowing the drugs to be directed to the 
targeted site with the application of a magnetic field. 
1.5.5. Microencapsulation of Phase Change Materials 
Certain substances undergo phase changes at a near constant temperature and are 
capable of releasing and storing large amounts of energy during the change. These 
are known as phase change materials (PCMs) and are employed in systems required 
to absorb or release large quantities of heat.34 Typically, PCMs need to be bound 
within polymer matrices in order to prevent loss during melting and improve 
conductivity. Unfortunately, PCMs leak from such composites significantly limiting their 
lifetime capability.35 Storing PCMs within polymer microcapsules avoids leakage whilst 




1.5.6. Functional Textiles 
Microcapsules containing a host of active liquid agents have been bound to the fibres 
of textiles to fabricate a wide range of functional materials.37 Microcapsules containing 
a number of fragrances have been used to prolong the freshness of clothing and 
linen.38 Microencapsulated insect repellents bound to linen have been produced39 to 
combat malaria and other insect borne diseases. A method of prolonged drug delivery 
using textiles that incorporate microencapsulated pharmaceuticals has been 
demonstrated.40 Clothing and blankets for use in extreme weather conditions that have 
potential to absorb or release heat by exploiting microencapsulated PCMs have been 
developed. 41  In addition, functional fabrics have been employed for protection of 
military personnel against chemical weapons. Microcapsules bound to the fabric fibres 
contain decontamination agents that chemical warfare agents diffuse into and undergo 
irreversible degradation reactions.42 
1.5.7. Healable Materials 
Microencapsulation technology has been employed to deliver crosslinkers in self-
healing composites. 43  Polymer materials are used extensively in electronics, the 
automotive industry, coatings and extreme environments such as aircraft 
fuselages.44,45 The harsh conditions of chemical attack, radiation, abrasion and impact 
experienced by these materials leads to the formation of micro-cracks.46 The ability to 
heal such defects reduces polymer degradation and maintenance down-time. 
Microcapsules containing healing agents have been synthesised and incorporated into 
polymer composites and matrices.43 Upon the formation of cracks, the microcapsules 
are ruptured, releasing the healing agent and drawing it to the damaged area via 
capillary action, subsequently repairing the damage. 47  An epoxy matrix containing 
Grubb’s catalyst and urea-formaldehyde capsules containing dicyclopentadiene 
(DCPD) has demonstrated successfully this healing strategy (Scheme 1.3). 48  The 
drawback of this technology is that the healed area is composed of a different polymer 
to the epoxy matrix with only 75 % of the original toughness. This performance 
differential renders the heterogeneous composite vulnerable to further microcrack 
formation. This approach was developed further by Yang et al. to encapsulate IPDI49 
and hexamethylene diisocyanate (HDI) 50  in polyurethane microcapsules using an 
interfacial polymerisation technique.49 Once embedded in an epoxy matrix the healing 
technology functions in an analogous fashion to the DCPD systems.50 An additional 
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limitation is that once a region has been healed, further damage events in the area 







Figure 1.4. Microcapsule release in a self-healing composite. a) pristine material, b) crack-
formation, c) crack-propagation and rupture of the macrocapsules, d) crack-healing via 
metathesis polymerisation and e) ring opening metathesis polymerisation of DCPD. 
One solution to this issue was to incorporate refillable microtubules that span the 
composite matrix which enabled repeated delivery of the healing agent to the same 
damaged zone. 53  Indeed the self-healing ability of this composite material was 
demonstrated over several break-heal cycles. 
1.6. Microcapsule Synthesis 
Microcapsule synthesis can be achieved using a variety of techniques. These are 
conveniently categorised into chemical and physical approaches. Physical methods 
include - suspension crosslinking, 54  solvent evaporation, 55  coacervation, 56  spray 
drying,57 layer-by-layer deposition,58 supercritical fluid expansion59 and the spinning 
disk approach.60  Chemical methods include suspension polymerisation, 61  emulsion 
polymerisation,62 interfacial polymerisation63 and dispersion polymerisation.64 Of these 
techniques, interfacial polymerisation and dispersion polymerisation most commonly 
are used to encapsulate liquid active agents.9 
a) b) c) d) 
Microencapsulated dicyclopentadiene 
Grubbs Catalyst 
Crack site Crack site Crack site 
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1.6.1. Dispersion Polymerisation Approach to Microcapsule Synthesis 
Microencapsulation using this technique involves dissolving the core material in a 
water-immiscible organic solvent followed by emulsion in the polymerisation medium 
(Scheme 1.4).65  
 
Scheme 1.3. Synthesis of microcapsules using dispersion polymerisation technique. a) core 
dispersed in polymerisation medium, b) oligomers begin to form, c) polymers collapse on 
surface of oil droplet and d) formation of the microcapsule shell. 
Following initiation, a polymerisation ensues and oligomers begin to form. Eventually 
polymers collapse onto the surface of the emulsion droplet and after several hours of 
reaction, the oil droplet is enveloped in a polymeric shell enclosing the active agent.66 
Most dispersion polymerisation encapsulations involve the reaction of formaldehyde 
with either melamine67 or urea68 at a controlled pH (3.5) to form an amino resin shell 
(Scheme 1.5).  
 







This approach to microencapsulation has been used to encapsulate pesticides and 
active agents able to provide self-healing ability in polymer materials. 69 , 70  The 
technique allows control of microcapsule properties by careful modification of the 
reaction procedure parameters, including - pH, monomer concentration, surfactant 
concentration and the agitation rate.71 
1.6.2. Interfacial Polymerisation Approach to Microcapsule Synthesis 
Interfacial polymerisation offers a simple and reliable approach to the synthesis of 
microcapsules. Microencapsulation typically employs oil-in-water emulsions. 72 
However, water-in-oil 73  and oil-in-oil 74  emulsions have also been developed. The 
microcapsule shell is formed by a condensation polymerisation reaction at the liquid-
liquid interface and usually employs polyisocyanates in the oil phase polymerised with 
polyols and polyamines to give polyurethane75 and polyurea76  shells, respectively. 
Polyamide microcapsules can also be synthesised by corresponding reaction of 
polyacylchlorides and polyamines.77 
Yang et al.49 microencapsulated IPDI successfully in polyurethane microcapsules. This 
was achieved by reaction of toluene-2,4-diisocyanate (TDI) with 1,4-butanediol to yield 
an isocyanate-terminated shell wall precursor capable of further chain extension 
(Scheme 1.6) to form a microcapsule shell. 
 
Scheme 1.5. Reaction of toluene-2,4-diisocyanate with 1,4-butanediol to yield a shell wall 
precursor. 
Microcapsules were formed following emulsification of a hydrophobic solution of the 
shell wall precursor and IPDI in water with the aid of a surfactant and mechanical 
agitation. Upon the addition of 1,4-butanediol, chain-extension occurred at the oil-
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water interface forming a polyurethane shell that enveloped the active IPDI core 
(Scheme 1.7). The reaction of IPDI was avoided as a result of the high reactivity of TDI 
outcompeting the relatively less reactive IPDI crosslinker.78,79 
 
Scheme 1.6. Synthesis of microcapsules using interfacial polymerisation showing the 
emulsified oil droplets containing the shell wall precursor reacting at the oil-water interface to 
form microcapsules. 
In this approach to polyurethane microcapsules, a reaction occurs predominately 
between the alcohol and isocyanate moieties of the polymerisation agents, although 
reaction with water is also expected. Subsequent decarboxylation to form an amine 
allows polymerisation with further isocyanate to form a urea. In addition, crosslinking 
occurs between the urethane and urea nitrogen with residual unreacted isocyanate 





Scheme 1.7. Reactions involved in the synthesis of polyurethane microcapsules. 
1.6.3. Multi-Walled Microcapsules 
Microcapsules are prone to damage and leakage which ultimately reduces their shelf-
lives. In order to increase their strength and durability, microcapsules with multiple 
layered shells have been developed. Caruso et al. have developed82 a synthesis that 
encompasses sequential interfacial and dispersion polymerisations to yield 
microcapsules that possess an internal polyurethane shell and an external polyurea-
formaldehyde shell (Scheme 1.9). These microcapsules demonstrated an increased 
mechanical strength and an improved stability at high temperatures (180 °C). Multi-
walled polyurethane-urea microcapsules have also been synthesised by Yang et al., 
using a similar approach and these materials also exhibit an increase in thermal 
stability.83 
 
Scheme 1.8. Synthesis of multi-walled polyurethane-urea microcapsules, highlighting the 




1.7. Microcapsule Properties 
The interfacial polymerisation approach allows control of the microcapsules properties 
- diameter and size distribution, shell wall thickness, payload of core in microcapsules 
and physical strength (Figure 1.4).49 These properties can be controlled by careful 
modification of the synthetic parameters - rate of agitation,84 concentration of shell wall 
precursor, concentration of chain extender, selection of the solvent, concentration of 
active encapsulant, surfactant concentration, 85  reaction temperature 86  and reaction 
time.87 
 
Figure 1.5. Design of a mononuclear microcapsule showing the microcapsule diameter, shell 
wall and microencapsulated core. 
1.7.1. Microcapsule Diameter and Size Distribution 
Microcapsule diameter can be controlled by rate of agitation88 and concentration of the 
surfactant.85 Interfacial polymerisation employs mechanical agitation of the emulsion to 
ensure the formation of uniformly sized oil droplets. Increasing the speed of agitation 
imparts a greater degree of shear force experienced by the emulsion leading to 
smaller oil droplets and in turn the formation of smaller microcapsules. Increasing 
agitation rate also narrows the size distribution,49,50,88 granting a way of designing 
microcapsules with diameters within a desired range.  
Surfactants are employed in interfacial polymerisation in order to achieve a stable 
emulsion.89 These amphiphilic materials work by reducing the surface tension at the 
oil-water interface and increasing the concentration of surfactant reduces the surface 
tension of the emulsion, thus forming smaller oil droplets, leading to the formation of 






such as gum arabic are often utilised,89 although polymeric surfactants such as 
polyvinyl alcohol are also used.91 
Selection of the hydrophobic solvent is also important. Organic solvents possess 
different surface tensions92  and thus employing different solvents will lead to the 
formation of different sized oil droplets. 
1.7.2. Shell Wall Thickness 
The physical strength of microcapsules is largely dependent on the thickness of the 
shell wall93 and control of this property is important in order to design microcapsules 
that possess suitable strength. Microcapsule shell wall thickness can be controlled by 
reaction temperature, reaction time, use of catalysts and concentration of shell wall 
precursor. 
It has been reported86 that at higher temperatures the rate of the isocyanate-alcohol 
reaction during microcapsule synthesis is increased. By increasing the inclusion of 
IPDI in shell wall synthesis, thicker shell walls are formed and therefore increase the 
mechanical strength of the microcapsules.50 
Control of the microcapsule shell wall thickness can also be achieved by changing the 
reaction time.70 It is thought that as the initial polymer shell forms, the chain extender 
will then diffuse across the membrane allowing further reaction to continue. A longer 
reaction time will, therefore, lead to an increase in shell wall thickness.87,50  
Urethane formation can be catalysed using a range of reagents. Typically tertiary 
amines 94  and organo-tin(VI) 95  complexes are employed in the synthesis of 
polyurethane microcapsules. Addition of catalysts to the oil phase may provide a way 
to controlling the shell wall thickness by increasing the contribution of aliphatic 
isocyanate to shell wall synthesis, allowing the formation of a thicker shell wall. 
1.7.3. The Microcapsule Core 
The microcapsule core typically consists of the active agent and a solvent. Ideally, the 
delivery of the maximum amount of active agent is desired and this payload can be 
controlled by changing the ratio of active agent and solvent used in microcapsule 
synthesis.43 However, Yang et al., have observed49 agglomeration when the loading of 
microcapsules exceeded 70 % in IPDI filled microcapsules. Therefore, a careful 
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balance must be found between achieving a maximum payload whilst avoiding 
undesired agglomeration. 
1.7.4. Physical Strength of Microcapsules 
The physical strength of microcapsules is largely affected by the shell wall thickness 
and microcapsule diameter. Smaller microcapsules with thicker shell walls have been 
shown to possess a greater degree of physical strength when compared to larger 
microcapsules.93 However, the nature and chemical composition of the shell wall 
polymer is also important. A degree of elasticity in microcapsule shell is desired, 
preventing damage during synthesis and also leading to the formation of stronger, 
more spherical microcapsules.96,97,98 The use of trifunctional isocyanate-terminated 
shell wall precursors leads to smaller more uniform microcapsules 99  and in turn 
increasing their physical strength. 
1.8. Microcapsule Release Triggers 
The release of the core content from microcapsules allows a desired controlled 
delivery of active agents. This objective has led to the development of a range of 
triggering mechanisms that cause the release of the microencapsulated core upon 
exposure to a specific stimulus including - external pressure, ultrasound, chemical 
(typically pH), light and heat.72,100 
1.8.1. Release of Microcapsules with External Pressure 
Perhaps the most simplistic triggering mechanism is the release of the encapsulated 
core upon exposure to an external pressure. The force is sufficient to bring about a 
breach to the structural integrity of the microcapsule.93 This trigger is used in self-
healing composites where the material experiences a break thus causing the release 
of microcapsule core into the fracture site.43 
1.8.2. Release of Microcapsules Using Ultrasound 
Ultrasonic radiation is a way of inducing pressure on the microcapsule surface without 
mechanical influence. There are two strategies of ultrasound which could be used to 
release microcapsules - acoustic cavitation and therapeutic ultrasound. Acoustic 
cavitation uses ultrasound at frequencies of 20 - 40 kHz, the sound waves bring about 
the formation and rapid collapse of microbubbles resulting in a short-lived high energy, 




Figure 1.6. The formation and rapid growth of air-filled microbubbles followed by implosion, 
observed in ultrasonic cavitation phenomena. 
Ultrasonic degradation of chain growth polymers has been well-reported.102,103 These 
studies involved irradiation of polymer solutions with a frequency of high powered 
ultrasound (24 kHz, 100 W)104 to degrade polymers to a limiting molecular weight 
(Figure 1.6). 
 
Figure 1.7. The effect of ultrasonic cavitation on linear polymers in solution. 
Previous studies105 conducted at The University of Reading demonstrated the release 
of IPDI and pyrene filled microcapsules. A suspension of microcapsules in CDCl3 was 
irradiated with a frequency of ultrasound (44 kHz) for 1 hour. The release of pyrene 
from the microcapsules was recorded using fluorescence spectrophotometry to reveal 
almost complete release of pyrene from the polyurethane microcapsules.  
High frequency, low powered therapeutic ultrasound (1 - 2.5 MHz, 0.035 - 0.5 W)106 
has been used to release polylactide microbubble ultrasound contrast agents (UCAs). 
Upon application of ultrasound, the UCAs resonate and bring about the degradation of 
the microcapsule shell wall (Scheme 1.10).107,108 
 




1.8.3. Release of Microcapsules using a Chemical Trigger 
The need for drug delivery mechanisms has increased in recent years and as a result, 
many anti-cancer drugs have been encapsulated. The pH in cancerous tissue is lower 
than that of healthy tissue and release mechanisms have been developed to exploit 
this change,109 often employing the acid catalysed covalent bond cleavage of acetal, 
orthoester, imine, hydrazone or ester linkages (Figure 1.7) in the polymer of the 
microcapsule shell wall.110 Upon the change in pH, the labile bond is cleaved causing 
the depolymerisation of the polymer shell of the microcapsule, releasing the core 
contents. 
 
Figure 1.8. Structures of acetals, orthoesters, imines, hydrazones and esters. 
1.8.4. Release of Microcapsules by Irradiation with Light 
The release of active agents from microcapsules has been in achieved by using light 
to switch polyelectrolyte microcapsules causing changes to the shell wall that lead to 
the formation of pores, allowing the core to be released. 111  Another route is to 
incorporate self-immolative polymers into the microcapsule shell that degrades upon 
exposure to different wavelengths of light causing rupture of the microcapsule and 
release of the core.112 
1.8.5. Release of Microcapsules by Exposure to Heat 
Release of microcapsules by exposure to heat can be achieved by heating the 
material above the boiling point of the core solvent causing rupture of the 
microcapsule shell brought about by the increase in internal pressure (Scheme 1.11).72  
 





Another method involves incorporating poly(N-isopropylacrylamide) (PNIPAM) into the 
pores of microcapsules. When exposed to heat PNIPAM shrinks, effectively opening 
the pores and allowing the release of the microcapsule core (Scheme 1.12).113 
 
Scheme 1.11. Release of core from microcapsules by incorporating PNIPAM within the shell 
of the microcapsule. PNIPAM shrinks upon exposure to heat revealing pores in the 
microcapsule shell wall. 
One approach that has not been widely documented in the literature is the 
incorporation of a thermally-labile linker within the polymer backbone of the 
microcapsule shell wall. Eggers et al. reported 114  the synthesis of microcapsules 
prepared using a complex coacervation technique that incorporated thermally-labile 
maleimide-furan Diels-Alder adduct within the microcapsule shell wall. Release of the 
microcapsule core was achieved at 90 °C (Scheme 1.13). However, to date 
polyurethane microcapsules have not been prepared using an interfacial 
polymerisation approach that incorporate thermally-reversible bonds within the 
polymeric backbone of the microcapsule shell wall. 
 
Scheme 1.12. Release of core from microcapsules achieved by depolymerisation of the 
microcapsule shell wall. 
1.9. Thermally Labile Linkers 
The field of thermally-cleavable covalent bonds has been, to date, dominated by the 







aromatic diene is stable at ambient temperature - however, elevated temperatures 
favour the reverse reaction, regenerating the diene and dienophile (Scheme 1.14).  
 
Scheme 1.13. The retro Diels-Alder reaction of a maleimide-furan adduct, regenerating the 
furanyl diene and maleimide dienophile. 
As such, the retro Diels-Alder reaction is employed extensively in thermally-healable 
materials. Generally, the reverse reaction requires in excess of 100 °C although recent 
developments have yielded adducts that cleave as low as 25 °C.115 Maleimide-furan 
Diels-Alder adducts have increasingly been applied in release and degradable polymer 
systems.116,117 
Another thermally labile bond is the hemiacetal ester.118 Upon exposure to heat at 
80 °C, the hemiacetal is transformed into a carboxylic acid with the elimination of vinyl 
ether. The hemiacetal ester linker has been employed in degradable and recyclable 
epoxy resin composites (Scheme 1.15).119 
 
Scheme 1.14. Dissociation of hemiacetal esters to form carboxylic acid and vinyl ether. 
1.10. Blocked Isocyanates 
Isocyanates react rapidly with H2O and as a result, coating formulations containing 
free isocyanate exhibit poor stability and can polymerise readily even under mild 
conditions.120 This has led to the development121 of blocking groups that protect the 
isocyanate moiety. The blocking reaction is reversible, generating free isocyanate 
when desired by the application of heat (Scheme 1.16). Extensive ranges of blocking 
groups have been patented and been the subject of several reviews.121,122,123 In the 
majority, studies of blocked isocyanates have been concerned primarily with the 
regeneration of active isocyanate, although these degradable systems have also 






Scheme 1.15. Dissociation of a blocked isocyanate, generating the isocyanate moiety and the 
blocking group (B). 
Blocking groups include - aromatic heterocycles, amines, phenols, oximes and 
amides.122 The following section serves to review the literature of these blocking 
groups, the temperature at which the reverse reaction can occur and their use as 
thermally-labile linkers in polymeric systems. 
1.10.1. The Effect of Isocyanate Structure on Dissociation Temperature 
It has been shown125 that the structure of the isocyanate can have an effect on the 
dissociation temperature of the blocked isocyanate. Aromatic isocyanates typically 
dissociate at lower temperatures as a result of the increased electron withdrawing 
effect of the aromatic ring. Steric hindrance surrounding the isocyanate moiety also 
contributes to a lower dissociation temperature. Marumatsu et al. investigated125 the 
dissociation temperature of a range of methyl ethyl ketoxime blocked isocyanates 
using thermogravimetric analysis (TGA). It was found that xylylene diisocyanate (XDI) 
had a lower dissociation temperature than the corresponding aliphatic H6XDI. In 
addition, sterically hindered tetramethylxylylene diisocyanate (TMXDI) possessed an 














Table 1.2. Dissociation temperatures of methyl ethyl ketoxime blocked HDI, IPDI, XDI, H6XDI 
and TMXDI, highlighting the importance of electronic and steric affects. 
Isocyanate Structure Dissociation 
Temperature (°C) 
Hexamethylene 
















1.10.2. Aromatic Heterocycles Blocking Groups 
Aromatic heterocycles that possess an acidic hydrogen are often used to block 
isocyanate functionalities. Imidazole has been patented extensively as a blocking 
agent for isocyanates.126,127  Such blocked isocyanates are typically used to crosslink 
hydroxyl-functionalised pre-polymers used in coatings and adhesives.128 Mϋhlebach 
reported 129  the synthesis of pyrazole-blocked isocyanates. TGA studies of IPDI 
blocked with 3,5-dimethylpyrazole revealed regeneration of the isocyanate at 150 °C 
with complete dissociation by 230 °C. Pyrazole blocked isocyanates have been used 
to cure amine terminated prepolymers and this was achieved within minutes at 
100-120 °C. HDI isocyanurate trimer blocked with 3,5-dimethylpyrazole possessed 
dissociation temperatures between 115-135 °C have been used to cure polyurethane 
coatings.130 Increasing the substitution on the pyrazole has proven to decrease the 
dissociation temperature. 1,2,4-Triazole-blocked isocyanates have been used to cure 




Figure 1.9. Generic structures of imidazole, pyrazole and triazole. 
Heterocycle-blocked isocyanates have also been used in vinyl polymers, 133 
incorporating thermally reversible urea crosslinks formed by a reaction of 
4-vinylimidazole and 3-isopropenyl-α,α-dimethyl-benzyl isocyanate (Scheme 1.17). 
 
Scheme 1.16. Dissociation of a urea crosslink to form 4-vinylimidazole and 3-isopropenyl-α,α-
dimethyl-benzyl isocyanate. 
The dissociation mechanism for such aromatic heterocycles operates by forming a five 
membered complex that leads to deprotonation of the urea followed by subsequent 
dissociation (Scheme 1.18). 134 
 
Scheme 1.17. The five-membered complex that aids in the deprotonation of the urea proton, 
leading to its dissociation. 
1.10.3. Isocyanates Blocked With Bulky Secondary Amines 
Ureas are stabilised by conjugation between the lone pair of the nitrogen and the 
-electrons of the carbonyl (Scheme 1.19). Introducing bulky groups onto the urea 
nitrogen hinders this stabilising effect, reducing the strength of the urea bond thus 
leading to its dissociation under mild conditions. 135 
 
Scheme 1.18. Conjugation of the urea bond that increases its stability. 
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Stowell et al. investigated136 the effect of bulky groups on ureas on the dissociation 
temperature to generate amine and isocyanate (Scheme 1.20). 1H NMR spectroscopic 
analysis revealed the percentage of dissociation of these ureas between 40 and 
140 °C. Increasing the steric hindrance on the blocking amine significantly reduced the 
dissociation temperature (Figure 1.9). 
 
Scheme 1.19. General dissociation of a sterically hindered urea to yield a secondary amine 
and isocyanate. 
 
Figure 1.10. The effect of steric hindrance on the dissociation of ureas. 
The self-healing potential of these ‘dynamic’ ureas was investigated. 137  The 
dissociation of 1-(Tert-butyl)-1-ethylurea reached equilibria after 20 hours at 37 °C. 
When inserted into a polyurea, experiments using gel permeation chromatography 
(GPC) revealed depolymerisation was achieved after 12 hours at the same 
temperature. 
Sankar et al. reported151 a series of aromatic secondary amines used to block TDI. 
The blocked isocyanates were used to cure HTPB upon the application of heat. 
Variable temperature IR (VTIR) spectroscopy was used to identify the appearance of 
the characteristic isocyanate absorbance which subsequently diminished as curing of 
HTPB was achieved. The dissociation temperature was reduced by the presence of 
electron withdrawing groups at the para-position and increased by increasing electron 
density onto the aromatic ring. Dissociation temperatures can also be controlled 




Scheme 1.20. a) Dissociation reaction of 1-(tert-butyl)-1-ethylurea to yield corresponding 
isocyanate and amine. b) Dissociation of a polyurea bearing thermally reversible ureas. 
1.10.4. Phenolic and Alcohol Blocking Groups 
Urethanes formed from alkyl-alcohols dissociate at high temperatures (typically 
~ 250 °C) and are thus not commonly used to block isocyanates, 138  although, 
dissociation of isopropyl alcohol blocked IPDI has been reported 139  to occur from 
180 °C. Conversely, the urethane linkage between aromatic isocyanates and phenols 
is unstable at high temperatures (Scheme 1.22).  
 
Scheme 1.21. Dissociation of TDI blocked with phenol to generate free diisocyanate. 
Kothandaraman and Nasar reported140 the synthesis and dissociation of a series of 
phenol-blocked toluene diisocyanates measured using variable temperature FTIR 
spectroscopy. Generally, the presence of electron donating groups reduced the 
dissociation temperature in contrast to that observed in aromatic amines (Figure 1.10). 
 
Figure 1.11. Dissociation temperatures of isocyanates blocked with substituted phenols, 
observed using FTIR spectroscopy.
140
 
IPDI and HDI have been blocked with bisphenol A and 4-hydroxybenzoic acid ethyl 
ester.139 FTIR spectroscopy revealed the generation of free HDI at 118 and 162 °C 
when blocked with bisphenol A and 4-hydroxybenzoic acid ethyl ester, respectively. 
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The corresponding blocked IPDI required much higher temperatures, 177 and 183 °C 
respectively, and maximum dissociation was not achieved until ~ 230 °C.  
1.10.5. Oxime Blocking Groups 
Oximes are used widely as thermally-labile blocking agents as a result of their low 
dissociation temperature and high reactivity with isocyanates, avoiding the use of 
catalysts in their preparation (Scheme 1.23).122 They are often found in industrial 
applications including automotive coatings.81 
 
Scheme 1.22. General dissociation reaction of an oxime-urethane to form the corresponding 
isocyanate and oxime. 
The dissociation mechanism is believed141 to occur in a similar manner observed in 
pyrazole blocked isocyanates, in which a five-membered transition state leads to 
deprotonation of the urethane nitrogen (Scheme 1.24). 
 
Scheme 1.23. Dissociation mechanism of isocyanates blocked with oximes at elevated 
temperatures. 
Thermally-reversible oxime-urethanes have been employed as crosslinks in thermally-
degradable polymers used as templates in the manufacture of microchips.124 
Templates are usually crosslinked polymers that can be difficult to remove without the 
use of harsh conditions. Employing thermally labile crosslinks allows easy removal of 
the template as a result of this heat-triggered depolymerisation (Scheme 1.25). 
 
Scheme 1.24. Dissociation of oxime-urethane crosslinks used in polymers applied as 
templates in the manufacture of microchips. 
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The effect of steric hindrance on the rate of dissociation has been investigated142  and 
it was found that more sterically hindered oximes dissociate faster. This observation 
was supported143 by a further study investigating the curing of epoxy pre-polymers 
with a range of oxime blocked isocyanate-terminated pre-polymers, derived from TDI. 
The curing time was measured at 60, 100, 120 and 140 °C (Table 1.3). 
Table 1.3. Curing times of epoxy using isocyanates blocked with oximes at 60, 100, 120 and 
140 °C. 
Oxime 
Cure time at: 
60 °C 100 °C 120 °C 140 °C 
 
1 day 15 minutes 10 minutes 5 minutes 
 
10 hours 15 minutes 10 minutes 5 minutes 
 
 1 day 30 minutes 20 minutes 15 minutes 
 
Immediate Immediate Immediate Immediate 
 
2 days 1 hour 45 minutes 15 minutes 
 
5 days 2 hours 1 hour 30 minutes 
To date, the electronic effects on the dissociation of isocyanates blocked with aromatic 
oximes have not been widely explored. Kothandaraman et al. reported144 that the 
dissociation of TDI blocked with analogues of benzophenone oxime was reduced by 
the presence of electron-donating methoxy moieties and in turn increased by the 
presence of electron-withdrawing chlorine. Further to this, the effect appeared to be 
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dependent on its position on the aromatic ring - meta-methyl substituted 
benzophenone oximes leading to a reduction in dissociation temperature and ortho 
and para-methyl substituted benzophenone oximes increasing the dissociation 
temperature. 
1.10.6. Amide Blocking Groups 
Amides react readily with isocyanates 145  and -caprolactam is a commonly 
encountered blocking agent found in powder coating formulations, 146  typically 
dissociating around 130 °C (Scheme 1.26). 
 
Scheme 1.25. Dissociation reaction of urea blocked with -caprolactam. 
Muramatsu et al. found125 that -caprolactam possessed a relatively high dissociation 
temperature when compared to other amides. HDI was blocked with -caprolactam, 
methyl acetamide, succinimide and acetamide. The dissociation temperature 
decreased in that order – 157, 130, 110 and 100 °C, respectively.  
Subramani et al. have developed 147 , 148  a range of water-borne polyurethane 
dispersions that utilise MDI and TDI blocked with a mixture of ε-caprolactam, methyl 
ethyl ketoxime and 3,5-dimethylpyrazole. The formulation recipe of the dispersions 
was modified to achieve a range of curing temperatures from 74 to 200 °C. 
1.10.7. The Effect of Catalysts on Dissociation Temperature 
Since DBDTL is present in Rowanex 1100 1A formulation, it is necessary to consider 
the effect a catalyst has on the dissociation temperature. Blocked isocyanates are 
often used in formulations containing catalysts. It has been found that the presence of 
a catalyst does not affect the dissociation temperature, instead increasing the rate of 
the curing of the formulations and allowing side reactions such as allophonate 
formation to occur.149,150 
1.10.8. Measuring the Dissociation Temperature 
There are a number of techniques used to measure the dissociation temperature. 
VTIR spectroscopy is commonly used.151 The blocked isocyanate is heated until the 
absorbance characteristic of the isocyanate stretching vibration is observed. 
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Thermogravimetric analysis (TGA) has also been used to study the loss of volatile 
blocking groups.152 Differential scanning calorimetry (DSC) measures thermal change 
in the blocked isocyanate as the dissociation occurs. Another method used to 
measure the dissociation temperature involves assessment of the volume of CO2 
evolved from a reaction of the generated isocyanate and water. 153  The blocked 
diisocyanate is heated in saturated solution barium hydroxide. Upon dissociation a 
reaction ensues between isocyanate and water. The subsequent decarboxylation 
leads to a further reaction between CO2 and barium hydroxide to yield insoluble 
barium bicarbonate. However, each technique can accord a different dissociation 
temperature for the same blocked isocyanate.153,154 
1.11. Project Aims 
Microencapsulation offers a route to deliver crosslinkers when desired, providing 
control over the polymerisation process used to bond explosives. This modified 
process shown in Scheme 1.27 prevents undesired crosslinking prior to filling of stores. 
A uniform delivery of crosslinker will also prevent the formation of voids and lead to the 
formation of a homogeneously crosslinked PBX material. The use of 
microencapsulated crosslinkers may allow for the increase in catalyst concentration, 
thus reducing cure times and contributing to an improved quality of curing. 
 
Scheme 1.26. Modified process for the manufacture of PBX highlighting addition of 
microencapsulated crosslinker, introduction to explosive store and formation of a uniformly 
crosslinked rubber matrix following a release mechanism. 
Pre-cure formulation 













The introduction of a new explosive formulation into a store requires a process of 
material and article qualification in order to prove safe function of the system. This is a 
long and expensive process. Thus, a new explosive formulation must not be generated 
and existing formulations such as Rowanex 1100 1A cannot be significantly modified. 
The microcapsules must be composed primarily of polyurethane to match the PBX 
material and the ageing characteristics of the stores must not be affected. In addition, 
high costs are associated with changes to the current mixing and filling process, 
therefore this should not be significantly altered. 
A previous study105 at the University of Reading led to the development of the 
synthesis of microcapsules containing IPDI. The use of ultrasound to effect the release 
of the microcapsule core was demonstrated, however, the extreme local environment 
created by ultrasonic cavitation could cause detonation of the explosive. Triggered 
release of microcapsules using light is not viable since light is unable to penetrate 
deeply into the opaque Rowanex 1100 1A formulation. Thus, a release mechanism 
using exposure to a heat stimulus is the most ideal triggering mechanism. 
The aim of this project can be described by five sub-targets. Firstly, a polymeric linker 
that degrades upon the application of a stimulus of heat was developed. This was 
achieved by exploiting the thermally reversible nature of the oxime-urethane bond. 
Secondly, the incorporation of these linkers into the polymer shell of microcapsules 
has been described and the control of microcapsule properties developed. Thirdly, the 
triggering of thermally-releasable microcapsules has been demonstrated and the 
curing of HTPB was achieved. Microcapsules have also been synthesised that 
incorporate a thermally-reversible Diels-Alder adduct within the shell wall. Finally, the 
use of blocked isocyanates to directly cure HTPB has been investigated. 
1.12. References 
 
1  J. P. Agrawal and R. Hodgson, Organic Chemistry of Explosives, Wiley, 
Chichester, 2007. 
2 S. Fordham, High Explosives and Propellants, Pergamon Press Ltd., Oxford, 1980.  
3 C. S. Peyratout and L. Dähne, Angew. Chem., 2004, 43, 3762-3783. 
4 H. N. Yow and A. F. Routh, Soft Matter, 2006, 2, 940-949. 





6 R. Atkin, P. Davies, J. Hardy and B. Vincent, Macromolecules, 2004, 37, 7979-
7985. 
7 E. Taqieddin and M. Amiji, Biomaterials, 2004, 25, 1937-1945. 
8 V. Araujo, A. Gamboa, N. Caro, L. Abugoch, M. Gotteland, F. Valenzuela, H. A. 
Merchant, A. W. Basit and C. Tapia, J. Pharm. Sci., 2013, 102, 2748-2759. 
9 S. K. Ghosh, Functional Coatings by Polymer Microencapsulation, Wiley, 
Chichester, 2006. 
10 S. N. Rodrigues, I. Fernandes, I. M. Martins, V. G. Mata, F. Barreiro and A. E. 
Rodrigues, Ind. Eng. Chem. Res., 2008, 47, 4142-4147.   
11 B. Peña, C. Panisello, G. Aresté, R. Garcia-Valls and T. Gumí, Chem. Eng. J., 
2012, 179, 394-403.   
12 A. Ahmadi, Asian J. Chem., 2007, 19, 187-194.   
13    S. S. Kuang, J.C. Oliveira and A.M. Crean, Crit. Rev. Food Sci., 2010, 50, 951-968. 
14 Á. Alcázar, A. de Lucas, M. Carmona, J. F. Rodríguez, React. Funct. Polym., 2011, 
71, 891-898. 
15 R. Teixeira and C. S. Nogueira, J. Text. I., 2010, 103, 269-282.   
16  K. Hong and S. Park, Matter. Chem. Phys., 1999, 58, 128-131. 
17  S. Park, Y. Shin and J. Lee, J. Colloid Interf. Sci., 2001, 241, 502-508. 
18  Y. Li, Y. Huang, H. Fan and Q. Xia, J. Appl. Polym. Sci., 2014, 131, 40053. 
19  N. Paret, A. Trachsel, D. L. Berthier and A. Herrmann,  Angew. Chem. Int. Edit., 
2015, 54, 2275-2279. 
20  M. J. Patterson, S. D. R. Galloway and M. A. Nimmo, Exp. Physiol., 2000, 85, 869-
875. 
21  I. Hofmeister, K. Landfester and A. Taden, Macromolecules, 2014, 47, 5768-5773. 
22 F. T. Lee, P. Nicholson, J. Szamosi and W. T. Sommer, Official Gazette of the 
United States Patent and Trademark Office Patents, 2002, 1261. 
23  L. Zhu, Z. H. Wang, S. T. Zhang and X. Y. Long, J. Pestic. Sci., 2010, 35, 339-
343.   
24 J. S. Yang, H. B. Ren and X. J. Xie, Biomacromolecules, 2011, 12, 2982-2987.   
25  A. L. Ilichev, L. L. Stelinski, D. G. Williams and L. J. Gut, J. Encon. Entomol., 2006, 
99, 2048-2054. 





27  P. M. M. Schrooyen, R. van der Meer and C. G. De Kruif, P. Nutr. Soc., 2001, 60, 
475-479. 
28  Y. Wang, Z. X. Lu, H. Wu and F. X. Lv, Int. J. Food Microbiol., 2009, 136, 71-74. 
29  H. Wu, N. Xue, C. L. Hou, J. T. Feng and X Zhang, Food Chem., 2015, 175, 344-
349. 
30  P. C. Naha, V. Kanchan, P. K. Manna and A. K. Panda, J. Microencapsul., 2008, 
25, 248-256.  
31  L. J. de Cock, S. de Koker, B. G. de Geest, J. Grooten, C. Vervaet, J. P. Remon, 
G. B. Sukhurokov and M. N. Antipina. Angew. Chem. Int. Ed., 2010, 49, 6954-
6973. 
32  B. G. de Geest, S. de Koker, G. B. Sukhurokov, O. Kreft, W. J. Parak, A. G. 
Skirach, J. Demeester, S. C. De Smedt and W. E. Hennink, Soft Matter, 2009, 5, 
282-291. 
33  J. Wei, X. J. Ju, X. Y. Zou, R. Xie, W. Wang, Y. M. Liu and L. Y. Chu, Adv. Funct. 
Mater., 2014, 24, 3312-3323. 
34  M. M. Farid, A. M. Khudair, S. A. K. Razack and S. Al-Hallaj, Energ. Convers. 
Manage., 2004, 45, 1597-1615. 
35  Y. P. Zhang, K. P. Lin, R. Yang, H. F. Di and Y. Jiang, Energ. Buildings, 2006, 38, 
1262-1269. 
36  A. Jamekhorsid, S. M. Sadrameli and M. Farid, Renew. Sust. Energ. Rev., 2014, 
31, 531-542.  
37  C. S. N. R. Teixeira, I. M. D. Martins, V. L. G. Mata, M. F. F. Barriero and A. E. 
Rodrigues, J. Text. I., 2012, 103, 269-282. 
38  J. Hu, M. Chen, Z. Xiao and J. Zhang, J. Appl. Polym. Sci., 2015, 132, 41678. 
39  G. Nelson, Int. J. Pharm., 2002, 242, 55-62. 
40  M. I. Re and B. Biscans, Powder Technol., 1999, 101, 120-133. 
41  L. Sanchez-Silva, J. F. Rodriguez, A. Romero and P. Sanchez, J. Appl. Polym. 
Sci., 2012, 124, 4809-4818. 
42  D. R. Cowsar, US Patent, Novel fabric containing microcapsules of chemical 
decontaminants encapsulated within semipermeable polymers, 1980, 4,201,822. 
43 S. R. White, N. R. Sottos, P. H. Geubelle, J. S. Moore, M. R. Kessler, S. R. Sriram, 





44  S. Burattini, B. W. Greenland, D. Chappell, H.M. Colquhoun and W. Hayes, Chem. 
Soc. Rev., 2010, 39, 1973-1985. 
45 B. J. Blaiszik, S. L. B. Kramer, S. C. Olugebefola, J. S. Moore, N. R. Sottos and S. 
R. White, Annu. Rev. Mater. Res., 2010, 40, 179-211. 
46  T. Osswald and G. Menges, Materials Science of Polymers for Engineers, Hanser 
Publishers, Munich, 2003. 
47  L. M. Meng, Y. C. Yuan, M. Z. Rong and M. Q. Zhang, J. Mater. Chem., 2010, 20, 
6030-6038. 
48   E. N. Brown, M. R. Kessler, J. S. Moore, N. R. Sottos and S. R. White, J. 
Microencapsul., 2003, 20, 719-730. 
49  J. L. Yang, M. R. Kessler, J. S. Moore, S. R. White and N. R. Sottos, 
Macromolecules, 2008, 41, 9650-9655. 
50  M. Huang and J. Yang, J.  Mater. Chem., 2011, 21, 11123-11130. 
51   S. H. Cho, H. M. Andersson, S. R. White, N. R. Sottos and P. V. Braun, Adv. 
Mater., 2006, 18, 997-1000. 
52   M. W. Keller, S. R. White and N. R. Sottos, Adv. Funct. Mater., 2007, 17, 2399-
2404. 
53  K. S. Toohey, N. R. Sottos, J. A. Lewis, J. S. Moore and R. S. White, Nat. Mater., 
2007, 6, 581-586. 
54  R. Arshady, Polym. Eng. Sci.,1989, 29, 1746-1758. 
55  P. B. O’Donnell and J. W. McGinty, Adv. Drug Deliver. Rev., 1997, 28, 25-42. 
56 T. M. Chang, Science, 1964, 146, 524-525. 
57 A. Gharsallaoui, G. Roudaut, O. Chambin, A. Voilley and R. Saurel, Food Res. Int.,  
2007, 40, 1107-1121. 
58  A. P. R. Johnston, C. Cortez, A. S. Angelatos and F. Caruso, Curr. Opin. Colloid 
In., 2006, 11, 203-209. 
59 N. Elvassore and A. Bertucco, Ind. Eng. Chem. Res., 2001, 40, 795-800. 
60  Y. Senuma, C. Lowe, Y. Zweifel, J. G. Hilborn and I. Marison, Biotechnol. Bioeng., 
2000, 67, 616-622. 
61  G. T. Vladisavljevic and R. A. Williams, Adv. Colloid Interfac., 2005, 113, 1-20. 
62  M. V. Sefton and W. T. K. Stevenson, Adv. Polym. Sci., 1993, 107, 143-197. 





64  K. Dietrich, H. Herma, R. Nastke, E. Bonatz and W. Teige, Acta Polym., 1989, 40, 
243-251. 
65  R. Arshady and M. H. George, Polym. Eng. Sci., 1993, 33, 865-876. 
66  L. Yuan, G. Liang, J. Q. Xie, L. Li and J. Guo, Polymer, 2006, 47, 5338-5349. 
67  K. Dietrich, E. Bonatz, H. Geistlinger, H. Herma, R. Nastke, H. J. Purz, M. 
Schlawne and W. Teige, Acta Polym., 1989, 40, 325-331. 
68  S. Cosco, V. Ambrogi, P. Musto and C. Carfagna, J. Appl. Polym. Sci., 2007, 105, 
1400-1411. 
69  B. Alic, U. Sebenik and M. Kranjc, J. Appl. Polym. Sci, 2011, 119, 3687-3695.   
70  L. Groenendaal, F. Jonas, D. Freitag, H. Pielartzik and J. R. Reynolds, Adv. Mater., 
2000, 7, 3317-3319.   
71  C. Fan, J. Tang and X. Zhou, J. Appl. Polym. Sci., 2013, 129, 2848-2856. 
72  A. P. Esser-Kahn, S. A. Odom, N. R. Sottos, S. R. White and J. S. Moore, 
Macromolecules, 2011, 44, 5539-5553.   
73  F. Salaün, G. Bedek, E. Devaux, D. Dupont and L. Gengembre, J. Membrane Sci., 
2011, 370, 3-33. 
74  M. Kobašlija and D. T. McQuade, Macromoecules, 2006, 39, 6371-6375. 
75  J. F. Su, L. X. Wang and L. Ren, Colloid. Surface. A, 2007, 299, 268-275. 
76  T. Takahashi, Y. Taguchi and M. Tanaka, J. Appl. Polym. Sci., 2007, 106, 3786-
3791. 
77  W. Chen, X. Liu and D. W. Lee, J. Mater. Sci., 2012, 47, 2040-2044. 
78  M. Sato, J. Org. Chem, 1962, 27, 819-825.   
79  J. Li, A. P. Hitchcock, H. D. H. Stöver and I. Shirley, Macromolecules, 2009, 42, 
2428-2432.   
80  A. Lapprand, F. Boisson, F. Delolme, F. Me´chin and J. P. Pascault, Polym. 
Degrad. Stabil., 2005, 90, 363-373. 
81 S. Lee and D. Randall, The Polyurethanes Book, Wiley, Chichester, 2002. 
82  M. M. Caruso, B. J. Blaisik, H. Jin, S. R. Schelkopf, D. S. Stradley, N. R. Sottos, S. 
R. White and J. S. Moore, ACS Appl. Mater. Interface., 2010, 2, 1195-1199. 
83  Y. Yang, Z. Wei, C. Wang and Z. Tong, ACS Appl. Mater. Interface., 2013, 5, 
2495-2502. 





85  L. M. Dong, J. Z. Shoa, L. Q. Cao, Y. Z. Wu and K. H. Zhang, P. Int. Conf. Adv. 
Text. Mater. Manuf. Technol., 2008, 160-165. 
86 Y. Frère, L. Danicher and P. Gramain, Eur. Polym. J., 1998, 34, 193-199. 
87  K. Dietrich, E. Bonatz, R. Nastke, H. Herma, M. Walter and W. Teige, Acta Polym, 
1990, 41, 91-95.   
88 P. Ni, M. Zhang and N. Yan, J. Membrane. Sci., 1995, 105, 51-55. 
89   R. Heinrich, H. Frensch and K. Albrecht, US Patent, Pressure-resistant 
polyurethane-polyurea particles for the encapsulation of active ingredients and 
process for their manufacture, 1980, 4 230 809. 
90  F. Saluan, E. Devaux, S. Bourbigot and P. Rumeau, C. Eng. J., 2009, 155, 457-
465. 
91  S.  Alexandridou, C. Kiparissides, F. Mange and A. Foissy, J. Microencapsul., 
2001, 18, 767-781. 
92   J. J. Jasper, J. Phys. Chem. Ref. Data, 1972, 1, 841-1009. 
93 T. Ohtsubo, S. Tsuda, and K. Tsuji, Polymer, 1991, 32, 2395-2399. 
94  D. E. Work, R. L. Hart and D. R. Virgallito, US Patent, Method for 
microencapsulating water-soluble or water-dispersible or water-sensitive materials 
in an organic continuous phase, 1999, 5 911 923. 
95  S. Fiori and A. Mariani, Macromolecules, 2003, 36, 2674-2679. 
96   B. S. Kim, H. Y. Jeong and B. K. Kim, Colloid. Surface. A., 2005, 268, 60-67. 
97   K. Hong and S. Park, React. Funct. Polym., 1999, 42, 193-200. 
98   H. Zhang and X. Wang, Sol. Energ. Mater. Sol. C., 2009, 93, 1366-1376. 
99  E. Campos, R. Cordeiro, A. C. Campos, C. Matos and M. H. Gil, Colloid. Surface. 
B., 2011, 88, 477-482. 
100  H. C. Wang, Y. Zhang, C. M. Possanza, S. C. Zimmerman, J. Cheng, J. S. Moore, 
K. Harris and J. S. Katz, ACS Appl. Mater. Interface., 2015, 7, 6369-6382. 
101   M. W. A. Kuijpers, P. D. Iedema, M. F. Kemmere and J. T. F. Keurentjes, Polymer, 
2004, 45, 6461-6467. 
102  J. Chakraborty, J. Sarkar, R. Kumar and G. Madras, Polym. Degrad. Stabil. 2004, 
85, 555-558. 
103   S. P. Vijayalakshmi and G. Madras, Polym. Degrad. Stabil., 2005, 90, 116-122. 





105  M. E. Budd, MSc Thesis, University of Reading, 2013. 
106  S. Thirumalai, M. Mobed-Miremadi and M. Sridar-Keralapura, 33rd Annual 
International Conference of the IEEE EMBS, Boston, Massachusetts USA, August 
2011. 
107  M. R. Böhmer, C. H. T. Chlon, B. I. Raju, C. T. Chin, T. Shevchenko and A. L. 
Klibanov, J. Control. Release, 2010, 148, 18-24. 
108  D. M. El-Sherif, J. D. Lathia, N. T. Le and M. A. Wheatley, J. Biomed. Mater. Res. 
A, 2004, 68, 71-78. 
109  Y. Qui and K. Park, Adv. Drug Delivery Rev., 2001, 53, 321-339. 
110  S. Binauld and M. H. Stenzel, Chem. Commun., 2013, 49, 2082-2102. 
111  M. Bedard, B. de Geest, A. Skirtach, H. Mohwald and G. Sukhorukov, Adv. Colloid 
Interf. Sci., 2010, 158, 2-14.   
112  N. Fomina, C. McFearin, M. Sermsakdi, O. Edigin and A. Almutairi, J. Am. Chem. 
Soc., 2010, 132, 9540-9542.   
113  L. Chu, S. Park, T. Yamaguchi and S. Nakao, Langmuir, 2002, 18, 1856-1864. 
114  K. Eggers, D. Szopinski and G. A. Luinstra, Macromol. Symp., 2014, 346, 32-35. 
115  P. J. Boul, P. Reutenauer and J. M. Lehn, Org. Lett., 2005, 7, 15-18. 
116  S. Yamashita, H. Fukushima, Y. Niidome, T. Mori, Y. Katayama and T. Niidome, 
Langmuir, 2011, 27, 14621-14626. 
117  K. C. Koehler, K. S. Anseth and C. N. Bowman, Biomacromolecules, 2013, 14, 
538-547. 
118  Y. Nakane, M. Ishidoya and T. Endo, J. Polym. Sci. Pol. Chem., 1999, 37, 609-614. 
119  H. Otsuka, H. Fujiwara and T. Endo, J. Polym. Sci. Pol. Chem., 1999, 37, 4478-
4482. 
120  A. Blencowe, A. Clarke, M. G. B. Drew, W. Hayes, A. Slark and P. Woodward, 
React. Funct. Polym., 2006, 66, 1284-1295. 
121  Z. W. Wicks, Prog. Org. Coat., 1981, 9, 3-28. 
122  D. A. Wicks and Z. W. Wicks, Prog. Org. Coat., 1999, 36, 148-172. 






124  W. H. Heath, F. Palmieri. J. R. Adams, B. K. Long, J. Chute, T. W. Holocombe, S. 
Zieren, M. J. Truitt, J. L. White and C. G. Wilson, Macromolecules, 2008, 41 719-
726. 
125  I. Muramatsu, Y. Tanimoto, M. Kase and N. Okoshi, Prog. Org. Coat., 1993, 22, 
279-286. 
126  F. W. C. Lee and K. S. B. Dublin, US Patent, Single package epoxy resin system, 
1985, 4 533 715, 
127  Beitchman and P. J. Zaluzka, US Patent, Isocyanate blocked imidazoles and 
imidazolines for epoxy powder coating, 1982, 4 335 228. 
128  A. Wenning and F. Schmitt, Canadian Patent, Pulverulent compounds, a process 
for their preparation and use, 1998, 2 210 043. 
129  A. Mühlebach, J. Polym. Sci. Pol. Chem., 1994, 32, 753-765. 
130 M. T. Keck, R. J. Lewarchik and J. C. Allman, US Patent, Non-blistering thick film 
coating compositions and method for providing non-blistering thick film coatings on 
metal surfaces, 1997, 5 688 598. 
131  E. Charriere and J. M. Bernard, US Patent, Mixed masked (poly)isocyanates, 2005, 
6 965 007. 
132  P. Ardaud, F. J. Williams, J. M. Bernard and B. Vogin, US Patent, Composition 
which is useful for obtaining a matt or satin coating, use of this composition and 
coating thus obtained, 2003, 6 627 725. 
133  J. Y. Chang, S. K. Do and M. J. Han, Polymer, 2001, 42, 7589-7594. 
134  A. S. Nasar, S. Subramani and G. Radhakrishnan, Polym. Int. 1999, 48, 614-620. 
135  M. Hutchby, C. E. Houlden, J. G. Ford, S. N. G. Tyler, M. R. Gagne, G. C. Lloyd-
Jones and K. I. Booker-Milburn, Angew. Chem. Int. Ed., 2009, 48, 8721-8724. 
136  J. C. Stowell and S. J. Padegimas, J. Org. Chem., 1974, 39, 2448-2449. 
137 H. Ying, Y. Zhang and J. Cheng, Nat. Commun., 2014, 5, 3218-3226. 
138 Z. R. Wicks, Prog. Org. Coat., 1975, 3, 73-99. 
139 M. Gedan-Smolka, L. Häuβler and D. Fischer, Thermochim. Acta, 2000, 351, 95-
105. 
140 A. S. Nasar, V. Shrinivas, T. Shanmugam and A. Raghavan, J. Polym. Sci. Pol. 
Chem., 2004, 42, 4047-4055. 





142 J. S. Witzeman, Prog. Org. Coat., 1996, 27, 269-276. 
143 G. B. Guise, G. N. Freeland and G. C. Smith, J. Appl. Polym. Sci., 1979, 23 353-
365. 
144 H. Kothandaraman and R, Thangavel, J. Polym. Sci. Pol. Chem., 1993, 31, 2653-
2657. 
145 P. F. Wiley, J. Am. Chem. Soc., 1949, 71, 1310-1311. 
146 R. Gras and E. Wolf, German Patent, Blocked isocyanate and isocyanurate -
containing compounds, 1978, 2 712 931. 
147 S. Subramani, Y. J. Park, Y. S. Lee and J. H. Kim, Prog. Org. Coat., 2003, 48, 71-
79. 
148 S. Subramani, I. W. Cheong and J. H. Kim, Prog. Org. Coat., 2004, 51, 329-338. 
149 G. M. Carlson, C. M. Neag, C. Kuo and T. Provder, Polym. Sci. Technol., 1987, 36, 
197. 
150  W. J. Blank, Z. A. He and M. E. Picci, prep. PMSE Div. ACS Mtg., 1998. 
151  G. Sankar and A. S. Nasar, J. Polym. Sci. Pol. Chem. 2007, 45, 1557-1570. 
152  A. S. Nasar, S. Subramani and G. Radhakrishnan, J. Polym. Sci. Pol. Chem., 
1999, 37, 1815-1821. 
153  S. Mohanty and N. Krishnamurti, Eur. Polym. J., 1998, 34, 77-83. 




Design of Thermally-Degradable Polymeric Shell Wall Precursors by Exploiting 
the Thermally Reversible Oxime-Urethane Bond 
The following chapter has, in part, been published by the author as a patent 
application in collaboration with BAE Systems plc. - M. E. Budd, W. C. Hayes, R. 
Stephens, Great British/European Patent Application, ‘Cast Explosive Composition’, 
2015, GB1511876.2/EP15275168.1. 
Abstract 
The release of contents from microcapsules using a thermal stimulus has, to date, 
been limited to either heating above the boiling point of the encapsulated core to bring 
about rupture of the shell or by inducing phase changes of the microcapsule shell to 
reveal a porous structure. An alternative approach is to incorporate thermally-labile 
linkers within the microcapsule polymer shell that dissociate upon the application of 
heat, resulting in the release of the microencapsulated core. Oxime-urethanes are 
labile when exposed to even moderate temperatures and have been employed as 
degradable crosslinking units in polymers. The temperature at which the oxime-
urethane bond breaks has been shown to be affected by the steric hindrance around 
the thermally-labile bond, thus allowing control of the temperature at which 
dissociation occurs. This chapter describes the synthesis of isocyanate-terminated 
shell wall precursors containing thermally-labile oxime-urethane linkages. Furthermore, 
control of the dissociation temperature is demonstrated by modifying the steric 
hindrance around the thermally-labile bond. 
2.1. Introduction 
Release mechanisms for microcapsules operate by responding to external stimuli that 
initiate either chemical or physical changes in the microcapsule shell wall that 
ultimately result in fracture or degradation and thus the desired release of their 
encapsulated active agents.1 Microcapsules that respond to a range of stimuli have 
been developed depending on their target application - pressure, 2  chemical (i.e. 
change in pH or solvent),3,4 light,5 ultrasound6 and exposure to elevated temperature.7 
The contraction of poly(N-isopropylacrylamide) (PNIPAM) when exposed to heat has 
been exploited for the thermal release of microcapsules.7 Upon the application of a 
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thermal stimulus PNIPAM shrinks to cause shell wall rupture or exposure of pores 
within the microcapsule shell wall. 8 , 9  However, to date, the disassembly of 
polyurethane microcapsule shell walls by the application of a heat stimulus has not 
been reported.  
Thermally reversible covalent bonds such as Diels-Alder adducts10 and hindered urea 
bonds11 have been incorporated within the bulk matrix of crosslinked polymers in order 
to generate self-healing and healable materials. 
Oxime-urethane systems are reversible at elevated temperatures, regenerating the 
oxime and isocyanate (Scheme 2.1). These systems are commonly referred to as 
‘blocked isocyanates’ in the adhesives industry and are used frequently to generate 
isocyanate crosslinkers in one pot adhesive formulations upon thermal stimulation.12-19 
 
Scheme 2.1. Thermally reversible oxime-urethane bond regenerating isocyanate and oxime. 
Oxime-urethanes systems have also been employed 20  as thermally degradable 
crosslinks in polymers used for the application of thermally-strippable templates 
employed in the manufacture of microchips. 
2.2. Results and Discussion 
The synthesis of microcapsules that incorporate stimuli-responsive groups within the 
microcapsule shell wall can be achieved using an interfacial polymerisation technique. 
The interfacial polymerisation approach to the synthesis of microcapsules requires the 
generation of an appropriate isocyanate-terminated shell wall precursor. Previous 
studies 21  carried out at the University of Reading identified that toluene-2,4-
diisocyanate (TDI) terminated shell wall precursors possessed the ideal reactive 
properties to synthesise microcapsules. Thus a synthetic route was designed to yield 
an isocyanate-terminated shell wall precursor that contained a thermally-labile oxime-
urethane bond and was capable of further chain extension to form microcapsules. 
The synthesis of shell wall precursors was achieved by initial protection of a hydroxy-
functionalised ketone (2.1a-b) followed by the conversion to the corresponding oxime 
(2.2a-b). The reaction of the generated oxime with a diisocyanate afforded a thermally 
labile oxime-urethane (2.3a-h). Deprotection to reveal the hydroxyl functionality 
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(2.4a-h) then allowed reaction with toluene-2,4-diisocyanate (TDI) to afford an 
isocyanate-terminated shell wall precursor (2.5a-h) (Scheme 2.3). 
 
Scheme 2.2. Synthesis of a thermally-labile oxime-urethane by initial conversion of a ketone 
to the corresponding oxime followed by reaction with an isocyanate. Subsequent deprotection 
to reveal the alcohol moiety allowed reaction with TDI to yield the desired shell wall precursor. 
The mixing temperatures of Rowanex 1100 is typically between 55-70 °C, so ideally, 
the release of the core contents from microcapsules will use an application 
temperature above 70 °C, in order to prevent undesired polymerisation during the 
mixing phase. For safety concerns and in order to avoid additional processing costs 
the release temperature should not exceed 120 °C, well below the ignition temperature 
of RDX (~220 °C), therefore, it was important to design shell wall precursors that 
dissociate within this temperature range. The steric hindrance around the oxime-
urethane has a significant effect on the temperature at which these functional groups 
dissociate.17,18,19 Thus, a library of shell wall precursors that possessed different 
degrees of steric hindrance proximal to the thermally-labile bond were synthesised. 
This was achieved by employing two different oximes, generated from 




Figure 2.1. Structures of protected analogues of 4’-hydroxyacetophenone oxime and 
4-hydroxybenzophenone oxime 
Steric hindrance was further imparted on the oxime-urethane by reaction of each 
oxime with a combination of four different diisocyanates - hexamethylene diisocyanate 
(HDI), m-xylylene diisocyanate (XDI), isophorone diisocyanate (IPDI) and 
m-tetramethylene diisocyanate (TMXDI) (Table 2.1). 
Table 2.1. Structures of hexamethylene diisocyanate (HDI), m-xylylene diisocyanate (XDI), 
isophorone diisocyanate (IPDI) and m-tetramethylxylylene diisocyanate (TMXDI). 
Diisocyanate Structure 
Hexamethylene diisocyanate (HDI) 
 
m-Xylylene diisocyanate (XDI) 
 






2.2.1. Protection of the Hydroxy-Functionalised Ketones 
Phenolic hydroxyls react readily with isocyanates and thus it was necessary to protect 
the hydroxyl moiety of the ketones in order to prevent undesired reactions. Protection 
of both ketones was afforded by reaction with tert-butyldimethylsilyl chloride 
(TBDMSCl) and trimethylamine in the presence of a catalytic quantity of 
4-dimethylaminopyridine (DMAP) yielding the desired products 2.1a/b as white 
coloured crystals following purification by column chromatography (Scheme 2.3). 
 
Scheme 2.3. Synthesis of silyl-protected oximes from 4’-hydroxyacetophenone (2.1a) and 
4-hydroxybenzophenone (2.1b) using TBDMSCl, Et3N and DMAP.  
43 
 
1H NMR spectroscopic analysis of 2.1a revealed the presence of resonances at 0.26 
and 1.01 ppm corresponding to the newly formed silyl protecting group (Figure 2.2). 
The protection of the alcohol moiety was also confirmed using FTIR spectroscopy, 
which revealed the absence of an absorption at ~ 3300 cm-1 characteristic of the OH 
stretching vibration.  
 
Figure 2.2. 1H NMR spectrum of 2.1a synthesised using TBDMSCl and triethylamine in the 
presence of a catalytic quantity of DMAP, highlighting the formed silyl-protecting group. 
2.2.2. Conversion of Protected Ketones to Oximes 
Conversion of 2.1a to an oxime 2.2a required the reaction of the ketone with 
hydroxylamine hydrochloride under reflux in the presence of a molar quantity of 
triethylamine. Workup by washing with H2O afforded the desired oxime without the 
need for further purification (Scheme 2.4).  
 
Scheme 2.4. Conversion of protected ketones to oximes using hydroxylamine hydrochloride in 
the presence of a base. 
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Ketones impart an electron withdrawing effect on a benzene ring - upon the 
conversion to an oxime this electron withdrawing effect is reduced. This affect can be 
observed using 1H NMR spectroscopic analysis, where a change in the chemical shift 
of the resonance corresponding to protons at the ortho-position of the aromatic ring 
move upfield from 7.90 to 7.51 ppm. Further analysis using 13C NMR spectroscopy 
revealed the disappearance of a ketone resonance characteristic of a carbonyl carbon 
at 196.9 ppm and the appearance of a carbon corresponding to C=N-OH functionality 
at 156.8 ppm (Figure 2.3). 
 
Figure 2.3. 13C NMR spectra of 2.1a (above) and 2.2a (below) highlighting the change in the 
resonances upon conversion from a ketone to an oxime. 
The increased steric hindrance on the protected benzophenone 2.1b prevented 
conversion to the oxime using sterically encumbered bases such as triethylamine. 
Thus, reaction could only be achieved by employing smaller bases such as pyridine in 
order to yield the oxime 2.2b. 1H NMR spectroscopic analysis of 2.2b revealed the 
presence of two resonances at 6.77 and 6.90 ppm that corresponded to the aromatic 
protons at the meta-position, suggesting the oxime was obtained as a mixture of E and 
Z isomers. A further pair of resonances at 8.78 and 8.93 were evident that correspond 




Figure 2.4. 1H NMR spectrum of silyl-protected benzophenone oxime 2.2b, highlighting the 
formation of a mixture of E and Z isomers. 
2.2.3. Synthesis of Thermally-Labile Oxime-Urethane 
Oxime-urethanes were obtained by the reaction of an excess oxime and diisocyanate 
in tetrahydrofuran (THF) under reflux for a period of 18-24 hours under an atmosphere 
of argon (Scheme 2.5).  
 
Scheme 2.5. Reaction of an oxime and diisocyanate to yield an oxime urethane that can 
dissociate upon the application of heat. 
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Following purification by column chromatography oxime-urethanes, 2.3a-h, were 
yielded as white crystalline powders. Table 2.2 lists the library of oxime-urethanes 
synthesised by combination of the two oximes and four diisocyanates. 
Table 2.2. List of different oxime-urethanes synthesised from different oximes and 
diisocyanates. 
 Oxime Diisocyanate Yield (%) 
2.3a Acetophenone HDI 88 
2.3b Benzophenone HDI 85 
2.3c Acetophenone XDI 54 
2.3d Benzophenone XDI 95 
2.3e Acetophenone IPDI quant. 
2.3f Benzophenone IPDI 95 
2.3g Acetophenone TMXDI 33 
2.3h Benzophenone TMXDI 75 
The oxime urethanes were characterised by a range of spectroscopic techniques 
including 1H NMR spectroscopy. The presence of a resonance corresponding to the 
urethane NH at 6.49 ppm was observed. In addition, FTIR spectroscopic analysis 
revealed the presence of an absorbance at ~ 1721 cm-1 corresponding to the carbonyl 
functionality of the formed oxime-urethane (Figure 2.5). 
 
Figure 2.5. FTIR spectrum of oxime urethane 2.3a synthesised by reaction of hexamethylene 
diisocyanate and protected acetophenone oxime, highlighting absorbances at 3367, 2929, 















With the exception of 2.3g and 2.3h, all of the oxime-urethanes were obtained in high 
yields without the need for catalysts. As a result of the high steric hindrance of TMXDI, 
long reaction times were required in order to afford the desired oxime-urethane. The 
use of a catalytic quantity of dibutyltin dilaurate (DBTDL) reduced this reaction time to 
48 hours. However, the presence of the catalyst led to the formation of a side product 
that was isolated using column chromatography. 1H NMR spectroscopic analysis of 
the isolated compound revealed that an undesired reaction had occurred which led to 
the cleavage of the silyl-ether protecting group. Integration of resonances at 0.21 and 
0.98 ppm corresponding to the protecting group were exactly half of the desired di-
protected oxime-urethane, 2.3h (Figure 2.6). 
 
Figure 2.6. 1H NMR spectra of di-protected oxime urethane (2.3h) (above) and mono-
protected oxime urethane side product (below). 
2.2.4. Deprotection to Reveal Reactive Phenolic Functionality 
In order to synthesize an isocyanate-terminated shell wall precursor, first, it was 
necessary to remove the silyl protecting group to reveal the hydroxyl functionality. 
Deprotection can be achieved by reaction with HF-pyridine,19 however, it was found 
that deprotection could also be achieved using tetrabutylammonium fluoride (TBAF), 
avoiding high hazards to health associated with HF-pyridine. The deprotected oxime-
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urethanes, 2.4a-h, were obtained as white powders following workup by washing with 
CHCl3 (Scheme 2.6). 
 
Scheme 2.6. Deprotection of silyl-ethers using TBAF to reveal the hydroxyl functionality 
The deprotected oxime-urethane was analysed with a range of techniques including 
1H NMR spectroscopy. Successful deprotection was confirmed as the proton 
resonances at 0.22 and 0.99 ppm that correspond to the silyl protecting group were 
not evident. In addition, FTIR spectroscopic analysis revealed a broad absorption at 
3278 cm-1, characteristic of the hydroxyl functionality (Figure 2.7).  
 
Figure 2.7. 1H NMR spectrum of deprotected oxime-urethane synthesised from HDI and 
acetophenone oxime, highlighting the absence of resonances corresponding to the cleaved 
silyl protecting group. 
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2.2.5. Synthesis of Isocyanate-Terminated Shell Wall Precursors 
The hydroxy end group moieties of the deprotected oxime-urethanes were then 
reacted with an excess of TDI to give isocyanate-terminated shell wall precursors 
bearing a thermally-degradable oxime-urethane 2.5a-h (Scheme 2.7). All shell wall 
precursors exhibited good solubility in common organic solvents with the exception of 
precursors synthesised from XDI which proved to be unsuitable candidates for the 
synthesis of microcapsules. 
 
Scheme 2.7. Synthesis of an isocyanate-terminated shell wall precursors 2.5a-h, achieved by 
the reaction of the hydroxyl functionality of the deprotected oxime-urethane and an excess of 
toluene-2,4-diisocyanate (TDI). 
As a result of the sensitivity of the isocyanate functional group to moisture, 
spectroscopic analysis was only performed on the crude material. The isocyanate 
functionality of the shell wall precursor is central to microcapsule synthesis and the 
stretching vibration of this moiety can be easily observed using FTIR spectroscopy. 
The IR spectrum revealed a strong absorption band at 2264 cm-1 corresponding to the 
isocyanate moiety. Further absorptions at 3287, 1704, 1596, 1502, 1196 and 900 cm-1 
were also observed, correlating of N-H, urethane C=O, C=N, C-N, C-O and N-O 




Figure 2.8. FTIR spectrum of isocyanate terminated shell wall precursor bearing a thermally-
degradable linker (2.5). Highlighting key absorptions at 3287, 2264, 1704, 1596, 1502, 1196 
and 900 cm-1 corresponding to N-H, NCO, urethane C=O, C=N, C-N, C-O and N-O 
functionalities.  
Terminating the deprotected oxime-urethanes with diisocyanate can lead to the 
formation of oligomers via a polymerisation reaction of the hydroxyl compound and 
TDI. Ideally, the formation of oligomers is undesired since increasing the molecular 
weight can result in poor solubility, hindering the formation of the microcapsule shell 
wall. Thus, it was important to measure the molecular weight of the shell wall 
precursor. Mass spectrometry was unable to accurately measure the molecular weight 
of the shell wall precursors. Thus molecular weight determination was achieved by end 
group analysis using titration analysis. 
End group analysis involved reacting the isocyanate functional groups of the shell wall 
precursor with a known excess quantity of ndibutylamine to form a urea. The resultant 
urea/amine mixture was titrated with HCl, using bromophenol blue to indicate the end 
point by a blue to yellow colour change. Comparison of this titre against that of blank 
ndibutylamine solution allowed the calculation of the isocyanate composition of the 
shell wall precursor using Equation 1.1.  
NCO % = [
(VBlank- VSample) x N x 0.0420
Sample Mass
]  x 100                 Equation 1.1 
Where: VBlank = blank titre, VSample = sample titre and N = normality of HCl. 
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The degree of polymerisation can thus be determined by comparison of the observed 
isocyanate composition against the predicted value for the desired shell-wall 
precursors. The synthesised shell wall precursors all possess isocyanate compositions 
close to the predicted values suggesting the synthesis of the desired shell wall 
precursors has been achieved (Table 2.3).  
Table 2.3. List of the isocyanate compositions and the predicted values of the isocyanate-
terminated shell wall precursors 2.5a-h. 





2.5a Acetophenone HDI 10 11 
2.5b Benzophenone HDI 9 9 
2.5e Acetophenone IPDI 10 11 
2.5f Benzophenone IPDI 8 8 
2.5g Acetophenone TMXDI 9 10 
2.5h Benzophenone TMXDI 8 9 
 
2.2.6. The Dissociation of Thermally Labile Linkers 
In order to design microcapsules that release their core contents at specific 
temperatures, it was important to observe the thermal dissociation of the oxime-
urethane linkers. A range of analytical techniques have been used to observe this 
dissociation including - variable temperature infra-red spectroscopy (VTIR), 22 
thermogravimetric analysis (TGA)23 and differential scanning calorimetry (DSC).24  
 
Scheme 2.8. Schematic representing the reversible reaction of oxime-urethanes when 
exposed to heat. 
The dissociation of oxime-urethanes regenerates isocyanate and oxime moieties 
(Scheme 2.8). Isocyanates possess a characteristic stretching vibration observed as a 
absorption at ~ 2250 cm-1 in the IR spectrum. Thus VTIR can be employed as an 
effective analytical tool for the dissociation reaction. Analysis of the protected oxime 
2.3a-h was carried out to avoid any possible interference that could occur resulting 
from reactions of deprotected oxime-urethanes 2.4a-h, or isocyanate-terminated shell 
wall precursors 2.5a-h.  
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2.2.6.1. Variable Temperature Infra-red Spectroscopy 
The oxime-urethanes 2.3a-h were dissolved in dried tetraethylene glycol dimethyl 
ether in a concentration of 3.0 M. This solution was injected into a variable 
temperature IR spectroscopy cell utilising NaCl windows separated by a 0.050 mm 
PTFE spacer. The cell was placed in a variable temperature cell holder and an IR 
spectrum recorded at 10 °C increments with a FTIR spectrometer and the appearance 
of an absorption corresponding to the isocyanate functionality formed upon 
dissociation was observed. 
 
Figure 2.9. Variable-temperature IR spectra of oxime-urethane at 10 °C increments between 
20 and 70 °C, highlighting the appearance of an absorbance corresponding to the isocyanate 
moiety. 
Figure 2.9 displays the VTIR experiment of 2.3h. At 20 °C, an absorbance 
corresponding to the C=O functionality of the oxime-urethane at 1757 cm-1 was 

















the isocyanate moiety appeared at 2263 cm-1. Literature studies quote this value as 
the dissociation temperature.22 Further increasing the temperature led to an increase 
in the intensity of this absorption indicating the dissociation occurred over a broad 
temperature range. 
The onset dissociation of the oxime-urethane linkers are listed in Table 2.4 and the 
results demonstrate how modifying the steric hindrance around the oxime-urethane 
can have a significant effect on the dissociation temperature. Employing sterically 
encumbered isocyanates leads to a significant reduction of the dissociation 
temperature and could allow the tailor of microcapsules designed to release their core 
contents at a specific temperature. Further control of the dissociation has been 
achieved by using a more sterically encumbered oxime, reducing the dissociation 
temperature by an additional 5-20 °C. These results are in agreement with degradation 
data reported in literature studies.22 
Table 2.4. List of dissociation temperatures of different oxime-urethanes 2.3a-h using VTIR 
spectroscopy. 
 Oxime Diisocyanate 
Dissociation 
Temperature (°C) 
2.3a Acetophenone HDI 120 
2.3b Benzophenone HDI 100 
2.3c Acetophenone XDI 110 
2.3d Benzophenone XDI 90 
2.3e Acetophenone IPDI 100 
2.3f Benzophenone IPDI 90 
2.3g Acetophenone TMXDI 70 
2.3h Benzophenone TMXDI 65 
When the temperature reaches 140 °C a further absorption appears at 2383 cm-1 typical 
of an absorption corresponding to carbon dioxide. Although great care was taken to 
remove water from the system - the solvent was dried prior to the experiment, NaCl 
windows were desiccated over phosphorous pentoxide and the experiment was 
performed inside a sealed cell - the observed carbon dioxide may have formed by 
decarboxylation of carbamic acid, resulting from the reaction of generated isocyanate 
and water. The resultant amine then has the capability to react with further isocyanate to 




Scheme 2.9. Reaction of isocyanate and water followed by decarboxylation to generate an amine. 
Further reaction with isocyanates yielding a urea. 
To support this observation, pure TMXDI was heated in the same conditions and a 
similar result was observed. At room temperature an absorption typical of the isocyanate 
vibration was observed at 2271 cm-1 and upon further heating to 140 °C, an absorption 
appeared at 2380 cm-1. Further absorptions at 3420 and 1734 cm-1 correspond to N-H 
and C=O vibrations, respectively, suggest the formation of a urea (Figure 2.10). This may 
prevent the observation of dissociation above 140 °C and thus poses a limitation on VTIR 
spectroscopy as a tool to analyse the dissociation of blocked isocyanates. 
 
Figure 2.10. FTIR spectra of TMXDI at 20 °C and 140 °C, observing the appearance of an 
absorbance at 2380 cm-1 corresponding to evolved carbon dioxide. 
2.2.6.2. Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) has also been used to observe the dissociation 
of blocked isocyanates in literature studies.24, 25  Heat is absorbed as dissociation 
occurs and appears as an endothermic thermal transition. The oxime-urethanes, 
2.3a-h, were heated at a rate of 10 °C/minute under an atmosphere of nitrogen.  
Figure 2.11 shows the DSC trace of 2.3h. An initial endothermic transition is observed 











until a broad endotherm at 141 °C that may correspond to the dissociation of the 
oxime-urethane. Literature studies typically quote the dissociation temperature at this 
point.24 Although VTIR studies observe the onset of dissociation of 2.3h at 70 °C, a 
thermal transition was not observed using DSC at this temperature. It has been 
reported 26  in literature studies that different techniques used to measure the 
dissociation of blocked isocyanates afford different results.27  
 
Figure 2.11. DSC trace of oxime-urethane synthesised from TMXDI and protected 
acetophenone oxime. 
Although a dissociation temperature was obtained for 2.3h, generally DSC proved to 
be an ineffective technique to analyse the dissociation of these oxime-urethanes. The 
dissociation of oxime-urethanes has been reported24 to be a slow process and occurs 
over a large temperature range. As a result, the endothermic transitions observed are 
often very broad, thus assigning a temperature of dissociation is difficult and unreliable.  
2.2.6.3. Thermogravimetric Analysis 
Thermogravimetric analysis can also allow observation of the dissociation of blocked 
isocyanates23 if the temperature reaches or exceeds the boiling point of the reaction 
products. Figure 2.12 shows the TGA trace of 2.3h. The sample was heated at a rate 
of 10 °C/minute under an atmosphere of nitrogen and the dissociation temperature is 
typically quoted at the temperature at which 5 wt% of the sample is lost.24 TGA was 
also performed on the individual oximes 2.2a and 2.2b revealing degradation 




























suggest dissociation arises at 70 °C, no weight change was observed until 177 °C 
leading to almost complete weight loss by 270 °C. It was clear that weight loss of 2.2h 
at 177 °C was caused by the degradation of the released oxime and therefore TGA 
was demonstrated to be an impractical technique for measuring the dissociation of 
these oxime-urethanes. TGA of the oxime-urethanes revealed weight loss at either 
160 °C or 175 °C resulting from the degradation of the generated oximes (Table 2.5). 
 
Figure 2.12. TGA trace of oxime-urethane synthesised from TMXDI and protected 
benzophenone oxime 
Table 2.5. List of degradation temperatures of different oxime-urethanes using TGA 
 Oxime Diisocyanate 
Degradation 
Temperature (°C) 
2.3a Acetophenone HDI 158 
2.3b Benzophenone HDI 170 
2.3c Acetophenone XDI 161 
2.3d Benzophenone XDI 176 
2.3e Acetophenone IPDI 168 
2.3f Benzophenone IPDI 174 
2.3g Acetophenone TMXDI 164 














































This chapter has described the design and synthesis of isocyanate-terminated shell 
wall precursors that possess a thermally-labile oxime-urethane bond and are capable 
of further chain extension to form microcapsules. The synthetic route employed 
involved the initial synthesis of protected hydroxy-functionalised acetophenone and 
benzophenone oximes from the corresponding ketones. Reaction of the oximes with a 
range of diisocyanates - HDI, XDI, IPDI and TMXDI, yielded a library of oxime-
urethanes possessing varying degrees of steric hindrance. Subsequent deprotection of 
these molecules to reveal the phenolic moiety allowed reaction with an excess of 
toluene-2,4-diisocyanate to afford the isocyanate-terminated shell wall precursors. 
VTIR spectroscopic analysis was employed to observe the dissociation of the oxime-
urethane bond, revealing the temperature of dissociation is dependent on the degree 
of steric hindrance around the bond. DSC was demonstrated to be an ineffective tool 
for observing the dissociation and thus could not be used to corroborate the results 
obtained using VTIR spectroscopic analysis. TGA was demonstrated to be unsuitable 
tool for the measurement of the dissociation of oxime-urethanes detecting only the 
degradation of the dissociated oximes. The successful incorporation of thermally-labile 
oxime-urethanes into polyurethane microcapsules is described in Chapter 3. 
2.4. Experimental 
Chemicals. All chemicals and reagents were purchased from Sigma Aldrich with the 
exception of xylylene diisocyanate (XDI) which was purchased from Tokyo Chemicals 
Industry and dibutyltin dilaurate (DBTDL) which was provided by BAE Systems plc. 
Tetrahydrofuran (THF) was distilled from sodium and benzophenone, dichloromethane 
was distilled from CaH2 and tetraethylene glycol dimethylether was vacuum distilled 
from CaH2 (100 °C, 0.1 mmHg). All other chemicals were used as supplied without 
further purification. 
Equipment. 1H and 13C NMR spectra were obtained using a Bruker Nanobay 
400 MHz spectrometer operating at 400 MHz and 100 MHz, respectively, referenced 
to the residual 1H solvent signal either from the deuterated chloroform (CDCl3) used 
(7.26 ppm), tetramethylsilane (TMS), deuterated dimethylsulfoxide (DMSO-d6) used 
(2.50 ppm) or deuterated acetone (acetone-d6) used (2.05 ppm). FTIR spectra were 
obtained using a Perkin Elmer Spectrum 100, using a PE Universal ATR sampling 
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accessory. Mass spectrometry was conducted using a ThermoFisher Scientific 
Orbitrap XL LCMS operating an electrospray ioniser (ESI). VTIR spectroscopy was 
carried out using a Perkin Elmer Spectrum 100 utilising a Specac variable temperature 
cell holder employing a static liquid sample cell. Differential scanning calorimetry (DSC) 
was carried out using a TA Instruments Q2000 calorimeter. Thermogravimetric 
analysis employed a TA instruments Q50 thermogravimetric analyser. 
Silyl-protection of 4’-hydroxyacetophenone 2.1a20 
 
4’-Hydroxyacetophenone (1.00 g, 7.3 mmol), tert-butyldimethylsilylchloride (TBDMSCl) 
(1.22 g, 8.1 mmol), 4-dimethylaminopyridine (DMAP) (0.027 g, 0.2 mmol) and 
triethylamine (0.82 g, 8.1 mmol) were dissolved in dry dichloromethane (20 mL) and 
stirred at room temperature for 18 hours under an atmosphere of argon. The solution 
was washed sequentially with NH4Cl (saturated), H2O, dried over MgSO4, filtered, 
concentrated in vacuo and then purified by column chromatography (Rf = 0.25, 5 % 
EtOAc/hexane) to yield a white crystalline solid 2.1a (1.67 g, 91 %) (m.p. 38-39 °C). 
1H NMR (400 MHz, CDCl3) H (ppm): 0.26 (6H, s, Hd), 1.01 (9H, s, He), 2.57 (3H, s, 
Ha), 6.90 (2H, app. d J = 9.0 Hz, Hc), 7.90 (2H, app. d J = 9.0 Hz, Hb); 
13C NMR (100 
MHz, CDCl3) C (ppm): -4.2, 18.4, 25.8, 26.5, 120.1, 130.7, 131.0, 160.4, 197.1; FTIR 
(ATR) cm-1):2928 (C-H), 2895 (C-H), 2857 (C-H), 1674 (C=O), 1253 (Si-O) 1175 
(C-O); ESIMS calculated mass (C14H22O2Si+H)
+ 251.1462 found 251.1461. 
Silyl-protection of 4-hydroxybenzophenone 2.1b 
 
4-Hydroxybenzophenone (3.59 g, 18.1 mmol), TBDMSCl (3.00 g, 20.0 mmol), DMAP 
(0.073 g, 0.6 mmol) and triethylamine (2.02 g, 20.0 mmol) were dissolved in dry 
dichloromethane (40 mL) and stirred at room temperature for 18 hours under an 
atmosphere of argon. The solution washed sequentially with NH4Cl (saturated), H2O, 
dried over MgSO4 followed by filtration and the solution was concentrated in vacuo and 
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then purified by column chromatography (Rf = 0.25, 5 % EtOAc/hexane) to leave a 
colourless oil 2.1b (5.50 g, 97 %).1H NMR (400 MHz, CDCl3) H (ppm): 0.25 (6H, s, Hf), 
1.00 (9H, s, Hg), 6.90 (2H, app. d J = 9.0 Hz, He), 7.47 (2H, app. t J = 7.0 Hz, Hb), 7.56 
(1H, app. t J = 7.5 Hz, Ha), 7.76 (2H, br. m, Hd) 7.78 (2H, br. m, Hc); 
13C NMR (100 
MHz, CDCl3) C (ppm): -4.3, 18.3, 25.6, 119.7, 128.2, 129.7, 130.7, 131.9, 132.5, 
138.2, 159.9, 195.5; FTIR (ATR) cm-1): 2954 (C-H), 2929 (C-H), 2867 (C-H), 1654 
(C=O stretch), 1263 (Si-O stretch) 1165 (C-O stretch); ESIMS calculated mass 
(C19H23O2Si+H)
+ 313.1618 found 313.1620. 
Conversion of 2.1a to the corresponding oxime 2.2a20 
 
Protected 4’-hydroxyacetophenone 2.1a (1.55 g, 6.2 mmol), hydroxylamine 
hydrochloride (0.47 g, 6.8 mmol) and triethylamine (0.75 g, 7.4 mmol) were dissolved 
in EtOH (20 mL) and maintained under reflux for 18 hours. EtOH was removed in 
vacuo and the resultant solid dissolved in EtOAc, washed with H2O and dried over 
MgSO4 followed by filtration and the solvent removed in vacuo to give a white solid 
2.2a (1.60 g, 98 %) (m.p. 67-71 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.21 (6H, s, 
Hd), 0.98 (9H, s, He), 2.27 (3H, s, Ha), 6.84 (2H, app. d J = 9.0 Hz, Hc), 7.51 (2H, 
app. d J = 9.0 Hz, Hb), 8.82 (1H, br. s, Hf); 
13C NMR (100 MHz, CDCl3) C (ppm): -4.2, 
12.3, 18.4, 25.8, 120.3, 127.5, 129.8, 155.8, 157.0; FTIR (ATR)  cm-1):3239 (O-H), 
2954 (C-H), 2929 (C-H), 2858 (C-H), 1601 (C=N), 1259 (Si-O), 1172 (C-O), 911 (N-O); 
ESIMS calculated mass (C14H23O2NSi+H)
+ 266.1571 found 266.1659. 
Conversion of 2.1b to the corresponding oxime 2.2b 
   
Protected 4’-hydroxybenzophenone 2.1b (1.01 g, 3.2 mmol), hydroxylamine 
hydrochloride (0.245 g, 3.5 mmol) and pyridine (0.278 g, 3.5 mmol) were dissolved in 
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EtOH (40 mL) and maintained under reflux for 24 hours. EtOH was removed in vacuo 
and the resultant solid dissolved in EtOAc and washed sequentially with NH4Cl 
(saturated), H2O and dried over MgSO4 followed by filtration and the solvent removed 
in vacuo to give a white solid 2.2b as a mixture of E/Z isomers (1:1) (0.998 g, 95 %) 
(m.p. 65-67 °C). E-isomer: 1H NMR (400 MHz, CDCl3) H (ppm): 0.19 (6H, s, Hf), 0.97 
(9H, s, Hg), 6.78 (2H, app. d J = 9.0 Hz, He), 7.34 (2H, br. m, Hb), 7.37 (1H, br. m, Ha), 
7.39 (2H, br. m, Hd), 7.41 (2H, br. m, Hc); 8.78 (1H, br. s, Hh); 
13C NMR (100 MHz, 
CDCl3) C (ppm): -4.4,14.2, 18.2, 60.5, 116.9, 125.1, 128.2, 129.3, 131.2, 136.8, 157.1, 
171.2; Z-isomer: 1H NMR (400 MHz, CDCl3) H (ppm): 0.24 (6H, s, Hf’), 1.00 (9H, s, 
Hg’), 6.90 (2H, app. d J = 9.0 Hz, He’), 7.35 (2H, br. m, Hb’)  7.37 (1H, br. m, Ha’), 7.41 
(2H, br. m, Hc’), 7.44 (2H, br. m, Hd’); 8.92 (1H, br. s, Hh’); 
13C NMR (100 MHz, CDCl3) 
C (ppm): -4.3, 21.1, 25.6, 60.5, 119.9, 128.3, 129.0, 129.1, 132.9, 156.4, 157.7, 171.2; 
FTIR (ATR) cm-1): 3251 (O-H), 2954 (C-H), 2928 (C-H), 2857 (C-H), 1601 (C=N), 
1252 (Si-O), 1160 (C-O), 908 (N-O); ESIMS calculated mass (C19H25O2NSi+H)
+ 
328.1727 found 328.1729. 
Synthesis of oxime-urethane 2.3a20 
 
Protected 4’-hydroxyacetophenone oxime 2.2a (1.36 g, 5.1 mmol) and hexamethylene 
diisocyanate (HDI) (0.391 g, 2.3 mmol) were dissolved in dry tetrahydrofuran (THF) 
(20 mL) and maintained under reflux for 18 hours in an argon atmosphere. The solvent 
was removed in vacuo and the crude product purified by column chromatography (Rf = 
0.2, 30 % EtOAc/hexane) to give a white solid 2.3a (1.40 g, 88 %) (m.p. 95-98 °C). 
1H NMR (400 MHz, CDCl3) H (ppm): 0.22 (12H, s, Hb), 0.99 (18H, s, Ha), 1.41 (4H, br. 
m, Hi), 1.61 (4H, br. m, Hh), 2.39 (6H, s, He), 3.33 (4H, q J = 6.5 Hz, Hg), 6.49 (2H, br. 
m, Hf), 6.87 (4H, app. d J = 9.0 Hz, Hc), 7.57 (4H, app. d J = 9.0 Hz, Hd); 
13C NMR 
(100 MHz, CDCl3) C (ppm): -4.4, 14.3, 18.3, 25.6, 26.4, 29.8, 41.0, 120.3, 127.7, 
128.2, 155.8, 158.1, 159.6; FTIR (ATR)  cm-1):3367 (N-H), 2929 (C-H), 2857 (C-H), 
1721 (C=O), 1600 (C=N), 1497 (C-N), 1253 (Si-O), 1172 (C-O), 904 (N-O); ESIMS 
calculated mass (C36H58O6N4Si2+H)
+ 699.3968 found 699.3967. 
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Synthesis of oxime-urethane 2.3b 
 
Protected 4-hydroxybenzophenone oxime 2.2b (0.906 g, 2.8 mmol) and HDI (0.233 g, 
1.38 mmol) were dissolved in dry THF (40 mL) and maintained under reflux for 18 
hours. The solvent was removed in vacuo to leave a yellow oil which was purified by 
column chromatography (Rf 0.26, 30 % EtOAc/hexane) to yield a white solid 2.3b 
(0.960 g, 85 %) (m.p. 61-65°C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.21-0.24 (12H, 
s, Hb), 0.98-1.00 (18H, s, Ha), 1.41 (4H, br. m, Hk), 1.62 (4H, br. m, Hj), 3.32 (4H, q J = 
6.5 Hz, Hi), 6.40 (1H, br. m, Hh), 6.50 (1H, br. m, Hh’), 6.82 (2H, app d J = 9.0 Hz, Hc), 
6.82 (2H, app d J = 9.0 Hz, Hc’), 7.32-7.50 (14H, m, Hdefg); 
13C NMR (100 MHz, CDCl3) 
C (ppm): -4.4, 18.2, 25.6, 26.4, 29.8, 41.1, 119.6, 120.0, 124.5, 127.9, 128.2, 128.4, 
129.1, 129.6, 130.3, 130.5, 131.8, 132.3, 135.8, 155.5, 155.6, 157.3, 158.3, 161.1, 
161.2; FTIR (ATR) cm-1):3350 (N-H), 2929 (C-H), 2857 (C-H), 1722 (C=O), 1602 
(C=N), 1505 (C-N), 1254 (Si-O), 1164 (C-O), 908 (N-O); ESIMS calculated mass 
(C46H62O6N4Si2+H)
+ 823.4281 found 823.4298. 
Synthesis of oxime-urethane 2.3c 
 
Protected 4’-hydroxyacetophenone oxime 2.2a (0.195 g, 0.8 mmol) and xylylene 
diisocyanate (XDI) (0.050 g, 0.3 mmol) were dissolved in THF (10 mL) and maintained 
under reflux for 24 hours. The solvent was removed in vacuo to leave a pale yellow oil 
which was purified by column chromatography (Rf 0.30, 30 % EtOAc/hexane) to give a 
white solid 2.3c (0.104 g, 54 %) (m.p. 48-51 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 
0.21 (12H, s, Hb), 0.98 (18H, s, Ha), 2.39 (6H, s, He), 4.53 (4H, s, Hg), 6.84 (2H, br. m, 
Hf), 6.85 (4H, app. d J = 9.0 Hz, Hc), 7.30 (3H, br. m, Hhi), 7.32 (1H, m, Hj), 7.55 (4H, 
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app. d J = 9.0 Hz, Hd); 
13C NMR (100 MHz, CDCl3) C (ppm): -4.4, 14.4, 18.2, 25.6, 
44.9, 120.3, 126.8, 126.8, 127.6, 128.3, 129.2, 138.7, 155.9, 158.1, 160.0; FTIR (ATR) 
cm-1):3399 (N-H), 2929 (C-H), 2857 (C-H), 1743 (C=O), 1600 (C=N), 1486 (C-N), 
1253 (Si-O), 1171 (C-O), 906 (N-O); ESIMS calculated mass (C38H54O6N4Si2+H)
+ 
719.3655 found 719.3658. 
Synthesis of oxime-urethane 2.3d 
 
Protected 4-hydroxybenzophenone oxime 2.2b (1.65 g, 5.1 mmol) and XDI (0.317 g, 
1.68 mmol) were dissolved in dry THF (40 mL) and maintained under reflux for 18 
hours. The solvent was removed in vacuo to leave a yellow oil which was purified by 
column chromatography (Rf 0.14, 20 % EtOAc/hexane) to yield a white solid 2.3d 
(1.35 g, 95 %) (m.p. 53-56 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.20-0.24 (12H, s, 
Hb), 0.97-1.00 (18H, s, Ha), 4.53 (4H, s, Hi), 6.73 (1H, br. m, Hh), 6.80 (2H, app. d J = 
8.5 Hz, Hc),  6.84 (1H, br. m, Hh’), 6.87 (2H, app. d J = 8.5 Hz, Hc’) 7.29-7.48 (18H, br. 
m, Hdefgjkl); 
13C NMR (100 MHz, CDCl3) C (ppm): -4.4, 18.2, 25.6, 45.0, 119.6, 120.0, 
124.5, 126.9, 127.0, 127.7, 128.3, 128.4, 129.2, 129.9, 130.4, 130.6, 131.8, 132.2, 
135.6, 138.7; FTIR (ATR) cm-1):3412 (N-H), 2929 (C-H), 2857 (C-H), 1727 (C=O), 
1602 (C=N), 1504 (C-N), 1254 (Si-O), 1164 (C-O), 907 (N-O); ESIMS calculated mass 
(C48H58O6N4Si2+Na)











Synthesis of oxime-urethane 2.3e 
 
Protected 4’-hydroxyacetophenone oxime 2.2a (4.44 g, 16.7 mmol) and isophorone 
diisocyanate (IPDI) (1.86 g, 8.4 mmol) were dissolved in THF (40 mL) and maintained 
under reflux for 24 hours. The solvent was removed in vacuo to leave a pale yellow 
solid 2.2e (6.64 g, quant.) (m.p. 63-83 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.22 
(12H, s, Hb), 0.99 (18H, s, Ha), 1.02 (3H, s, Hi), 1.06 (1H, m, Hm), 1.09 (1H, m, Hj), 1.12 
(3H, m, Hh), 1.15 (1H, m, Hk), 1.17 (3H, s, Hi’), 1.28 (1H, m, Hj’), 1.85 (1H, m, Hm’), 1.88 
(1H, m, Hk’), 2.38 (3H, m, He), 2.40 (3H, m, He’), 3.12 (1H, br. m, Hl), 4.00 (2H, br. m, 
Hg), 6.26 (1H, br. m, Hf’), 6.62 (1H, br. m, Hf), 6.87 (2H, app. d J = 6.0 Hz, Hc), 6.89 
(2H, app. d J = 6.0 Hz, Hc’), 7.56 (2H, app. d J = 6.0 Hz, Hd); 7.57 (2H, app. d J = 
6.0 Hz, Hd’); 
13C NMR (100 MHz, CDCl3) C (ppm): -4.4, 14.4, 18.3, 23.3, 32.0, 35.1, 
36.6, 41.7, 44.9, 46.2, 47.3, 55.0, 120.3, 127.7, 128.2, 156.2, 158.7, 159.7; FTIR (ATR) 
cm-1):3408 (N-H), 2929 (C-H), 2857 (C-H), 1722 (C=O), 1601 (C=N), 1504 (C-N), 
1266 (Si-O), 1172 (C-O), 906 (N-O); ESIMS calculated mass (C40H64O6N4Si2+Na)
+ 
775.4236 found 775.4257. 
Synthesis of oxime-urethane 2.3f 
 
Protected 4-hydroxybenzophenone oxime 2.2b (3.60 g, 11.0 mmol) and IPDI (1.22 g, 
5.5 mmol) were dissolved in dry THF (40 mL) and maintained under reflux for 24 hours. 
The solvent was removed in vacuo to leave a yellow oil which was purified by column 
chromatography (Rf 0.18, 20 % EtOAc/hexane) to yield a white solid 2.3f (8.01 g, 95 %) 
(m.p. 57-58 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.21-0.24 (12H, s, Hb), 0.98-
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1.00 (18H, s, Ha), 1.00 (3H, s, Hk), 1.06 (1H, m, Ho), 1.09 (1H, m, Hl), 1.12 (3H, m, Hk’), 
1.12 (3H, m, Hj), 1.17 (1H, m, Hm), 1.31 (1H, m, Hl’), 1.85 (1H, m, Ho’), 1.85 (1H, m, 
Hm’), 3.11 (2H, br. m, Hi), 4.00 (1H, br. m, Hn), 6.51 (1H, br. m, Hh), 6.63 (1H, br. m, 
Hh’), 6.82 (2H, br. m, Hc), 6.88 (2H, br. m, Hc’), 7.31-7.57 (14H, m, Hdefg); 
13C NMR 
(100 MHz, CDCl3) C (ppm): -4.4, 18.2, 32.0, 35.1, 36.6, 41.7, 45.0, 46.3, 47.2, 54.9, 
119.6, 120.0, 127.7,  128.3, 128.5, 129.2, 130.3, 131.8, 156.0, 158.3, 161.2; FTIR 
(ATR) cm-1):3412 (N-H), 2929 (C-H), 2857 (C-H), 1732 (C=O), 1602 (C=N), 1505 
(C-N), 1265 (Si-O), 1163 (C-O), 907 (N-O); ESIMS calculated mass 
(C50H68O6N4Si2+Na)
+ 899.4548 found 899.4570. 
Synthesis of oxime-urethane 2.3g 
 
Protected 4’-hydroxyacetophenone oxime 2.2a (5.0 g, 18.9 mmol), dibutyltin dilaurate 
(DBTDL) (0.505 g, 0.8 mmol) and tetramethylxylylene diisocyanate (TMXDI) (1.54 g, 
6.3 mmol) were dissolved in THF (40 mL) and maintained under reflux for 24 hours. 
The solvent was removed in vacuo to leave a pale yellow oil which was purified by 
column chromatography (Rf 0.19, 20 % EtOAc/hexane) to give a white solid 2.3g 
(1.6 g, 33 %) (m.p. 43-44 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.22 (12H, s, Hb), 
0.99 (18H, s, Ha), 1.78 (12H, s, Hf), 2.36 (6H, s, He), 6.85 (4H, app. d J = 9.0 Hz, Hc), 
6.88 (2H, br. m, Hj), 7.35 (3H, br. m, Hgh), 7.54 (1H, br. m, Hi), 7.56 (4H, app. d J = 
9.0 Hz, Hd); 
13C NMR (100 MHz, CDCl3) C (ppm): -4.4, 14.2, 18.3, 25.6, 29.2, 56.0, 
120.3, 121.2, 123.3, 127.7, 128.1, 128.7, 147.0, 153.5, 158.0, 159.1; FTIR (ATR) 
cm-1):3357 (N-H), 2928 (C-H), 2857 (C-H), 1722 (C=O), 1601 (C=N), 1496 (C-N), 
1254 (Si-O), 1172 (C-O), 905 (N-O); ESIMS calculated mass (C42H62O6N4Si2+H)
+ 






Synthesis of oxime-urethane 2.3h 
 
Protected 4-hydroxybenzophenone oxime 2.2b (3.60 g, 11.0 mmol), DBTDL (0.253 g, 
0.4 mmol) and TMXDI (0.896 g, 3.7 mmol) were dissolved in dry THF (40 mL) and 
maintained under reflux for 72 hours. The solvent was removed in vacuo to leave a 
yellow oil which was purified by column chromatography (Rf = 0.17, 10 % 
EtOAc/hexane) to yield a white solid 2.3h (2.50 g, 75 %) (m.p. 51-57 °C). 1H NMR 
(400 MHz, CDCl3) H (ppm): 0.20-0.24 (12H, s, Hb), 0.97-1.00 (18H, s, Ha), 1.78 (12H, 
s, Hi), 6.74 (1H, br. m, Hh), 6.80 (2H, app. d J = 9.0 Hz, Hc), 6.85 (1H, br. m, Hh’),  6.87 
(2H, app. d J = 9.0 Hz, Hc’), 7.32-7.55 (18H, br. m, Hdefgjkl); 
13C NMR (100 MHz, CDCl3) 
C (ppm): -4.4, 18.2, 25.6, 29.1, 56.1, 119.6, 120.0, 121.3, 123.4, 127.9, 128.2, 128.4, 
128.7, 129.1, 130.2, 131.8, 135.7, 147.0, 153.4, 158.3, 160.8; FTIR (ATR) 
cm-1):3398 (N-H), 2928 (C-H), 2856 (C-H), 1748 (C=O), 1602 (C=N), 1506 (C-N), 
1254 (Si-O), 1163 (C-O), 907 (N-O); ESIMS calculated mass (C52H66O6N4Si2+Na)
+ 
921.4413 found 921.4390. 
Deprotection of silyl-ethers to form 2.4a 
 
Oxime-urethane 2.3a (2.93 g, 4.2 mmol) was dissolved in THF (20 mL) and 
tetrabutylammonium fluoride (TBAF) (1.0 M) (4.2 ml, 4.2 mmol) was added and stirred 
at room temperature for 1 hour. The reaction was quenched with NH4Cl (20 mL) 
(saturated) and the product extracted with EtOAc (50 mL). The organic extract was 
washed with H2O (3 x 50 mL), dried over MgSO4 followed by filtration and the solvent 
removed in vacuo to give a pale yellow solid which was purified by washing 
sequentially with Et2O (3 x 50 mL) and CHCl3 (2 x 50 mL) leaving a white solid that 
degraded before melting 2.4a (1.78 g, 90 %). 1H NMR (400 MHz, DMSO-d6) H (ppm): 
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1.34 (4H, br. m, Hg), 1.53 (4H, br. m, Hf), 2.31 (6H, s, Hc), 3.15 (4H, q J = 6.5 Hz, He), 
6.85 (4H, app. d J = 9.0 Hz, Ha), 7.54 (2H, br. m, Hd), 7.75 (4H, app. d J = 9.0 Hz, Hb), 
9.96 (2H, s, Hh); 
13C NMR (100 MHz, DMSO-d6) C (ppm): 13.21, 26.0, 29.3, 40.4, 
115.2, 125.1, 128.5, 154.9, 158.7, 159.5; FTIR (ATR)  cm-1):3407 (O-H) 3278 (N-H), 
2929 (C-H), 2856 (C-H), 1714 (C=O), 1600 (C=N), 1505 (C-N), 1278 (C-O), 904 (N-O); 
ESIMS calculated mass (C24H30O6N4+Na)
+ 493.2058 found 493.2053. 
Deprotection of silyl-ethers to form 2.4b 
 
Oxime-urethane 2.3b (1.23 g, 1.5 mmol) was dissolved in THF (20 mL) and TBAF 
(1.0 M) (1.5 ml, 1.5 mmol) was added and stirred at room temperature for 1 hour. The 
reaction was quenched with NH4Cl (20 mL) (saturated) and the product extracted with 
EtOAc (50 mL). The organic extract was washed with H2O (3 x 50 mL), dried over 
MgSO4 followed by filtration and the solvent removed in vacuo to give a pale yellow 
solid which was purified by washing sequentially with Et2O (3 x 50 mL) and CHCl3 (2 x 
50 mL) leaving a white solid 2.4b (0.86 g, 96 %) (m.p. 105-108 °C). 1H NMR (400 MHz, 
DMSO-d6) H (ppm): 1.32 (4H, br. m, Hi), 1.51 (4H, br. m, Hh), 3.13 (4H, br. m, Hg), 
6.84 (2H, app. d J = 9.0 Hz, Ha), 6.91 (2H, app. d J = 9.0 Hz, Ha’), 7.59 (2H, br. m, Hf), 
7.22-7.58 (14H, br. m, Hbcde), 9.96 (2H, s, Hj);
 13C NMR (100 MHz, DMSO-d6) C (ppm): 
25.9, 29.2, 40.4, 115.0, 115.3, 122.2, 125.0, 128.3, 128.7, 129.2, 130.0, 130.4, 131.0, 
132.6, 135.3, 154.8, 158.7, 159.9, 160.6; FTIR (ATR) cm-1):3407 (O-H), 3264 (N-H) 
2929 (C-H), 2857 (C-H), 1712 (C=O), 1600 (C=N), 1514 (C-N), 1278 (C-O), 904 (N-O); 
ESIMS calculated mass (C34H34O6N4+Na)








Deprotection of silyl-ethers to form 2.4e 
 
Oxime-urethane 2.3e (3.46 g, 4.6 mmol) was dissolved in THF (20 mL) and TBAF 
(1.0 M) (4.6 ml, 4.6 mmol) was added and stirred at room temperature for 1 hour. The 
reaction was quenched with NH4Cl (20 mL) (saturated) and the product extracted with 
EtOAc (50 mL). The organic extract was washed with H2O (3 x 50 mL), dried over 
MgSO4 followed by filtration and the solvent removed in vacuo to give a pale yellow 
solid which was purified by washing sequentially with Et2O (3 x 50 mL) and CHCl3 (2 x 
50 mL) leaving a white solid 2.4e (2.31 g, 96 %) (m.p. 104-110 °C). 1H NMR (400 MHz, 
DMSO-d6) H (ppm): 0.97 (3H, s, Hg), 1.08 (1H, m, Hh), 1.08 (3H, m, Hf), 1.11 (3H, m, 
Hg’), 1.15 (1H, m, Hk), 1.16 (1H, m, Hi), 1.23 (1H, m, Hh’), 1.47 (1H, m, Hk’), 1.57 (1H, 
m, Hi’), 2.94 (6H, s, Hc), 3.18 (1H, m, Hj), 3.81 (2H, m, He), 6.86 (4H, m, Ha), 7.25 (1H, 
m, Hd), 7.46 (1H, m, Hd’), 7.71 (2H, app. d J = 8.5 Hz, Hb), 7.73 (2H, app. d J = 8.5 Hz, 
Hb’), 9.96 (2H, br. s, Hl); 
13C NMR (100 MHz, DMSO-d6) C (ppm): 23.2, 31.5, 35.0, 
36.5, 40.8, 44.3, 44.4, 45.0, 46.5, 54.1, 115.2, 128.4, 128.5, 154.1, 155.5, 159.0, 159.5; 
FTIR (ATR)  cm-1):3412 (O-H), 3283 (N-H), 2965 (C-H), 2943 (C-H), 1710 (C=O), 
1610 (C=N), 1500 (C-N), 1227 (C-O), 912 (N-O); ESIMS calculated mass 
(C28H36O6N4+Na)
+ 547.2527 found 547.2524. 
Deprotection of silyl-ethers to form 2.4f 
 
Oxime-urethane 2.3f (2.50 g, 2.9 mmol) was dissolved in THF (20 mL) and TBAF 
(1.0 M) (2.9 ml, 2.9 mmol) was added and stirred at room temperature for 1 hour. The 
reaction was quenched with NH4Cl (20 mL) (saturated) and the product extracted with 
EtOAc (50 mL). The organic extract was washed with H2O (3 x 50 mL), dried over 
MgSO4 followed by filtration and the solvent removed in vacuo to give a pale yellow 
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solid which was purified by washing sequentially with Et2O (3 x 50 mL) and CHCl3 (2 x 
50 mL) leaving a white solid 2.4f (1.34 g, 72 %) (m.p. 114-120°C). 1H NMR (400 MHz, 
DMSO-d6) H (ppm): 0.92 (3H, s, Hg), 1.01 (1H, s, Hj), 1.02 (3H, s, Hh), 1.08 (1H, m, 
Hm), 1.15 (1H, m, Hk), 1.16 (3H, m, Hg’), 1.21 (1H, m, Hj’), 1.48 (1H, m, Hm’), 1.52 (1H, 
m, Hk’), 2.91 (2H, m, Hi), 3.77 (1H, m, Hl), 6.81 (2H, br. m, Ha), 6.88 (2H, app. d J = 8.5 
Hz, Ha’), 7.21-7.53 (14H, m, Hbcde), 7.48 (2H, m, Hf), 10.05 (2H, br. s, Hn); 
13C NMR 
(100 MHz, DMSO-d6) C (ppm): 23.3, 27.5, 31.6, 34.5, 35.1, 40.9, 44.5, 45.1, 46.9, 
54.3, 115.6, 128.3, 128.7, 130.0, 130.4, 131.2, 132.3, 155.5, 158.7, 160.1; FTIR (ATR) 
 cm-1):3412 (O-H), 3295 (N-H), 2963 (C-H), 2946 (C-H), 1715 (C=O), 1612 (C=N), 
1500 (C-N), 1226 (C-O), 911 (N-O); ESIMS calculated mass (C38H40O6N4+Na)
+ 
671.2840 found 671.2839. 
Deprotection of silyl-ethers to form 2.4g 
 
Oxime-urethane 2.3g (0.781 g, 1.0 mmol) was dissolved in THF (20 mL) and TBAF 
(1.0 M) (1.0 ml, 1.0 mmol) was added and stirred at room temperature for 1 hour. The 
reaction was quenched with NH4Cl (20 mL) (saturated) and the product extracted with 
EtOAc (50 mL). The organic extract was washed with H2O (3 x 50 mL), dried over 
MgSO4 followed by filtration and the solvent removed in vacuo to give a pale yellow 
solid which was purified by washing sequentially with Et2O (3 x 50 mL) and CHCl3 (2 x 
50 mL) leaving a white solid 2.4g (0.490 g, 90 %) (m.p. 92-100 °C). 1H NMR (400 MHz, 
DMSO-d6) H (ppm): 1.63 (12H, s, He), 2.29 (6H, s, Hc), 6.81 (4H, app. d J = 9.0 Hz, 
Ha), 7.27 (3H, m, Hfg), 7.46 (1H, m, Hh), 7.55 (2H, br. m, Hd), 7.62 (4H, app. d J = 
8.0 Hz, Hb), 9.93 (2H, s, Hi);
 13C NMR (100 MHz, DMSO-d6) C (ppm): 13.2, 43.9, 79.1, 
115.2, 125.0, 125.7, 125.8, 128.2, 128.6, 139.6, 155.2, 159.0, 159.6; FTIR (ATR)  
cm-1):3378 (O-H), 3230 (N-H), 2993 (C-H), 2953 (C-H), 1706 (C=O), 1605 (C=N), 
1499 (C-N), 1238 (C-O), 911 (N-O); ESIMS calculated mass (C30H34O6N4+Na)
+ 




Deprotection of silyl-ethers to form 2.4h 
 
Oxime-urethane 2.3h (1.00 g, 1.1 mmol) was dissolved in THF (20 mL) and TBAF 
(1.0 M) (1.1 ml, 1.1 mmol) was added and stirred at room temperature for 1 hour. The 
reaction was quenched with NH4Cl (20 mL) (saturated) and the product extracted with 
EtOAc (50 mL). The organic extract was washed with H2O (3 x 50 mL), dried over 
MgSO4 followed by filtration and the solvent removed in vacuo to give a pale yellow 
solid which was purified by washing sequentially with Et2O (3 x 50 mL) and CHCl3 (2 x 
50 mL) leaving a white solid 2.4h (0.666 g, 86 %) (m.p. 102-105 °C). 1H NMR 
(400 MHz, DMSO-d6) H (ppm): 1.65 (12H, s, Hg), 6.83 (2H, br. m, Ha), 6.91 (2H, br. m, 
Ha’), 7.19-7.63 (18H, br. m, Hbcdehij), 7.55 (2H, br. m, Hf), 9.83 (2H, s, Hk);
 13C NMR 
(100 MHz, DMSO-d6) C (ppm): 55.2, 115.0, 115.4, 122.3, 127.4, 128.2, 128.4, 128.6, 
129.9, 130.8, 131.2, 147.1, 154.9, 155.1, 159.9, 161.1; FTIR (ATR)  cm-1):3410 
(O-H), 3256 (N-H), 2984 (C-H), 2955 (C-H), 1716 (C=O), 1608 (C=N), 1491 (C-N), 
1231 (C-O), 943 (N-O); ESIMS calculated mass (C40H38O6N4+Na)
+ 693.2684 found 
693.2687. 
Synthesis of shell wall precursor 2.5a 
 
Deprotected oxime-urethane 2.4a (0.620 g, 1.3 mmol) and toluene-2,4-diisocyanate 
(TDI) (0.643 g, 3.7 mmol) were dissolved in cyclohexanone (30 mL) and stirred 80 °C 
under an atmosphere of argon for 18 hours. The solvent was removed by vacuum 
distillation and excess TDI was removed by washing with cyclohexane (3 x 50 mL) at 
80 °C leaving a pale yellow solid that decomposed before melting 2.5a (0.981 g, 92 %). 
1H NMR (400 MHz, DMSO-d6) H (ppm): 1.41 (4H, br. m, Hl), 1.60 (4H, br. m, Hk), 2.28 
(6H, s, Hh), 2.40 (6H, s, Ha), 3.27 (4H, br. m, Hj), 6.75 (4H, app. d J = 9.0 Hz, Hf), 7.29 
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(2H, m, Hb), 7.39 (2H, br. m, Hi), 7.55 (4H, app. d J = 9.0 Hz, Hg), 7.70 (2H, m, Hd), 
7.86 (2H, m, Hc), 8.75 (2H, s, He); 
13C NMR (100 MHz, DMSO-d6) C (ppm): 13.1, 16.7, 
25.7, 29.8, 40.7, 115.3, 115.9, 116.2, 117.0, 122.1, 128.2, 128.6, 133.4, 155.5, 155.6, 
155.7, 159.1, 159.3; FTIR (ATR)  cm-1):3287 (N-H), 2928 (C-H), 2854 (C-H), 2264 
(NCO), 1704 (C=O), 1596 (C=N), 1502 (C-N), 1196 (C-O), 900 (N-O). 
Synthesis of shell wall precursor 2.5b 
 
Deprotected oxime-urethane 2.4b (0.250 g, 0.42 mmol) and TDI (0.205 g, 1.2 mmol) 
were dissolved in THF (30 L) and maintained under reflux for 24 hours. The solvent 
was removed in vacuo and excess TDI was removed by washing with cyclohexane 
(3 x 60 mL) at 80 °C to leave a yellow solid 2.5b (0.447 g, 100 %) (m.p. 98-102 °C). 
1H NMR (400 MHz, Acetone-d6) H (ppm): 1.41 (4H, m, Hn), 1.61 (4H,  m, Hm), 2.27 
(6H, s, Ha), 3.28 (4H, m, Hl), 7.10-7.63 (24H, m, Hbcdfghij), 7.10-7.63 (2H, m, Hk), 8.49 
(2H, s, He); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 17.6, 27.0, 31.9, 41.7, 115.8, 
117.1, 122.6, 122.7, 127.0, 129.3, 129.4, 129.5, 129.8, 130.6, 131.1, 131.8, 132.4, 
133.1, 133.5, 139.9, 153.4; FTIR (ATR)  cm-1):3284 (N-H), 2928 (C-H), 2860 (C-H), 
2262 (NCO), 1721 (C=O), 1593 (C=N), 1501 (C-N), 1194 (C-O), 957(N-O). 
Synthesis of shell wall precursor 2.5e 
 
Deprotected oxime-urethane 2.4e (0.679 g, 1.3 mmol) and TDI (0.631 g, 3.6 mmol) 
were dissolved in THF (30 mL) and maintained under reflux for 24 hours. The solvent 
was removed in vacuo and excess TDI was removed by washing with cyclohexane 
(3 x 60 mL) at 80 °C to leave a yellow solid 2.5e (1.10 g, 98 %) (m.p. 117-121 °C). 
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1H NMR (400 MHz, Acetone-d6) H (ppm): 0.97 (3H, s, Hl), 1.11 (3H, m, Hk), 1.15 (3H, 
m, Hl’), 1.21 (1H, m, Hm),  1.22 (1H, m, Hn), 1.25 (1H, m, Hp), 1.28 (1H, m, Hm’), 1.74 
(1H, m, Hp’), 1.76 (1H, m, Hn’), 2.29-2.37 (6H, s, Ha), 2.40 (6H, s, Hh), 3.09 (1H, m, Ho), 
4.00 (2H, m, Hj), 6.88-7.37 (10H, br. m, Hbcdf), 7.50 (2H, m, Hi), 7.86 (4H, m, Hg), 8.32 
(2H, s, He); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 14.0, 17.6, 27.5, 32.5, 35.5, 
37.6, 42.1, 45.9, 47.8, 55.4, 115.9, 117.1, 122.8, 123.2, 128.9, 131.5, 131.8, 132.4, 
133.2, 138.5, 152.2,  155.0, 156.3, 159.6; FTIR (ATR)  cm-1):3290 (N-H), 2981 
(C-H), 2923 (C-H), 2262 (NCO), 1722 (C=O), 1592 (C=N), 1503 (C-N), 1195 (C-O), 
913 (N-O). 
Synthesis of shell wall precursor 2.5f 
 
Deprotected oxime-urethane 2.4f (0.205 g, 0.3 mmol) and toluene-2,4-diisocyanate 
(0.154 g, 0.9 mmol) were dissolved in THF (30 mL) and maintained under reflux for 
48 hours. The solvent was removed in vacuo and the resultant solid washed with 
cyclohexane (3 x 60 mL) at 80 °C to leave a pale yellow solid 2.5f (0.313 g, 98 %) (m.p. 
135-139 °C). 1H NMR (400 MHz, Acetone-d6) H (ppm): 0.96 (3H, s, Hn), 1.08 (3H, m, 
Hm), 1.12 (3H, m, Hn’), 1.18 (1H, m, Ho),  1.24 (1H, m, Hp), 1.24 (1H, m, Hq), 1.25 (1H, 
m, Ho’), 1.73 (1H, m, Hp’), 1.75 (1H, m, Hq’), 2.05-2.15 (6H, s, Ha), 3.06 (1H, m, Hr), 
3.97 (2H, m, Hl), 6.96-7.37 (24H, m, Hbcdfghij), 6.96-7.37 (2H, m, Hk), 8.32 (2H, s, He); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 13.9, 17.6, 17.7, 20.4, 23.6, 24.4, 26.2, 
27.9, 28.1, 31.0, 115.8, 117.1, 122.7, 127.0, 129.2, 129.4, 129.7, 129.8, 130.5, 131.5, 
131.8,133.1, 139.9, 153.3; FTIR (ATR) cm-1):3298 (N-H), 2925 (C-H), 2266 (NCO), 







Synthesis of shell wall precursor 2.5g 
 
Deprotected oxime-urethane 2.4g (0.603 g, 1.1 mmol) and TDI (0.538 g, 3.1 mmol) 
were dissolved in THF (30 mL) and heated to 50 °C for a period of 24 hours. The 
solvent was removed in vacuo and excess TDI was removed by washing with 
cyclohexane (3 x 60 mL) at 80 °C to leave a yellow solid 2.5g (0.822 g, 84 %) (m.p. 
86-91 °C). 1H NMR (400 MHz, Acetone-d6) H (ppm): 1.78 (12H, s, Hj), 2.27-3.31 (6H, 
s, Ha), 2.89 (6H, s, Hh), 7.13-7.54 (14H, br. m, Hbcdf), 7.71 (2H, s, Hj), 7.94 (4H, app. d 
J = 9.0 Hz, Hg), 8.35 (2H, s, He); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 14.2, 17.7, 
30.6, 61.9, 115.9, 116.8, 117.1, 118.0, 121.5, 124.2, 125.7, 127.1, 128.8, 129.5, 131.5, 
131.7, 133.2, 133.5, 138.3, 147.3, 153.7, 160.9; FTIR (ATR)  cm-1):3357 (N-H), 
2979 (C-H), 2924 (C-H), 2255 (NCO), 1723 (C=O), 1593 (C=N), 1505 (C-N), 1193 
(C-O), 901(N-O). 
Synthesis of shell wall precursor 2.5h 
 
Deprotected oxime-urethane 2.4h (0.560 g, 0.8 mmol) and TDI (0.349 g, 2.0 mmol) 
were dissolved in THF (30 mL) and heated to 60 °C for a period of 24 hours. The 
solvent was removed in vacuo and excess TDI was removed by washing with 
cyclohexane (3 x 60 mL) at 80 °C to leave a yellow solid 2.5h (0.875 g, 100 %) (m.p. 
93-96 °C). 1H NMR (400 MHz, Acetone-d6) H (ppm): 1.44 (12H, s, Hl), 2.26-2.31 (6H, 
s, Ha), 7.12-7.66 (28H, m, Hbcdfghijmno), 7.12-7.66 (2H, m, Hk), 8.19 (2H, s, He); 
13C NMR 
(100 MHz, Acetone-d6) C (ppm): 17.7, 27.5, 116.0, 116.7, 117.2, 118.0, 122.2, 122.6, 
122.8, 123.2, 127.2, 129.3, 129.4, 129.7, 129.8, 130.8, 131.4, 131.7, 133.2, 133.3, 
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139.7, 152.7, 152.8, 153.9, 162.5; FTIR (ATR)  cm-1):3289 (N-H), 2979 (C-H), 2922 
(C-H), 2261 (NCO), 1724 (C=O), 1590 (C=N), 1501 (C-N), 1165 (C-O), 996 (N-O). 
2.5. References 
 
1 S. H. Cho, H. M. Andersson, S. R. White, N. R. Sottos and P. V. Braun, Adv. 
Mater., 2006, 18, 997-1000.Mater., 2006, 18, 997-1000. 
2 T. Ohtsubo, S. Tsuda and K. Tsuji, Polymer, 1991, 32, 2395-2399. 
3 A. P. Esser-Khan, N. R. Sottos, S. R, White and J. S. Moore, J. Am. Chem. Soc., 
2010, 132, 10266-10268.   
4 A. N. Zelikin, J. F. Quinn and F. Caruso, Biomacromolecules, 2006, 7, 27-30.   
5 N. Fomina, C. McFearin, M. Sermsakdi, O. Edigin and A. Almutairi, J. Am. 
Chem. Soc., 2010, 132, 9540-9542.   
6 M. R. Böhmer, C. H. T. Chlon, B. I. Raju, C. T. Chin, T. Shevchenko and A. L. 
Klibanov, J. Control. Release, 2010, 148, 18-24. 
7 L. Chu, S. Park, T. Yamaguchi and S. Nakao, Langmuir, 2002, 18, 1856-1864. 
8 W. Yang, R. Xie, X. Pang, X. Ju and L. Chu, J. Membr. Sci., 2008, 321, 324-330.  
9 Z. Lu, M. D. Prouty, Z. Guo, V. O. Golub, C. S. S. R. Kumar and Y. M. Lvov 
Langmuir, 2005, 21, 2042-2050. 
10 T. A. Plaisted and S. Nermat-Nasser, Acta Materiala, 2007, 55, 5684-5696. 
11 H. Ying, Y. Zhang and J. Cheng, Nat. Commun., 2014, 5, 3218-3226. 
12 A. Blencowe, A. Clarke, M. G. B. Drew, W. Hayes, A. Slark, P. Woodward, React.  
Funct. Polym., 2006, 66, 1284-1295. 
13 Z. W. Wicks, Prog. Org. Coat., 1981, 9, 3-28. 
14 D. A. Wicks and Z. W. Wicks, Prog. Org. Coat., 1999, 36, 148-172. 
15 E. Delebecq, J. P. Pascault, B. Boutevin and F. Ganachaud, Chem. Rev., 2013, 
113, 80-118. 
16 S. Lee and D. Randall, The Polyurethanes Book, Wiley, Chichester, 2002. 
17 I. Muramatsu, Y. Tanimoto, M. Kase and N. Okoshi, Prog. Org. Coat., 1993, 22, 
279-286. 
18 J. S. Witzeman, Prog. Org. Coat., 1996, 27, 269-276. 





20 W. H. Heath, F. Palmieri. J. R. Adams, B. K. Long, J. Chute, T. W. Holocombe, S. 
Zieren, M. J. Truitt, J. L. White and C. G. Wilson, Macromolecules, 2008, 41 719-
726. 
21 M. E. Budd, MSc Thesis, Microencapsulation Approach for Use in Delayed Quick-
Cure Munitions, University of Reading, 2013. 
22 G. Sankar and A. S. Nasar, J. Polym. Sci. Polym. Chem. 2007, 45, 1557-1570. 
23 A. S. Nasar, S. Subramani and G. Radhakrishnan, J. Polym. Sci. Polym. Chem., 
1999, 37, 1815-1821. 
24 T. Shen, M. Lu and L. Liang, Macromol. Res., 2012, 20, 827-834. 
25 J. M. Lee, S. Subramani, Y. S. Lee and J. H. Kim, Macromol. Res., 2005, 13, 427-
434. 
26 H. Kothandaraman and A. S. Nasar, Polymer, 1993, 34, 610-615. 




Synthesis of Thermally-Releasable Microcapsules for the Controlled Delivery of 
Isocyanate Crosslinkers 
The following chapter has, in part, been published by the author as a patent 
application in collaboration with BAE Systems plc. - M. E. Budd, W. C. Hayes, R. 
Stephens, Great British/European Patent Application, ‘Cast Explosive Composition’, 
2015, GB1511876.2/EP15275168.1. 
Abstract 
The current procedure used to bind explosives within polyurethane matrices involves 
the addition of a diisocyanate crosslinker to a mixture of the explosive and hydroxy-
terminated polybutadiene (HTPB). The ensuing polymerisation reaction can prevent 
the uniform distribution of the crosslinker and can lead to several detrimental 
processes that generate an unusable product that must be wasted. By containing IPDI 
within polyurethane microcapsules, the uniform delivery of the crosslinker may be 
achieved. Following an application of a heat stimulus, IPDI can be released from the 
microcapsules thus achieving the uniform cure of HTPB. The following chapter 
describes the synthesis of microcapsules that release their core contents upon the 
application of heat using an interfacial polymerisation technique employing the shell 
wall precursors described in Chapter 2. The capability of these IPDI filled 
microcapsules to achieve the controlled cure of HTPB has been demonstrated. This 
chapter also investigates how the physical properties of microcapsules can be 
controlled in order to tailor microcapsules towards their specific application in the use 
of quick cure munitions.  
3.1. Introduction 
Modern explosives consist of the energetic material bound within a rubbery polymer 
matrix and are known as plastic or polymer bonded explosives (PBX). The current 
method employed to produce PBX matrices involves the addition of a diisocyanate 
crosslinker along with a catalyst to a mixture of the explosive in a hydroxy-
functionalised polymer. One such PBX formulation, Rowanex 1100 1A utilises 
isophorone diisocyanate (IPDI) and hydroxy-terminated polybutadiene (HTPB) in a 
polymerisation catalysed by dibutyltin dilaurate (DBTDL). Upon the addition of IPDI an 
immediate polymerisation reaction occurs and thus the rapidly curing material must be 
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deployed without delay. This can lead to several problems - the cured PBX can be 
inhomogeneous with regions of poor crosslinking density, the quality of the matrix 
varies with consecutively filled stores, the formation of voids that can cause accidental 
detonation of the explosive upon firing and ultimately can lead to wasting of material 
associated with high disposal costs. It is hoped that these problems can be resolved 
by uniformly delivering the IPDI crosslinker in polyurethane microcapsules. This 
modified process must meet specific criteria - the generation of new explosive 
formulations requires requalification, a long and expensive process; thus existing 
explosive formulations must not be significantly altered, microcapsule shells must be 
composed primarily of polyurethane in order to match the PBX material and the 
lifetimes of the stores must not be changed. 
Microcapsules that respond to a range of stimuli have been developed including - 
pressure,1 chemical (i.e. change in pH or solvent),2 light,3 ultrasound4 and exposure to 
elevated temperature.5 Explosive formulations such as Rowanex 1100 1A are opaque 
and thus light is unable to penetrate deeply. The extreme local environment created by 
ultrasonic cavitation may be sufficient to cause detonation of the explosive. Therefore, 
release of microcapsules using an external application of heat is the most favoured 
mechanism. 
Many physical techniques have been developed for the synthesis of microcapsules 
including - suspension crosslinking,6 solvent evaporation,7 coacervation,8 spray 
drying,9 layer-by-layer deposition,10 supercritical fluid expansion11 and the spinning 
disk approach.12 Chemical methods include suspension polymerisation,13 emulsion 
polymerisation,14 interfacial polymerisation15 and dispersion polymerisation.16 Of these 
techniques, interfacial polymerisation and dispersion polymerisation most commonly 
are used to encapsulate liquid active agents.14 Previous studies conducted17 at the 
University of Reading demonstrated how IPDI crosslinkers can be contained in 
polyurethane microcapsules synthesised using an interfacial polymerisation technique. 
This chapter first describes how the isocyanate-terminated shell wall precursors 
containing thermally-labile oxime-urethanes described in Chapter 2 were used to 
synthesise microcapsules. The potential of the afforded microcapsules to release their 
core contents upon the application of a heat stimulus has been investigated. The 
second part of this chapter describes how the physical properties of microcapsules 
can be controlled in order to tailor microcapsules with specific properties. 
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3.2. Results and Discussion 
The microencapsulation of IPDI in polyurethane microcapsules 3.1a-h using an 
interfacial polymerisation approach first requires the synthesis of an appropriate 
isocyanate-terminated shell wall precursor and this has been described in Chapter 2 
(Table 3.1). 

















The synthetic procedure used to generate microcapsules initially involves the 
dissolution of the shell wall precursor and IPDI in a hydrophobic solvent that 
possesses a boiling point >150 °C - this is to prevent evaporation of the core during 
microcapsule synthesis - suitable candidates are chlorobenzene, 1,2-dichlorobenzene, 
1,2,4-trichlorobenzene, phenylacetate and ethyl phenylacetate. All shell wall 
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precursors 2.5a-h exhibited good solubility in either 1,2-dichlorobenzene and ethyl 
phenylacetate. However, upon the addition of IPDI precipitation of 2.5a occurred, thus 
microencapsulation of IPDI could not be achieved using this shell wall precursor. A 
similar problem was encountered for 2.3f, although solubilisation was achieved by the 
addition of anisaldehyde (5 wt. %) (Table 3.2). 











2.5a 3.1a Yes No 
2.5b 3.1b Yes Yes 
2.5e 3.1e Yes Yes 
2.5f 3.1f Yes * Yes 
2.5g 3.1g Yes Yes 
2.5h 3.1h Yes Yes 
* 5 wt. % anisaldehyde added 
Following dissolution of the shell wall precursor and IPDI in a solvent, the organic 
phase was emulsified in water with aid of a surfactant, gum arabic (15 wt. %), and 
mechanical agitation provided by an overhead stirrer driving a three-bladed marine-
type impeller at a rate of 1000 rpm. Subsequent addition of 1,4-butanediol as a chain 
extender allowed polymerisation to occur at the oil-water interface of the emulsion oil 
micro-droplets. The interfacial polymerisation reaction occurs primarily with the 
relatively more reactive aromatic isocyanate-terminated shell wall precursors, leaving 
the majority of the IPDI to be encapsulated.18 
In addition to the alcohol isocyanate polymerisation reaction, a variety of reactions can 
occur at the oil-water interface.19 Water is able to react with the isocyanates to form a 
carbamic acid, subsequent decarboxylation results in the formation of an amine that 
can react with further isocyanate to form a urea. Allophonate and biuret crosslinks are 
also generated from the reactions of isocyanate and urethane and urea, respectively 
(Scheme 3.1). The microcapsules were obtained by filtration followed by washing with 
H2O and were then allowed to dry for a period of 48 hours prior to analysis. 
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The yielded microcapsules were analysed using a range of analytical techniques 
including - optical microscopy, scanning electron microscopy (SEM), 1H NMR 






                        
             
             
             
             
             
             
             
Scheme 3.1. Interfacial polymerisation technique employed for the synthesis of 
microcapsules. 
3.2.1. Optical Microscopic Analysis 
Optical microscopy allows visual confirmation of the successful microencapsulation of 
a liquid core and can also allow the measurement of the microcapsule diameters and 
size distribution.20 Microcapsules synthesised using shell wall precursor 2.5a yielded 
mechanically robust microcapsules that possessed good quality spherical shapes. 
Upon crushing the microcapsules between two microscope slides the release of a 
liquid core was observed. Microencapsulation using 2.5b led to the formation of 
puckered-shaped microcapsules that ruptured with little force. It has been reported21 
that such shapes can be caused by mechanically-weak microcapsule shells and could 
be a result of the sterically encumbered nature of the shell wall precursor, preventing 
the formation of a strong polymer shell. Microencapsulation using 2.5e afforded 
spherical microcapsules - however, they exhibited poor mechanical strength, rupturing 
easily. This result suggests the highly encumbered IPDI-based shell wall precursor 




synthesised using 2.5f revealed that upon crushing between two microscope slides no 
liquid core was released. The reaction of isocyanates and aldehydes at high 
temperatures ~ 200 °C has been reported22 and the presence of anisaldehyde may 
have led to the formation of solid particles rather than the desired mononuclear 
microcapsules. Microcapsules yielded using 2.5g afforded robust spherical 
microcapsules, suggesting that the high steric hindrance of the TMXDI-based shell 
wall precursor did not prevent the formation of strong microcapsules. Synthesis of 
microcapsules using 2.5h generated microcapsules that ruptured during filtration. 
Careful handling allowed capture of microscopic images - however no further analysis 
could be obtained (Figure 3.1). A correlation between the steric hindrance of the shell 
wall precursor and the afforded microcapsules was observed. As a result of high steric 
hindrance, benzophenone oxime-based shell wall precursors 2.5b,f,h prevented the 
formation of robust microcapsules. Further to this, the sterically encumbered IPDI-
based shell wall precursors 2.5e-f also led to microcapsules with poor mechanical 
strength. In comparison, HDI and TMXDI based precursors generated microcapsules 
that exhibited high mechanical strength.  
 
Figure 3.1. Optical microscopic images of microcapsules before crushing between microscope 
slides a) 3.1a, b) 3.1b, c) 3.1e, d) 3.1f, e) 3.1g and f) 3.1h. 
The diameter of microcapsules 3.1a-h was measured using optical microscopy which 
revealed that the microcapsules all possessed a similar average diameter (33-68 m). 
The uniformity of the microcapsule diameter was also measured and it was revealed 





300 m 300 m 300 m 
300 m 300 m 300 m 
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range (Table 3.3). The hydrophobic solvent 1,2-dichlorobenzene was employed in the 
synthesis of 3.1a whereas microcapsules 3.1b-3.1h were afforded using ethyl 
phenylacetate and may have contributed to this result. 








2.5a 3.1a 59 17-302 
2.5b 3.1b 45 9-83 
2.5e 3.1e 42 15-99 
2.5f 3.1f 33 8-75 
2.5g 3.1g 68 22-117 
2.5h 3.1h 35 5-84 
3.2.2. Analysis Using Scanning Electron Microscopy 
Scanning electron microscopy (SEM) allows the high resolution microscopic analysis 
of microcapsules,23 allowing images to be obtained of the exterior and interior 
morphologies of the microcapsule shell wall. The obtained microcapsules were 
prepared for SEM analysis by first sputtering with a layer of gold and imaged using a 
scanning electron microscope in a high vacuum (0.45 torr). Analysis revealed that 
mononuclear microcapsules 3.1a were generated that possessed a smooth exterior 
surface morphology. Images obtained of 3.1b revealed non-spherical microcapsules 
that had a rough surface morphology - literature studies have reported21 that 
microcapsules that contain stimuli-responsive linkages within the shell wall of the 
microcapsule possess such surface morphologies. In addition, the exterior shells of 
3.1e were revealed to be slightly puckered. This may result from the formation of a 
structurally weak microcapsule shell wall and supports the poor mechanical strength 
observed of 3.1b and 3.1e. Microscopic images of the exterior shell of 3.1f discovered 
a rough surface morphology and further analysis of a crushed microcapsule revealed 
the absence of an internal cavity, supporting optical microscopic observations that 
solid particles had been generated and not the desired mononuclear microcapsules. 
SEM analysis of 3.1g observed spherical microcapsules that possessed smooth 
exterior shell walls (Figure 3.2).  
82 
 
   
   
Figure 3.2. Scanning electron microscopic images of microcapsules a) 3.1a, b) 3.1b, c) 3.1e, 
d) 3.1f, e) 3.1g (crushed) and f) 3.1h. 
SEM analysis of cross-sections of microcapsules can allow the measurement of the 
microcapsule shell wall thickness.24 Samples of microcapsules were embedded in an 
epoxy resin and allowed to cure for a period of 48 hours. Cross-sections were 
prepared using an ultramicrotome employing a glass knife and analysed using an 
environmental scanning electron microscope operating in a thin aqueous atmosphere 
(0.68 torr). Figure 3.3 shows an image of a microcapsule cross-section highlighting the 
microcapsule shell wall and lists the average shell wall thickness observed of 
microcapsules 3.1a-3.1g. 
           
Figure 3.3. SEM image of a microcapsule 3.1g cross-section and list of the average shell wall 
thicknesses of microcapsules 3.1a-3.1h. 
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The average shell wall thickness of 3.1a, 3.1b and 3.1g were within 2-4 m, which is 
concurrent with literature results for microcapsules of this size.18 However, the average 
shell wall thickness of microcapsules 3.1e were much larger than expected, the 
sterically encumbered nature of the shell wall precursor 2.5e may have led to the 
formation of a polymeric shell with a low density and may have in turn contributed to 
the poor structural strength of the microcapsules. 
3.2.3. FTIR Spectroscopic Analysis of Microencapsulated Core 
In order to achieve the delivery of isocyanate crosslinkers, the encapsulation of active 
isocyanate was desired. Thus, it was important to confirm the microencapsulation of 
the active isocyanate crosslinker. Isocyanates possess a characteristic stretching 
vibration that appears as an absorption in an IR spectrum at ~ 2250 cm-1. A sample of 
microcapsules was crushed and the released core analysed using FTIR 
spectroscopy.18 
A broad absorption at 2258 cm-1 was observed, corresponding to the isocyanate 
moiety of IPDI, confirming the envelopment of the active isocyanate crosslinker within 
polyurethane microcapsules. A further notable absorption at 1736 cm-1 was observed 
that is likely to correspond to the urethane carbonyl functional group of the 
polyurethane microcapsule shell wall (Figure 3.4). 
  
Figure 3.4. FTIR spectrum of released core of microcapsules 3.1g, highlighting an 








3.2.4. 1H NMR Spectroscopic Analysis of the Microencapsulated Core 
1H NMR spectroscopy is a powerful analytical tool employed in the characterisation of 
organic molecules. Analysis of the microcapsules with this technique provides 
examination of the composition of the microencapsulated core.25 A sample of 
microcapsules was crushed and the released core dissolved in CHCl3 and followed by 
filtration to remove the solid microcapsule shell wall. The obtained 1H NMR spectrum 
of the microcapsule core was compared to individual spectra of IPDI and ethyl 
phenylacetate revealing a clear overlap between the separate isocyanate and solvent 
components and the microcapsule core, corroborating the observation of the 
microencapsulation of IPDI using FTIR spectroscopic analysis (Figure 3.5). 
 
Figure 3.5. 1H NMR spectra of separate components of released core of microcapsules 3.1g - 
ethyl phenylacetate and IPDI. 1H NMR spectra of microencapsulated core with an internal 
standard - methyl 4-nitrobenzoate 
1H NMR spectroscopy can also be used to quantify the microencapsulated core by the 
addition of a known quantity of an internal standard. Methyl 4-nitrobenzoate was 
employed because its spectroscopic resonances did not overlap with the encapsulated 
components. Comparing the integration of the resonances corresponding to the 




IPDI 3.49-3.70 ppm allowed calculation of the composition of the microencapsulated 
core. Microcapsules 3.1a, 3.1e and 3.1g all possessed core compositions within the 
range 49-66 wt. % which is concurrent with literature studies.18 Microcapsules 3.1b, 
however, possessed a relatively low core composition suggesting the core had leaked 
from the microcapsules and leading to the formation of puckered microcapsules 
observed using SEM. As expected, a low core composition was observed in 
microcapsules 3.1f (Table 3.4). 




(wt. % of microcapsule) 
IPDI Composition  
(wt. % of microcapsule) 
3.1a 49 - 
3.1b 14 18 
3.1e 22 36 
3.1f 6 7 
3.1g 27 39 
3.2.5. Thermogravimetric Analysis of the Microencapsulated Core 
Thermogravimetric analysis (TGA) can be used to measure the weight loss of a 
sample upon heating. Thus, literature studies have employed26 TGA to quantify the 
volatile components of the microencapsulated core. A sample of microcapsules was 
crushed prior to analysis and heated at a rate of 10 °C minute-1 under an atmosphere 
of argon (Figure 3.6).  
  
























































Weight loss was observed almost immediately until just below 200 °C, corresponding 
to the loss of 58 wt. % of the sample. A further weight change between 200-250 °C of 
5 wt. % is observed. TGA of the separate components suggests that these weight 
changes are associated with the sequential loss of ethyl phenylacetate followed by 
IPDI - however, the observed weight compositions do not correlate with the data 
derived from 1H NMR spectroscopic analysis. It is possible that ethyl phenylacetate 
and IPDI evolve jointly from the crushed microcapsules and thus a combined weight 
loss of 64 wt. % between 20-250 °C corroborates the core composition results 
observed using 1H NMR spectroscopic analysis (Table 3.5). Further weight loss above 
250 °C likely corresponds to the degradation of the polyurethane microcapsule shell 
wall. 
Table 3.5. List of the core compositions of microcapsules 3.1a-3.1g. 
Microcapsules 
Core Composition 
Using TGA (wt. %) 
Core Composition 
Using 1H NMR (wt. %) 
3.1a 44 49 
3.1b 26 32 
3.1e 41 58 
3.1f 11 13 
3.1g 64 66 
3.2.6. Release of Microencapsulated Core Using a Heat Stimulus 
Microcapsules 3.1a-3.1g have been synthesised using a shell wall precursor that 
possesses a thermally-labile oxime-urethane bond and thus incorporating the labile 
bond within the polymer of the microcapsule shell (Figure 3.7). The potential of these 
microcapsules to release the encapsulated IPDI crosslinker upon the exposure to a 
heat stimulus was investigated. Microcapsules 3.1a-3.1g were heated to 200 °C at a 
rate of 1 °C/minute using a hot stage mounted to an optical microscope utilising a 
digital camera. In conjunction with optical microscopy, microcapsules were analysed 
using SEM after heating (Figure 3.7).  
 






    
    
    
    
   
Figure 3.8. a.i) optical microscopic image of 3.1a at 25 °C, a.ii) SEM image of 3.1a before 
heating, a.iii) optical microscopic image of 3.1a at 135 °C a.iv) SEM image of 3.1a after 
heating to 200 °C, b.i) optical microscopic image of 3.1b at 25 °C, b.ii) SEM image of 3.1b 
before heating, b.iii) optical microscopic image of 3.1b at 150 °C b.iv) SEM image of 3.1b 
after heating to 200 °C, c.i) optical microscopic image of 3.1e at 25 °C, c.ii) SEM image of 
3.1e before heating, c.iii) optical microscopic image of 3.1e at 135 °C, c.iv) SEM image of 
3.1e after heating to 200 °C, d.i) optical microscopic image of 3.1f at 25 °C, d.ii) SEM image 
of 3.1f before heating, d.iii) optical microscopic image of 3.1f at 200 °C d.iv) SEM image of 
3.1f after heating to 200 °C, e.i) optical microscopic image of 3.1g at 25 °C, e.ii) SEM image of 
3.1g before heating, e.iii) optical microscopic image of 3.1g at 150 °C e.iv) SEM image of 






a.i  25 °C 135 °C a.iii  a.ii  a.iv  








b.i  25 °C 150 °C b.iii  b.ii  b.iv  
c.i  25 °C 135 °C c.iii  c.ii  c.iv  
 
300 m 300 m 
d.i  25 °C 200 °C d.iii  d.ii  d.iv  
 
300 m 300 m 
 
300 m 300 m 
e.i  25 °C 150 °C e.iii  e.ii  e.iv  
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Upon heating to 135 °C the microcapsules 3.1a shell wall appeared to dissociate and 
the liquid core was released. Analysis of the microcapsules after heating to 200 °C 
using SEM revealed the absence of spherical-shaped microcapsules, suggesting that 
complete dissociation of the microcapsule shell wall was achieved. Optical 
microscopic images of 3.1b suggested that only partial dissociation was achieved and 
SEM analysis revealed that indeed the majority of the microcapsules had remained 
intact, 3.1b possessed a comparatively low core composition and this may suggest 
that the dissociation of the oxime-urethane linkages may be catalysed by the presence 
of the polar encapsulated solvent in the core. The observed dissociation of 3.1a was 
replicated for 3.1e and 3.1g at 135 °C and 150 °C, respectively. VTIR studies 
described in Chapter 2 suggested that microcapsules containing more sterically 
hindered oxime-urethane linkages in the shell wall would be expected to dissociate 
and release their core contents at a lower temperature. However, this was not 
observed and the high mechanical strength of 3.1g may have prevented the release of 
the core at a lower temperature. As expected, no change to 3.1f was observed upon 
exposure to heat. 
3.2.7. Delayed Cure of HTPB Using Microencapsulated Crosslinkers 
In addition to release studies, the potential of the generated microcapsules for the 
controlled delivery of IPDI in HTPB using an external stimulus of heat was 
investigated. Microcapsules 3.1g were selected for this investigation because of their 
high mechanical strength and thus can withstand shear forces when mixed with HTPB. 
A formulation of HTPB (100 mg), DBTDL (0.24 mg) and 3.1g (23 mg) were mixed 
together in a composition according to Rowanex 1100 1A formulation.  
As a control experiment, ‘control microcapsules’ were synthesised using a shell wall 
precursor that did not possess thermally-labile linkages in the shell wall. This was 
achieved by first synthesising a shell wall precursor using 1,4-butanediol and an 
excess of TDI. Microcapsule synthesis followed an identical method employed in the 
synthesis of 3.1g. The synthesis of this shell wall precursor and microcapsules is 
described in Section 3.4. A second formulation comprised of HTPB (100 mg), DBTDL 
(0.24 mg) and control microcapsules (18 mg) was generated. Both mixtures were 
placed between two films of cellulose acetate and heated to 150 °C for a period of 30 
minutes followed by a further 24 hours at 60 °C. Tensile testing was performed before 
and after heating and revealed that upon exposure to heat an increase in the tensile 
89 
 
strength of both mixtures was observed, suggesting that IPDI had been released from 
both 3.1g and control microcapsules leading to the cure of HTPB (Figure 3.9). The 
permeability of microencapsulated core through the shell wall has been reported27 in 
literature investigations. The application of heat may have accelerated this diffusion 
process and resulted in the cure of HTPB observed in the control microcapsules. This 
characteristic could be exploited as a method of delivery of the microcapsule core. 
  
Figure 3.9. Stress-strain curves of - HTPB and 3.1g before exposure to heat stimulus, HTPB 
and control microcapsules before exposure to heat stimulus, HTPB and 3.1g after exposure to 
heat stimulus, HTPB and control microcapsules after exposure to heat stimulus. 
It was also important to investigate the stability of microcapsules under the mixing 
conditions employed in the production of PBX. Both mixtures along with a third mixture 
comprised of IPDI, HTPB and DBTDL were placed between two films of cellulose 
acetate and heated at 60 °C for a period of 24 hours. Tensile testing after this time 
revealed no curing had occurred from either of the microcapsule mixtures suggesting 























HTPB and 3.1g before heat exposure 
HTPB and control microcapsules before 
heat exposure 
HTPB and 3.1g after heat exposure  
HTPB and control microcapsules after 




Figure 3.10. Stress-strain curves of HTPB and 3.1g, HTPB and control microcapsules and 
HTPB and IPDI after 24 hours at 60 °C. 
3.2.8. Control of the Microcapsule Properties 
Microencapsulation using interfacial polymerisation has many reaction parameters 
associated with the synthetic process,28 including - rate of agitation, type of agitation 
paddle employed, concentration of the core and its composition, shell wall precursor 
concentration, hydrophobic solvent used, chain extender concentration, surfactant 
concentration and type of surfactant, reaction temperature and reaction time. The 
following section describes how modification of these parameters allow control of the 
microcapsule properties - diameter and size distribution, shell wall thickness, amount 
of active crosslinker released29 and the physical strength of microcapsules which are 
in turn dependent on diameter and shell wall thickness1 in order to tailor microcapsules 
with specific physical properties (Figure 3.11). 
 
Figure 3.11. Design of a mononuclear microcapsule showing the microcapsule diameter, 
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Previous studies undertaken17 at the University of Reading investigated the effect of 
the rate of agitation, shell wall precursor concentration and reaction time on the 
microcapsule properties. However, the conditions used in this investigation prevented 
the reproducibility of these results. Thus it was important to investigate the effect of 
these reaction parameters using a developed reproducible synthetic procedure. 
Microcapsules in this section were synthesised using a shell wall precursor previously 
developed17 at University if Reading afforded by termination of 1,4-butanediol with 
toluene-2,4-diisocyanate 3.2 (TDI) (Scheme 3.2). 
 
Scheme 3.2. Synthesis of a shell wall precursor 3.2 by reaction of 1,4-butanediol with toluene-
2,4-diisocyanate. 
3.2.8.1. The Effect of the Rate of Agitation 
The interfacial polymerisation approach to the synthesis of microcapsules employs 
mechanical agitation in order to achieve a stable emulsion.30 Increasing the speed of 
the applied agitation imparts a greater degree of shear force on the emulsion leading 
to the formation of smaller oil droplets. Literature studies have exploited18,31 this 
parameter in order to yield microcapsules with specific diameters. Microcapsules were 
synthesised at 500, 750, 1000, 1250, 1500, 1750 and 2000 rpm employing 
chlorobenzene as the hydrophobic solvent. Other experimental conditions include - 
18 wt. % shell wall precursor concentration, 0.06 M chain extender concentration, 
26 vol. % IPDI concentration, 11.0 wt. % surfactant concentration and a reaction time 




Figure 3.12. The effect of the rate of agitation on the average microcapsule diameter. 
Analysis using optical microscopy revealed a decrease in the average microcapsule 
diameter in an exponential fashion as the agitation rate was increased reaching an 
almost negligible change between 1750-2000 rpm. In addition, a decrease in the size 
distribution was observed in conjunction with the decrease in microcapsule diameter 
(Figure 3.12). 
The minimum microcapsule diameter that could be obtained was ~ 12 m and this 
result is in agreement with literature studies.18 The generation of sub-micron sized 
microcapsules must employ the use of ultrasonic agitation.32 Analysis of the core 
composition of the microcapsules using 1H NMR spectroscopy observed the amount of 
encapsulated IPDI per weight of microcapsules decreased in conjunction with the 
diameter (Table 3.6) and has also been observed in literature investigations.18,31,33 
Table 3.6. The amount of IPDI encapsulated is dependent on the average diameter of the 
generated microcapsules. 
Agitation Rate (rpm) Average Diameter (m) IPDI Composition (wt. %) 
500 393 37.2 
750 140 32.5 
1000 110 29 
1250 52 24.8 
1500 32 24.5 
1750 19 23.2 
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Literature studies have observed18 a decrease in the shell wall thickness as the 
average microcapsule diameter decreased. The shell wall thicknesses of the 
generated microcapsules was investigated by preparing cross-sections using a 
microtome and measured using SEM and indeed a linear relationship between shell 
wall thickness and microcapsule diameter was observed (Figure 3.13). 
   
Figure 3.13. Relationship between shell wall thickness and a) agitation rate b) microcapsule 
diameter. 
3.2.8.2. The Effect of the Surfactant Concentration 
The role of the surfactant in microcapsule synthesis is to aid the formation of a stable 
emulsion, working by reducing the surface tension at the oil-water interface.34,35 
Although only gum arabic has been used in this investigation, literature studies have 
reported a range of surfactants employed in the synthesis of microcapsules.36 Studies 
have also reported31 increasing the surfactant concentration further reduces the 
surface tension at the interface, thus leading to the formation of smaller and more 
uniformly sized oil droplets. Microcapsules were synthesised using a range of different 
concentrations of gum arabic - 5, 10, 15, 20 and 25 wt. % in H2O whilst employing 
chlorobenzene as the hydrophobic solvent and maintaining a constant agitation rate of 
1000 rpm. Other experimental conditions include - 18 wt. % shell wall precursor 
concentration, 0.94 M chain extender concentration, 53 vol. % IPDI concentration, 
reaction time of 165 minutes at 70 °C. The generated microcapsules were measured 
using optical microscopy revealing, as expected, increasing the surfactant 
concentration generated smaller more uniform microcapsules (Figure 3.14). Although 
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< 1 wt. %, reducing the surfactant concentration below 5 wt. % did not lead to the 
formation of microcapsules. Thus the role of the surfactant may go beyond reducing 
the surface tension of the emulsion oil droplets - high concentrations of surfactant 
(> 5 wt. %) may form a hydrophobic layer around the oil-droplet thus preventing the 
undesired hydrolysis of the isocyanate end group whilst allowing the 1,4-butanediol 
chain extender to diffuse through this region and promoting the interfacial 
polymerisation reaction. 
 
Figure 3.14. Graph showing the effect of surfactant concentration on the average diameter 
and size distribution of microcapsules. 
3.2.8.3. The Effect of the Hydrophobic Solvent 
Selection of the hydrophobic solvent used for the synthesis of microcapsules is 
important for several reasons. Organic solvents possess a unique surface tension37 
thus the microcapsule diameter is dependent on the solvent employed. Efficient 
dissolution of the shell wall precursor and a poor solubility of the consequent growing 
shell wall are desired in order to generate mononuclear microcapsules. In addition, 
release of microcapsules using a heat stimulus requires temperatures in excess of 
100 °C - therefore the solvent must have low vapour pressure at the desired release 
temperature in order to prevent the formation of voids in the PBX material. A range of 
microcapsules were synthesised using several different solvents - chlorobenzene, 
1,2-dichlorobenzene, 1,2,4-trichlorobenzene, phenyl acetate and ethyl phenylacetate. 
A rate of agitation of 1000 rpm was used and other reaction conditions include - 
24 wt. % shell wall precursor concentration, 0.94 M chain extender concentration, 































Surfactant Concentration (wt %) 
95 
 
47 vol. % IPDI concentration, 15 wt. % surfactant concentration, reaction time of 
165 minutes at 70 °C. All of the formulations using different solvents generated 
successfully mononuclear microcapsules and the average diameters and core 
compositions were measured using optical microscopy and 1H NMR spectroscopy, 
respectively. A correlation between the surface tension of the hydrophobic solvent 
employed and the diameter of the generated microcapsules was expected, however 
optical microscopic analysis revealed that the microcapsule diameter was independent 
of the hydrophobic solvent. Table 3.7 lists the average diameter of the yielded 
microcapsules demonstrating the dependency of microcapsule diameter on the solvent 
used. In addition, as expected, the composition of the encapsulated core is dependent 
on the solvent employed, with more dense solvents contributing to a higher proportion 
by weight of the microencapsulate core.  
Table 3.7. Average diameter and core composition of microcapsules synthesised using a 














Chlorobenzene 33.5937 51 44 21 
Ethyl phenylacetate 24.9237 38 48 24 
Phenyl acetate 34.9337 44 44 30 
1,2-Dichlorobenzene 36.6137 37 44 33 
1,2,4-Trichlorobenzene 39.1237 128 32 42 
3.2.8.4. The Effect of the Concentration of the Shell Wall Precursor 
The shell wall precursor forms the majority of the polyurethane material of the shell 
wall, thus it is expected that increasing the concentration of the shell wall precursor will 
lead to the formation of thicker shell walls. Microcapsules were synthesised using 
several concentrations of shell wall precursor - 13, 23, 35, 52 and 68 wt. % in 
chlorobenzene. Other reaction conditions employed include - A rate of agitation of 
1000 rpm, 0.06 M chain extender concentration, 26 vol. % IPDI concentration, 
11 wt. % surfactant concentration and a reaction time of 165 minutes at 70 °C. The 
shell wall thickness of the yielded microcapsules was measured using SEM following 
preparation of cross-sections using a microtome. As expected, as the concentration of 
the shell wall was increased thicker shell walls were formed (Figure 3.15). Although 
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only a small increase in the shell wall thickness was observed, this led to a significant 
increase in the microcapsules mechanical strength. 
 
Figure 3.15. Graph showing the effect of the shell wall precursor concentration on the shell 
wall thickness of the generated microcapsules. 
3.2.8.5. The Effect of the Reaction Time 
Literature studies investigating38,16 the synthesis of polyurethane microcapsules 
reported that increasing the reaction time leads to the formation of microcapsules with 
thicker shell walls. It is thought that the formation of the initial shell wall occurs quickly 
and becomes progressively slower as the chain extender must diffuse through the 
increasingly thicker shell wall, therefore increasing the reaction time may allow the 
formation of a thicker shell. To investigate, microcapsules were synthesised at a range 
of reaction times - 45, 75, 105, 135 and 165 minutes employing chlorobenzene as the 
hydrophobic solvent. Other microencapsulation reaction conditions include - agitation 
rate of 1000 rpm, 18 wt. % shell wall concentration, 0.94 M chain extender 
concentration, 53 vol. % IPDI concentration, 15 wt. % surfactant concentration and a 
reaction temperature of 70 °C. Cross-sections of the microcapsules were prepared 
using a microtome and the shell wall thickness of the microcapsules measured using 
SEM. It was revealed that increasing the reaction time from 45-165 minutes only led to 
a small increase in the shell wall thickness (Figure 3.16). However, even this small 
change had a significant effect on the mechanical strength of the microcapsules. 




























Concentration (wt. %) 
97 
 
combination of high concentration of shell wall precursor in conjunction with long 
reaction times. 
 
Figure 3.16. Graph showing that increasing the reaction time leads to the formation of 
microcapsules with thicker shell walls. 
3.2.8.6. Maximising the IPDI Content of Microcapsules 
The microcapsule core is comprised of IPDI and a solvent. Ideally, a maximum IPDI 
encapsulation is desired in order to achieve a high payload of the crosslinker. 
However, Yang et al. observed18 agglomeration when loading of IPDI microcapsules 
exceeded 70 wt. %. In order to investigate the maximum IPDI loading achievable, 
microcapsules were synthesised using a range of concentrations of IPDI - 0, 11, 26, 
42, 53, 63, 79, 89 and 100 vol. % in chlorobenzene as the hydrophobic solvent. Other 
reaction conditions include - an agitation rate of 1000 rpm, 18 wt. % shell wall 
precursor concentration, 0.94 M chain extender concentration, 15 wt. % surfactant 
concentration and a reaction time of 165 minutes at 70 °C.  The core composition of 
the microcapsules was assessed using 1H NMR spectroscopy and this data is 
presented in Figure 3.17. As expected, increasing the concentration of IPDI used in 
the synthesis of microcapsules led to an increase in the IPDI composition of the 
generated microencapsulated core. The agglomeration reported18 by Yang et al. was 
not observed - however, as the composition of IPDI increased the structural integrity of 
the microcapsules became increasingly compromised reaching an extreme case 
where rupture occurred with minimal physical force. Therefore, a careful balance must 






























Reaction Time (minutes) 
98 
 
loss of the physical strength. Analysis of the yielded microcapsules with optical 
microscopy revealed that changing the core composition did not have an effect on the 
microcapsule diameter. However, when a concentration of 100 vol. % IPDI was used, 
larger microcapsules were generated and this is likely to have resulted from a change 
in the density of the hydrophobic phase. 
   
Figure 3.17. Graph showing the amount of IPDI encapsulated increases with the 
concentration of IPDI employed in microcapsule synthesis. Microcapsules were weaker when 
containing >50 wt. % IPDI. 
3.2.8.7. The Effect of the Chain Extender Concentration 
Long storage lifetimes of microcapsules containing IPDI are desired, thus the longevity 
of microcapsules was investigated by measuring the core composition after 4 weeks 
and observing the leaching of IPDI from the core. It was found that a loss of 14 wt. % 
of IPDI was observed after this period of time. Literature investigations have reported39 
that the porosity of microcapsules can be controlled by increasing the concentration of 
the chain extender. Microcapsules were synthesised using a range of concentrations 
of 1,4-butanediol - 0.06, 0.28, 0.65, 0.94 and 1.14 M. Other reaction conditions include 
- an agitation rate of 1000 rpm, 18 wt. % shell wall precursor concentration, 26 vol. % 
IPDI concentration in chlorobenzene, 11 wt. % surfactant concentration and a reaction 
time of 165 minutes at 70 °C. The surface morphology of all the afforded 
microcapsules was analysed using SEM revealing the formation of microcapsules that 
possessed smooth non-porous exterior shells. The leaching of IPDI from these 
microcapsules after a period of 4 weeks at a temperature of 20 °C was investigated by 









































measuring the core composition after this period of time using 1H NMR spectroscopy. 
The loss of IPDI from microcapsules was significantly reduced upon increasing the 
concentration of 1,4-butanediol, this may be attributed to the formation of a denser 
polyurethane shell wall (Figure 3.18). 
  
Figure 3.18. Graph showing the loss of IPDI from microcapsules after a period of 4 weeks 
from microcapsules synthesised using a range of chain extender concentrations. 
3.2.9. Microencapsulation of a Dye 
In order to aid in the study of the release of microcapsules core contents using the 
application of heat it was necessary to synthesise microcapsules containing a dye that 
can be easily quantified. Isocyanates react readily with functional groups such as 
alcohols, amines and carboxylic acids40 typically present within the conjugated 
structure of many organic dyes, thus the apolar -conjugated dye -carotene was 
selected (Figure 3.19).  
 
Figure 3.19. Structure of the apolar -conjugated dye -carotene. 
Microcapsules containing IPDI, chlorobenzene and -carotene were afforded utilising 
the developed interfacial polymerisation technique employing the shell wall precursor 
3.7 at a rate of agitation of 1000 rpm in an aqueous gum arabic (15 wt. %) medium. 
The physical properties of the generated microcapsules were analysed and were all 
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within the expected range - average diameter of 37.2 m within a range of 
10.5-66.4 m. The average microcapsule shell wall thickness was 1.74 m and 
analysis of the encapsulated core revealed a composition of 42 wt. % IPDI and 
27 wt. % chlorobenzene. 
-carotene absorbs UV light (max = 450 nm) and thus the encapsulated dye can be 
quantified using ultraviolet (UV) spectroscopy. A series of standard -carotene 
concentrations were prepared in chloroform and the absorbance intensities measured. 
Plotting this data affords a linear plot of concentration vs. intensity, thus the 
concentration of an unknown solution from the microcapsule core can be determined 
(Figure 3.20). 
 
Figure 3.20. Linear plot of concentration vs. intensity of a known series of standard -carotene 
concentrations. 
Microcapsules containing -carotene (112 mg) were crushed and the released core 
diluted in chloroform by a factor of 500 and a UV-spectrum of this solution was 
recorded (Figure 3.21). The measured absorbance intensity allows calculation of the 
amount of -carotene released from the microcapsules: 14.1 mg g-1 of microcapsules. 
-carotene filled microcapsules were afforded using 40 mg of the dye to yield 1.99 g of 
microcapsules, this equates to a maximum theoretical encapsulation of -carotene of 
21.0 mg g-1 of microcapsules and thus an encapsulation efficiency of the dye was 
calculated 67 %. 
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The permeability of the dye through the microcapsule shell was also studied by 
soaking a sample of microcapsules (112 mg) in chloroform (100 mL) for a period of 
1 hour. The solution was diluted by a factor of 5 and the absorbance intensity 
measured, revealing a small portion of -carotene (10 %) had leaked into the 
chloroform solution. 
 
Figure 3.21. UV spectra of microcapsules before and after crushing and microcapsules 
soaked in chloroform for 1 hour. 
3.3. Conclusion 
IPDI has been contained successfully within polyurethane microcapsules that contain 
thermally-labile oxime-urethane bonds within the polymer of the microcapsule shell 
wall. Spectroscopic analysis of the encapsulated core has confirmed the presence of 
the active isocyanate crosslinker. The mechanical strength of the generated 
microcapsules is dependent on the nature of the shell wall precursor, in particular 
benzophenone oxime and IPDI based shell wall precursor led to the formation of 
structurally weak microcapsules. The successful release of the microencapsulated 
core was demonstrated using heat as the stimulus and the potential of these 
microcapsules to deliver IPDI in order to cure a non-energetic HTPB formulation that is 
analogous to Rowanex 1100 1A was investigated. The physical properties of 
microcapsules can be controlled by modification of the reaction parameters. 
Microcapsule diameter can be controlled by rate of agitation, surfactant concentration 
and selection of the hydrophobic solvent. Microcapsule shell wall thickness can also 
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time. In addition, the maximum amount of IPDI that can be encapsulated has been 
investigated. The permeability of the microcapsule shell wall has been reduced by 
increasing the concentration of the diol chain extender. The encapsulation of a red 
dye, -carotene has been achieved and the generated microcapsules have 
demonstrated how UV spectroscopy can be employed to quantify the microcapsule 
core. This will allow quantification of the release of the core contents of microcapsules 
that respond to a stimulus of heat in future investigations of this microcapsule 
technology. 
3.4. Experimental 
Chemicals. All chemicals and reagents were purchased from Sigma Aldrich with the 
exception of hydroxy-terminated polybutadiene (HTPB) (Mn 2800, Ð 2.5) and dibutyltin 
dilaurate (DBTDL) which was provided by BAE Systems plc. Cyclohexanone was 
purified by vacuum distilling from CaH2 (40 °C, 0.1 mmHg). All other chemicals were 
used as supplied without further purification. 
Equipment. All experimental techniques employed in this chapter are identical to 
those described in Chapter 2 with the exception of the following. Ultraviolet-visible 
spectroscopic analysis was carried out using a Cary 300 Bio UV-vis 
spectrophotometer. Optical microscopy was carried out using a Leica DM2500M 
optical microscope employing a Mettler Toledo FP82HT hot stage and images were 
recorded using an Infinity 1 digital camera. Samples analysed using electron 
microscopy were first coated with a layer of gold using an Edwards Sputter Coater 
S150B and then imaged using an FEI Quanta FEG 600 Environmental Scanning 
Electron Microscope operating under a high vacuum (0.45 torr). SEM images of 
microcapsule cross-sections were obtained by first embedding samples in Agar 100 
epoxy resin and cured at 70 °C for 48 hours. Thin sections were prepared using a 
Reichert-Jung Ultracut microtome employing a glass knife and imaged using an FEI 
Quanta FEG 600 Environmental Scanning Electron Microscope operating in a thin 
aqueous atmosphere (0.68 torr). 
Synthesis of Thermally-Releasable Microcapsules 
The general procedure described below describes the synthesis of polyurethane 
microcapsules that contain a thermally-labile oxime-urethane bond in the shell wall of 
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the microcapsule. A list of microcapsules synthesised using 3.1a-3.1h is detailed in 
Table 3.8. 
Gum arabic (9 g) was dispersed in H2O (60 mL) in a 150 mL beaker with the aid of 
mechanical agitation at a rate of 1000 rpm. Shell wall precursor 2.5b (0.104 g, 
0.11 mmol) and IPDI (0.12 g, 0.54 mmol) were dissolved in ethyl phenylacetate 
(0.14 mL). This solution was added to the aqueous solution and the resultant emulsion 
heated to 70 °C at a rate of 10 °C/minute. When the temperature reached 50 °C, 
1,4-butanediol (5.2 g, 56.6 mmol) was added and agitated at the same rate for an 
additional 30 seconds. Agitation was reduced to a rate of 150 rpm for 45 minutes at 
70 °C followed by a further 2 hours at room temperature. After this period, agitation 
was ceased, H2O (100 mL) was added and the generated microcapsules allowed to 
settle at the bottom of the beaker over a period of 1 hour at room temperature. The 
aqueous solution was decanted to leave polyurethane microcapsules 3.1b that were 
collected by vacuum filtration, washed with H2O and then air dried for a period of 48 
hours (0.153 g). FTIR (ATR)  (cm-1): 3368 (N-H), 2256 (NCO), 1734 (C=O), 1540 
(C-N), 1034 (C-O). 






















































Synthesis of Shell Wall Precursor 3.217 
 
Toluene-2,4-diisocyanate (6.07 g, 35 mmol) was dissolved in cyclohexanone (19 mL). 
1,4-Butanediol (9.15 g, 10 mmol) was added and the solution stirred for a period of 
18 hours at 80 °C under argon. Cyclohexanone and excess toluene-2,4-diisocyanate 
were then removed by vacuum distillation (120 °C, 1 mmHg) over a period of 4 hours 
to leave a viscous dark yellow oil 3.2 (4.24 g, 97 %). 1H NMR (400 MHz, CDCl3) H 
(ppm): 1.79 (4H, m, Hg), 2.30 (6H, s, Ha), 4.22 (4H, m, Hf), 7.01 (2H, app. d J = 9.0 Hz, 
Hb), 7.09 (2H, app. dd J = 8.0, 2.0 Hz, Hc), 7.23 (2H, app d J = 2.0 Hz, Hd); 
13C NMR 
(100 MHz, CDCl3) C (ppm): 17.6, 26.4, 65.1, 115.5, 116.8, 127.5, 131.6, 133.3, 139.3, 
154.5, 206.2; FTIR (ATR)  (cm-1): 3304 (N-H), 2955 (C-H), 2256 (NCO), 1701 (C=O), 
1518 (C-N), 1062 (C-O); ESIMS of 3.2 derivative from its reaction with methylamine, 
calculated mass (C24H33O6N6)
+ 501.2456 found 501.2452. 
Microencapsulation of Isophorone Diisocyanate 
The general procedure described below describes the synthesis of polyurethane 
microcapsules containing IPDI. A list of microcapsules synthesised using different 
reaction conditions is detailed in Table 3.9. 
Gum arabic (9 g) was dispersed in H2O (60 mL) in a 150 mL beaker with the aid of 
mechanical agitation at a rate of 1000 rpm. Shell wall precursor 3.2 (1.90 g, 4.3 mmol) 
and IPDI (5.5 g, 24.7 mmol) were dissolved in chlorobenzene (5.5 mL). This solution 
was added to the aqueous solution and the resultant emulsion heated to 70 °C at a 
rate of 10 °C/minute. When the temperature reached 50 °C, 1,4-butanediol (5.2 g, 
56.6 mmol) was added and agitated at the same rate for an additional 30 seconds. 
Agitation was reduced to a rate of 150 rpm for 45 minutes at 70 °C followed by a 
further 2 hours at room temperature. After this period, agitation was ceased, H2O 
(100 mL) was added and the generated microcapsules allowed to settle at the bottom 
of the beaker over a period of 1 hour at room temperature. The aqueous solution was 
decanted to leave polyurethane microcapsules that were collected by vacuum 
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filtration, washed with H2O and then air dried for a period of 48 hours (9.80 g). FTIR 
(ATR)  (cm-1): 3312 (N-H), 2256 (NCO), 1701 (C=O), 1518 (C-N), 1062 (C-O). 
Microencapsulation of -carotene and Isophorone Diisocyanate 
Gum arabic (9 g) was dispersed in H2O (60 mL) in a 150 mL beaker with the aid of 
mechanical agitation at a rate of 1000 rpm. Shell wall precursor 3.2 (0.350 g, 
0.8 mmol), IPDI (1.10 g, 4.9 mmol) and -carotene (0.040 g, 0.07 mmol) were 
dissolved in chlorobenzene (0.9 mL). This solution was added to the aqueous solution 
and the resultant emulsion heated to 70 °C at a rate of 10 °C/minute. When the 
temperature reached 50 °C, 1,4-butanediol (5.2 g, 56.6 mmol) was added and agitated 
at the same rate for an additional 30 seconds. Agitation was reduced to a rate of 
150 rpm for 45 minutes at 70 °C followed by a further 2 hours at room temperature. 
After this period, agitation was ceased, H2O (100 mL) was added and the generated 
microcapsules allowed to settle at the bottom of the beaker over a period of 1 hour at 
room temperature. The aqueous solution was decanted to leave polyurethane 
microcapsules that were collected by vacuum filtration, washed with H2O and then air 
dried for a period of 48 hours (1.99 g). FTIR (ATR)  (cm-1): 3302 (N-H), 2252 (NCO), 
1704 (C=O), 1530 (C-N), 1067 (C-O). 
 
 























500 18.0 0.06 Chlorobenzene 26 11.0 70 165 
750 18.0 0.06 Chlorobenzene 26 11.0 70 165 
1000 18.0 0.06 Chlorobenzene 26 11.0 70 165 
1250 18.0 0.06 Chlorobenzene 26 11.0 70 165 
1500 18.0 0.06 Chlorobenzene 26 11.0 70 165 
1750 18.0 0.06 Chlorobenzene 26 11.0 70 165 
2000 18.0 0.06 Chlorobenzene 26 11.0 70 165 
1000 13.0 0.06 Chlorobenzene 26 11.0 70 165 
1000 28.0 0.06 Chlorobenzene 26 11.0 70 165 
1000 35.0 0.06 Chlorobenzene 26 11.0 70 165 
1000 52.0 0.06 Chlorobenzene 26 11.0 70 165 
1000 68.0 0.06 Chlorobenzene 26 11.0 70 165 
1000 18.0 0.28 Chlorobenzene 26 11.0 70 165 
1000 18.0 0.65 Chlorobenzene 26 11.0 70 165 
1000 18.0 0.94 Chlorobenzene 26 11.0 70 165 
1000 18.0 1.14 Chlorobenzene 26 11.0 70 165 
1000 24.0 0.94 Dichlorobenzene 47 15.0 70 165 





























1000 24.0 0.94 Phenyl acetate 47 15.0 70 165 
1000 24.0 0.94 Ethyl phenylacetate 47 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 0.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 11.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 26.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 42.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 53.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 63.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 79.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 89.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 100.0 15.0 70 165 
1000 18.0 0.94 Chlorobenzene 53 5.0 70 165 
1000 18.0 0.94 Chlorobenzene 53 10.0 70 165 
1000 18.0 0.94 Chlorobenzene 53 20.0 70 165 
1000 18.0 0.94 Chlorobenzene 53 25.0 70 165 
1000 18.0 0.94 Chlorobenzene 53 15.0 70 45 
1000 18.0 0.94 Chlorobenzene 53 15.0 70 75 
1000 18.0 0.94 Chlorobenzene 53 15.0 70 105 









1 T. Ohtsubo, S. Tsuda and K. Tsuji, Polymer, 1991, 32, 2395-2399. 
2 A. N. Zelikin, J. F. Quinn and F. Caruso, Biomacromolecules, 2006, 7, 27-30.   
3 N. Fomina, C. McFearin, M. Sermsakdi, O. Edigin and A. Almutairi, J. Am. Chem. 
Soc., 2010, 132, 9540-9542.   
4 M. R. Böhmer, C. H. T. Chlon, B. I. Raju, C. T. Chin, T. Shevchenko and A. L. 
Klibanov, J. Control. Release, 2010, 148, 18-24. 
5 L. Chu, S. Park, T. Yamaguchi and S. Nakao, Langmuir, 2002, 18, 1856-1864. 
6  R. Arshady, Polym. Eng. Sci.,1989, 29, 1746-1758. 
7  P. B. O’Donnell and J. W. McGinty, Adv. Drug Deliver. Rev., 1997, 28, 25-42. 
8 T. M. Chang, Science, 1964, 146, 524-525. 
9  A. Gharsallaoui, G. Roudaut, O. Chambin, A. Voilley and R. Saurel, Food Res. 
 Int., 2007, 40, 1107-1121. 
10  A. P. R. Johnston, C. Cortez, A. S. Angelatos and F. Caruso, Curr. Opin. Colloid 
In., 2006, 11, 203-209. 
11 N. Elvassore and A. Bertucco, Ind. Eng. Chem. Res., 2001, 40, 795-800. 
12  Y. Senuma, C. Lowe, Y. Zweifel, J. G. Hilborn and I. Marison, Biotechnol. Bioeng., 
2000, 67, 616-622. 
13  G. T. Vladisavljević and R. A. Williams, Adv. Colloid Interface Sci., 2005, 113, 
1-20. 
14  M. V. Sefton and W. T. K. Stevenson, Adv. Polym. Sci., 1993, 107, 143-197. 
15  P. Rambourg, J. Lévy and M. C. Lévy, J. Pharm. Sci., 1982, 71, 753-758. 
16  K. Dietrich, H. Herma, R. Nastke, E. Bonatz and W. Teige, Acta Polym., 1989, 40, 
243-251. 
17 M. E. Budd, MSc Thesis, Microencapsulation Approach for use in Delayed Quick 
Cure Munitions, University of Reading, 2013. 
18  J. L. Yang, M. R. Kessler, J. S. Moore, S. R. White and N. R. Sottos, 
Macromolecules, 2008, 41, 9650-9655. 
19  C. Perignon, G. Ongmayeb, R. Neufeld, Y. Frere and D. Poncelet, J. 
Microencapsul., 2014, 32, 1-15. 
20  Y. Zhang and D. Rochefort, J. Microencapsul., 2012, 29, 636-649. 
21  A. P. Esser-Khan, N, R, Sottos, S. R. White and J. S. Moore, J. Am. Chem. Soc., 




22  I. Yamamoto, T. Furukawa, H. Nakajima and H. Gotoh, J. Chem. Soc. Perkin 
Trans. 1, 1976, 1597-1602. 
23  W. Chen, X. Liu and D. W. Lee, J. Mater. Sci., 2012, 47, 2040-2044. 
24  M. M. Caruso, B. J. Blaisik, H. Jin, S. R. Schelkopf, D. S. Stradley, N. R. Sottos, S. 
 R. White and J. S. Moore, ACS Appl. Mater. Interface., 2010, 2, 1195-1199. 
25  L. Gonzalez, M. Kostrzewska, M. Baoguang, L. Li, J. H. Hansen, S. Hvilsted and 
 A. L. Skov, Macromol. Mater. Eng., 2014, 299, 1259-1267.  
26   H. Yi, Y. Yang, X. Gu, J. Huang and C. Wang, J. Mater. Chem. A, 2015, 3, 13749-
 13757. 
27  C. P. Chang, J. C. Chang, K. Ichikawa, T. Dobashi, Colloid. Surface. B, 2005, 44, 
187-190. 
28   R. Arshady, J. Microencapsul., 1989, 6, 13-28. 
29  S. K. Ghosh, Functional Coatings by Polymer Microencapsulation, Wiley, 
 Chichester, 2006. 
30  P. Ni, M. Zhang and N. Yan, J. Membrane. Sci., 1995, 105, 51-55. 
31  M. Huang and J. Yang, J.  Mater. Chem., 2011, 21, 11123-11130. 
32  U. Paiphansiri, J. Dausend, A. Musyanovych, V. Mailänder and K. Landfester, 
Macromol. Biosci., 2009, 9, 575-584. 
33   H. Guo, X. Zhao and J. Wang, J. Colloid Interf. Sci.. 2005, 284, 646-651. 
34  R. Heinrich, H. Frensch and K. Albrecht, US Patent, Pressure-resistant 
polyurethane-polyurea particles for the encapsulation of active ingredients and 
process for their manufacture, 1980, 4 230 809. 
35  F. Saluan, E. Devaux, S. Bourbigot and P. Rumeau, C. Eng. J., 2009, 155, 457-
 465. 
36  S. Alexandridou,C. Kiparissides, F. Mange and A. Foissy, J. Microencapsul., 
 2001, 18, 767-781. 
37   J. J. Jasper, J. Phys. Chem. Ref. Data, 1972, 1, 841-1009. 
38   L. Groenendaal, F. Jonas, D. Freitag, H. Pielartzik and J. R. Reynolds, Adv. 
 Mater., 2000, 7, 3317-3319.   
39   E. Jabbari and M. Khakpour, Biomaterials, 2000, 21, 2073-2079. 




Exploiting Reversible Diels-Alder Adducts in the Design of Thermally-Releasable 
Microcapsules 
Abstract 
The crosslinking of polyurethane matrices used to bind explosives can be controlled by 
employing microcapsules that release the crosslinker from its core upon the 
application of a stimulus. Such stimuli include - pressure, ultrasound, chemical 
change, light and heat. The release of a substrate from microcapsules can be 
achieved by incorporating thermally-reversible bonds within the polymer of the shell 
wall. The Diels-Alder reaction involves the [4+2] cycloaddition of a conjugated diene 
and a substituted alkene and certain Diels-Alder adducts, such as maleimide-furans 
undergo the reverse reaction - the retro-Diels-Alder process - when exposed to 
elevated temperatures. This chapter describes the design and synthesis of 
polyurethane microcapsules that contain thermally-reversible Diels-Alder adducts 
within the polymer of the shell wall. The release of crosslinkers from such 
microcapsules using a heat stimulus is demonstrated showing the potential for such 
systems to be used in the controlled crosslinking of hydroxy-functionalised polymers 
used to bind explosives. 
4.1. Introduction 
The manufacture of plastic or polymer bonded explosives (PBX) involves the addition 
of an isocyanate crosslinker to a mixture of the explosive and a hydroxy-functionalised 
polymer. This process exhibits poor control of the crosslinking reaction and can lead to 
several detrimental processes that can lead to wasting of the hazardous material. 
Control of the crosslinking and more reliable production of PBX could be achieved by 
employing microcapsules that release the crosslinker from its core upon the 
application of a thermal stimulus. 
Chapter 2 and 3 describes the synthesis of polyurethane microcapsules that release 
their core contents upon exposure to a heat stimulus. This was achieved by 
incorporating thermally-labile oxime-urethane bonds within the polymeric shell of the 
microcapsule. However, it was important to investigate other thermally-reversible 




Conjugated dienes and substituted alkenes can undergo a [4+2] cycloaddition to form 
a cyclic adduct.1 This reaction is known as the Diels-Alder reaction and many adducts 
are able to undergo the reverse, retro-Diels-Alder reaction under certain conditions 
including elevated temperature.2,3 
One such adduct, maleimide-furan exhibits this reversible nature when exposed to 
heat (>80 °C).4 This character has been exploited for use in healable materials,5 
degradable crosslinks6 and controlled release of substrates such as pharmaceuticals 
from polymeric delivery systems.7,8 In addition, Diels-Alder linkages have been 
incorporated9 into the shell wall of microcapsules prepared using a complex 
coacervation technique. However, to date polyurethane microcapsules have not been 
synthesised using an interfacial polymerisation technique that incorporates thermally-
reversible Diels-Alder linkers within the microcapsule shell. 
4.2. Results and Discussion 
In order to synthesise such polyurethane microcapsules, first the preparation of an 
isocyanate-terminated shell wall precursor containing a Diels-Alder adduct was 
required. The synthetic approach initially involved the protection of maleic anhydride 
with furan to form a Diels-Alder adduct 4.1. The reaction of this adduct with 3-amino-1-
propanol to yield the alcohol 4.2 followed by deprotection afforded a hydroxy-
functionalised maleimide 4.3. A Diels-Alder reaction of 4.3 with furfuryl alcohol to yield 
the cycloadduct 4.4 followed by reaction with excess toluene-2,4-diisocyanate (TDI) 
led to the formation of an isocyanate-terminated shell wall precursor 4.5 capable of 
further chain extension to form polyurethane microcapsules (Scheme 4.1). 
 
Scheme 4.1. Reaction scheme for the synthesis of a shell wall precursor 4.5 that incorporates 
a thermally-reversible Diels-Alder adduct. 
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4.2.1. Protection of Maleic Anhydride with Furan 
The first step of the synthesis of the shell wall precursor 4.5 involved the protection of 
maleic anhydride with furan to form a Diels-Alder adduct 4.1. This protection was 
necessary in order to prevent undesired Michael addition upon the required conversion 
of the anhydride to a maleimide (Scheme 4.2). 
 
Scheme 4.2. Reaction of maleic anhydride and furan to form a Diels-Alder adduct 4.1. 
Maleic anhydride and excess furan were mixed in toluene for a period of 72 hours at 
room temperature. Removal of toluene and excess furan in vacuo afforded the desired 
product without the need for further purification. The protected maleic anhydride was 
analysed with a range of analytical techniques including 13C NMR spectroscopy. The 
presence of resonances corresponding to the four different environments of carbon at 
48.7, 82.2, 137.0 and 169.9 ppm were observed in the spectrum (Figure 4.1).  
 
Figure 4.1. 13C NMR spectrum of 4.1 highlighting key resonances at 48.7, 82.2, 137.0 and 
169.9 ppm in CDCl3. 
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4.2.2. Conversion of Protected Maleic Anhydride to Maleimide 
The second step of the synthesis involved the conversion of the protected maleic 
anhydride with 3-amino-1-propanol to the corresponding maleimide 4.2. The superior 
nucleophillic nature of the amino-terminus of 3-amino-1-propanol allowed the 
generation of the desired maleimide whilst avoiding the formation of an ester 
(Scheme 4.3). 
 
Scheme 4.3. Reaction of Diels-Alder adduct 4.1 with 3-amino-1-propanol to form the 
corresponding maleimide 4.2. 
The protected maleic anhydride was refluxed with 3-amino-1-propanol in MeOH to 
give the desired maleimide. Following purification using column chromatography, the 
product was analysed with FTIR spectroscopy. A broad absorbance corresponding to 
the newly formed hydroxy moiety was observed at 3516 cm-1. Further notable 
absorptions corresponding to the carbonyl and C-N functionalities were also observed 
at 1692 and 1160 cm-1, respectively (Figure 4.2). 
 
Figure 4.2. FTIR spectrum of maleimide 4.2 highlighting the key absorbance at 3516 cm-1 
corresponding to the hydroxy moiety. Further notable resonances at 1692 and 1160 cm-1 









4.2.3. Deprotection to form Hydroxy-Functionalised Maleimide 
The deprotection of 4.2 could be achieved easily by exploiting the thermally-reversible 
nature of Diels-Alder adducts. By maintaining a solution of 4.2 in toluene under reflux it 
was demonstrated that the retro-Diels-Alder reaction could be triggered to afford the 
desired maleimide 4.3. The reaction temperature used exceeded the boiling point of 
furan, thus the protecting group was removed during the ensuing reaction and minimal 
workup was required to isolate 4.3 (Scheme 4.4). 
 
Scheme 4.4. Deprotection of maleimide-furan 4.2 to form maleimide 4.3. 
Deprotection of 4.2 was achieved after exposure to toluene under reflux for 7 hours. 
The solvent was removed in vacuo to leave the desired maleimide 4.3 without the 
need for further purification. Resonances observed using 1H NMR spectroscopy 
confirmed that the deprotection had been successful, notably the key resonance at 
6.74 ppm corresponding to the formed alkene protons (Figure 4.3). 
 
Figure 4.3. 1H NMR spectrum of maleimide 4.3 highlighting the key resonances in CDCl3. 
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4.2.4. Diels-Alder Reaction of Maleimide and Furfuryl Alcohol 
In order to synthesise an isocyanate-terminated shell wall precursor, first it was 
necessary to generate a Diels-Alder adduct that possesses two hydroxy moieties 4.4 
capable of reaction with TDI. This was achieved by the Diels-Alder reaction of 4.3 with 
furfuryl alcohol (Scheme 4.5). 
 
Scheme 4.5. Reaction of maleimide 4.3 with furfuryl alcohol to form Diels-Alder adduct 4.4. 
The dihydroxy-functionalised Diels-Alder adduct was analysed with a range of 
analytical techniques including mass spectrometry. Mass spectrometry utilising 
electrospray ionisation was employed and mass ions at 254.1025 and 276.0844 were 
observed, corresponding to the protonated (C12H15O5N+H)
+ and sodiated 
(C12H15O5N+Na)
+ forms of the molecular ions of 4.4, respectively (Figure 4.4). 
 
Figure 4.4. Mass spectrum highlighting mass ions at 254.1025 and 276.0844 corresponding to 
the protonated and sodiated forms of the molecular ions of 4.4, respectively. 
4.2.4. Synthesis of the Shell Wall Precursor 
The shell wall precursor was generated by the reaction of Diels-Alder adduct 4.4 with 
an excess of TDI. Removal of the excess TDI by washing with cyclohexane at 80 °C 
left an isocyanate-terminated shell wall precursor 4.5 capable of further chain 
extension in order to form microcapsules (Scheme 4.6). 
 
Scheme 4.6. Reaction of 4.4 with an excess of TDI to form shell wall precursor 4.5. 
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Isocyanates possess a characteristic stretching vibration that appears as an 
absorption at ~ 2250 cm-1 in an IR spectrum. Thus FTIR spectroscopy was employed 
to confirm the formation of the desired isocyanate-terminated shell wall precursor. 
Analysis indeed revealed the presence of a broad absorption at 2268 cm-1 
corresponding to the isocyanate moiety (Figure 4.5). 
 
Figure 4.5. FTIR spectrum of 4.5 highlighting the absorbance at 2268 cm-1 corresponding to 
the isocyanate moiety. 
It is possible that a polymerisation can occur in the reaction of 2.4 and TDI. The high 
molecular weight of the resulting oligomer can lead to poor solubility in the 
hydrophobic solvents employed in the synthesis of microcapsules. Thus it was 
important to determine the extent of chain extension. Mass spectrometry could not be 
performed on the isocyanate terminated shell wall precursor 4.5, thus it was 
derivatised by reacting the isocyanate termini with MeOH to form the urethane 
analogue. Mass spectrometry of this derivative revealed a molecular ion with a mass 
of 688.2225 (C32H35O11N5+Na)
+ confirming the desired shell wall precursor had been 
generated - mass of 4.5 = 601, mass of MeOH = 32, sodiated ion = 601 + 32 +32 + 23 
= 688. 
In addition to mass spectrometry, the molecular weight of 4.5 was determined using 
end group analysis using titration. The shell wall precursor 4.5 was reacted with a 
known quantity of excess ndibutylamine to form a urea. The resultant mixture was 
titrated with HCl (1M) using bromophenol blue as an indicator of the end point by a 






determination of the quantity of isocyanate in the shell wall precursor and thus the 
molecular weight. 
NCO % = [
(VBlank- VSample) x N x 0.0420
Sample Mass
]  x 100                 Equation 4.1 
Where: VBlank = blank titre, VSample = sample titre and N = normality of HCl. 
Titrational analysis revealed an isocyanate content of 4.5 of 12 %. Although 
comparison with the expected value, 14 %, suggests a small degree of polymerisation 
had occurred, in general the desired shell wall precursor had been afforded. In 
addition, the presence of excess TDI not removed during the workup procedure may 
have also prevented accurate measurement of the isocyanate content of 4.5. 
4.2.4. Dissociation of the Diels-Alder Adduct 
1H NMR spectroscopy was employed to investigate the potential of the maleimide-
furan Diels-Alder adduct to dissociate upon exposure to heat. The dihydroxy-
functionalised maleimide furan 4.4 was dissolved in deuterated DMSO (DMSO-d6) and 
analysed using 1H NMR spectroscopy before and after exposure to a temperature of 
140 °C for 15 minutes. Analysis revealed that after exposure to this temperature the 
Diels-Alder adduct had almost completely dissociated regenerating the maleimide and 
furan components (Figure 4.6). 
 
Figure 4.6. 1H NMR spectra of maleimide-furan 4.4 before and after exposure to heat, 





4.2.5. Synthesis of Microcapsules 
The microencapsulation of isophorone diisocyanate (IPDI) crosslinkers in polyurethane 
microcapsules 4.6 using the shell wall precursor containing a thermally reversible 
Diels-Alder adduct 4.5 employed an interfacial polymerisation technique similar to that 
described in Chapter 3. The shell wall precursor 4.5 and IPDI were dissolved in a 
hydrophobic solvent, o-methoxyacetophenone and emulsified in a surfactant solution 
of gum arabic with the aid of mechanical agitation. Upon the addition of a water 
soluble chain extender, 1,4-butanediol, a reaction occurred at the oil-water interface to 
form a polyurethane shell that contained thermally-reversible Diels-Alder linkages. In 
addition to this polymerisation reaction, a host of other reactions are expected to 
occur. Water can react with the isocyanate to form a carbamic acid, decarboxylation of 
this leads to the formation of an amine which is in turn capable of reacting with further 
isocyanate to form a urea. In addition, crosslinking reactions between isocyanate and 
urea and urethane can form biuret and allophonate bonds (Figure 4.7). The generated 
microcapsules were isolated from the polymerisation medium by filtration, followed by 
washing with water and then allowed to air dry for 48 hours prior to analysis. 
The properties of the microcapsules were assessed using a range of analytical 
techniques including - optical microscopy, scanning electron microscopy, FTIR 
spectroscopy and 1H NMR spectroscopy. 
 
 
Figure 4.7. Interfacial polymerisation technique to synthesise the microcapsules incorporating 
a thermally-reversible Diels-Alder adduct in the shell walls and a core of IPDI. 
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4.2.6. Optical Microscopic Analysis of Microcapsules 
The successful microencapsulation of a liquid core can be confirmed using optical 
microscopy. In addition, analysis using optical microscopy also allows measurement of 
the microcapsule diameter. The synthesis of microcapsules using a shell wall 
precursor that contains a thermally-reversible Diels-Alder adduct within the polymer of 
the shell wall was successful. Crushing the microcapsules between two microscope 
slides revealed the release of a liquid core. However, the microcapsules exhibited poor 
mechanical strength and were easily ruptured with minimal force. The high steric 
hindrance of the shell wall precursor may have prevented the formation of a strong 
polymer shell and this observation is supported by results described in Chapter 3. In 
addition, the non-linear structure of the shell wall precursor may have also contributed 
to the formation of a mechanically weak shell (Figure 4.8). The poor mechanical 
strength of the generated microcapsules demonstrates further optimisation of these 
initial studies is required. 
Analysis of the microcapsule diameters revealed that the average diameter of the 
microcapsules was 76 m within a range of 29-138 m. This result is within the 
expected literature values for microcapsules synthesised at a rate of agitation of 
1000 rpm.10 
 
Figure 4.8. Optical microscopic image of microcapsules 4.6 synthesised using a shell wall 
precursor containing the thermally-reversible Diels-Alder adduct 4.5. 
4.2.7. Analysis of Microcapsules using Scanning Electron Microscopy 
High resolution images of microcapsules can be obtained using scanning electron 
microscopy (SEM), thus providing detailed images of the internal and external 
microcapsule surface morphology. Microcapsules were analysed using an 




(0.68 torr). Analysis revealed that spherical mononuclear microcapsules had been 
generated and they possessed a smooth external surface and a rough internal surface 
and this is in accordance with data in related literature studies.10 A sample of 
microcapsules was embedded in an epoxy resin and cross-sections prepared using an 
ultramicrotome employing a glass knife. The shell wall thickness of the microcapsules 
was measured in an environmental scanning electron microscope operating in a thin 
aqueous atmosphere (0.68 torr). An average shell wall thickness of 3.45 m was 
observed, within the reported literature range of microcapsules prepared using an 
interfacial polymerisation technique (Figure 4.9).10 
   
Figure 4.9. SEM images of a) microcapsules synthesised using a shell wall precursor 
containing a thermally-reversible Diels-Alder adduct b) internal surface morphology of a 
ruptured microcapsule c) cross-sectional image of a microcapsule highlighting the shell wall. 
4.2.8. Analysis of Microencapsulated Core Using FTIR Spectroscopy 
The delivery of active isocyanate crosslinkers is desired, thus it was important to 
confirm the successful encapsulation of the isocyanate functional group. Isocyanates 
possess a characteristic vibration that is observed as an absorbance ~ 2250 cm-1 in an 
IR spectrum. Microcapsules were crushed and the released liquid core analysed using 
FTIR spectroscopy.11 
Indeed a broad absorption at 2255 cm-1 was observed corresponding to the 
isocyanate moiety of IPDI confirming the successful encapsulation of an isocyanate 
crosslinker in polyurethane microcapsules. Further absorbances were observed at 
1706 and 1677 cm-1 corresponding to the urethane and maleimide carbonyl moieties, 
respectively (Figure 4.10). 
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Figure 4.10. FTIR spectrum of microcapsule core, highlighting the absorption at 2255 cm-1 
corresponding to the isocyanate moiety of IPDI. 
4.2.9. 1H NMR Spectroscopic Analysis of the Microencapsulated Core 
In addition to FTIR spectroscopy, the microcapsule core can also be analysed using 
1H NMR spectroscopy,12 and allow the composition of the core to be determined. In 
addition, employing a known quantity of an internal standard can allow quantification of 
these components.  
Microcapsules were crushed and the released core was washed with CDCl3 and the 
washings analysed with 1H NMR spectroscopy. The 1H NMR spectrum was compared 
to spectra of IPDI and o-methoxyacetophenone and a clear overlap between the 
microcapsule core and the individual components was observed corroborating the 
observation via FTIR spectroscopic analysis of the successful microencapsulation of 
the active IPDI crosslinker (Figure 4.11). 
Methyl 4-nitrobenzoate was employed as an internal standard since the resonances 
did not overlap with those of the microcapsule core components. Comparison of the 
integration of resonances of the internal standard at 8.23-8.29 with those of IPDI at 
3.53-3.66 and o-methoxyacetophenone at 6.98 allowed the composition of the 
microcapsule core to be quantified. It was revealed the microcapsule core was 
composed of 40 wt. % IPDI and 10 wt. % of o-methoxyacetophenone. The quantity of 
IPDI encapsulated is within the expected values in accordance with results described 















Figure 4.11. 1H NMR spectra of o-methoxyacetophenone, IPDI and the released core of 
microcapsules including an internal standard in CDCl3.  
4.2.10. Release of Microencapsulated Core Using a Heat Stimulus 
A thermally-reversible maleimide-furan Diels-Alder adduct has been successfully 
incorporated into the polymer of the shell wall of microcapsules 4.6. The capability of 
these microcapsules to release isocyanate crosslinkers upon exposure to a stimulus of 
heat was then investigated. Microcapsules were heated to 150 °C at a rate of 
10 °C/minute using a hot stage mounted to an optical microscope and images 
recorded using a digital camera. In addition to optical microscopy, SEM images were 
obtained before and after heating. 
Upon heating to 125 °C the shell wall of the microcapsules began to dissociate and 
shell wall breakdown occurred rapidly above this temperature reaching complete 
fracture of the shell wall and release of the core from the microcapsules by 140 °C. As 
expected, SEM analysis of the microcapsules after heating revealed the absence of 
spherical-shaped microcapsules suggesting complete dissociation of the 




thermally-reversible Diels-Alder adduct, designated as control microcapsules, were 
also heated to 140 °C. At this temperature the shells of the control microcapsules 
began to pucker, suggesting the core had leached from the microcapsules. However, 
dissociation of the shell wall was not observed. 
   
  
Figure 4.12. Optical microscopic images of microcapsules a) at 25 °C and b) 140 °C. c) SEM 
image of microcapsules after heating to 140 °C. Optical microscopic images of control 
microcapsules d) at 25 °C and e) 140 °C. 
4.2.11. Increasing the Mechanical Strength of Microcapsules 
Attempts were made to increase the mechanical strength of the microcapsules. This 
was achieved by using the same interfacial polymerisation technique described in 
Section 4.25  with the exception of a mixture of the shell wall precursor containing the 
Diels-Alder adduct 4.5 and a shell wall precursor not containing the thermally-
reversible adduct 3.2 (Figure 4.13) was employed. The synthesis of mechanically 
strong microcapsules required at least a ratio of 2:8 of 4.5:3.2. 
 
Figure 4.13. Structure of shell wall precursor not containing a thermally-reversible Diels-Alder 
adduct 3.2. 
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The microcapsules were generated with an average diameter of 46 m within a range 
of 12-98 m and a shell wall thickness of 2.85 m. Analysis of the microencapsulated 
core revealed a composition of 28 wt. % IPDI and 31 wt. % chlorobenzene. 
The capability of these microcapsules to release their core contents upon exposure to 
a heat stimulus was also investigated. A sample of microcapsules was heated to 
140 °C on a hot stage mounted to an optical microscope. The shell walls of the 
microcapsules began to dissociate at 140 °C and after a period of 1 hour the shells of 
adjacent microcapsules had fused together (Figure 4.14). As a result of the long term 
exposure to this temperature, a large portion of the microcapsule core had leached 
through the microcapsule shell wall. 
  
Figure 4.14. Optical microscopic images of microcapsules a) at 25 °C and b) 140 °C. 
Although the physical strength of these microcapsules was improved, their release 
capabilities were mitigated. Thus further studies will be required in order to generate 
strong microcapsules that can release their core contents effectively. 
4.3. Conclusion 
The successful synthesis of an isocyanate-terminated shell wall precursor that 
contains a thermally-reversible Diels-Alder adduct has been achieved. The synthetic 
route employed the initial protection of maleic anhydride with furan followed by 
conversion to a hydroxy-functionalised maleimide-furan. Deprotection afforded a 
maleimide that was reacted with furfuryl alcohol to generate a dihydroxy-functionalised 
maleimide-furan Diels-Alder adduct. The capability of this adduct to dissociate upon 
exposure to elevated temperature was demonstrated using 1H NMR spectroscopy. 
The reaction of this adduct with an excess of TDI afforded the isocyanate-terminated 
shell wall precursor. The synthesis of microcapsules containing IPDI crosslinkers using 
this shell wall precursor was successful and the capability of the afforded 
microcapsules to release their core contents upon exposure to a heat stimulus was 




demonstrated. The mechanical strength of the microcapsules was enhanced by using 
a synthesis that employed a mixture of a shell wall precursor containing the Diels-
Alder adduct and a shell wall precursor not containing the thermally-reversible adduct. 
Although the mechanical strength of the microcapsules was increased the capability to 
release the core using a heat stimulus was significantly reduced. 
4.4. Experimental 
All chemical purification and experimental techniques employed in this chapter are 
identical to those described in Chapter 2 and 3. 
Protection of Maleic Anhydride with Furan 4.18 
 
Maleic anhydride (3.07 g, 31.0 mmol) and furan (5.06g, 74.4 mmol) were dissolved in 
toluene (50 mL) and stirred at room temperature for a period of 72 hours. The solvent 
was removed in vacuo to leave a white solid 4.1 (4.35 g, 84 %) (m.p. 117-121 °C lit. 
114-116 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 3.18 (2H, s, Ha), 5.47 (2H, s, Hb), 
6.58, (2H, s, Hc); 
13C NMR (100 MHz, CDCl3) C (ppm): 48.7, 82.2, 137.0, 169.9; FTIR 
(ATR)  cm-1): 3060 (C-H), 2999 (C-H), 1785 (C=O), 1212 (C-O), 1086 (C-O). 
Conversion of Protected Maleic Anhydride to Maleimide 4.213 
 
The protected maleic anhydride 4.1 (1.53 g, 9.3 mmol) and 3-amino-1-propanol 
(0.830 g, 11.1 mmol) were dissolved in MeOH (50 mL) and maintained under reflux for 
a period of 18 hours. The solvent was removed in vacuo to leave a yellow coloured oil 
that was purified by column chromatography (Rf = 0.29, 2 % MeOH/CHCl3) to afford a 
white solid 4.2 (0.694 g, 36 %) (m.p. 119-124 °C, lit. 118-120 °C). 1H NMR (400 MHz, 
Acetone-d6) H (ppm): 1.70 (2H, quint. J = 6.5 Hz, Hc), 2.93 (2H, s, He), 3.51 (2H, t J = 
5.0 Hz, Hd), 3.52 (2H, t J = 7.0 Hz, Hb), 4.84 (1H, s, Ha), 5.15 (2H, s, Hf), 6.59 (2H, s, 
Hg); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 31.6, 36.2, 48.3, 59.7, 81.8, 137.4, 
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177.4; FTIR (ATR)  cm-1): 3511 (O-H), 3099 (C-H), 2952 (C-H), 1691 (C=O), 1405 
(C-N), 1158 (C-O); ESIMS calculated mass (C11H13O4N+H)
+ 224.0917 found 
224.0918. 
Deprotection to Form Hydroxy-Functionalised Maleimide 4.3 
 
Protected maleimide 4.2 (0.650 g, 2.9 mmol) was dissolved in toluene (20 mL) and 
maintained under reflux for a period of 7 hours. The solvent was removed in vacuo to 
leave a pale pink coloured oil 4.3 (0.375 g, 83 %). 1H NMR (400 MHz, CDCl3) H 
(ppm): 1.80 (2H, quint. J = 6.0 Hz, Hc), 2.60 (1H, s, Ha), 3.59 (2H, br. m, Hb), 3.69 (2H, 
t J = 7.0 Hz, Hd), 6.74 (2H, s, He); 
13C NMR (100 MHz, CDCl3) C (ppm): 31.7, 36.2, 
58.0, 165.4, 170.5; FTIR (ATR)  cm-1): 3478 (O-H), 3110 (C-H), 2954 (C-H), 1695 
(C=O), 1409 (C-N), 1149 (C-O); ESIMS calculated mass (C7H9O3N+H)
+ 156.0655 
found 156.0654. 
Synthesis of Dihydroxy-Functionalised Diels-Alder Adduct 4.4 
 
Hydroxy-functionalised maleimide 4.3 (0.340 g, 2.19 mmol) and furfuryl alcohol 
(0.258 g, 2.6 mmol) were dissolved in toluene (40 mL) and maintained at 80 °C for a 
period of 72 hours. The solvent was removed in vacuo to leave a yellow coloured oil 
that was purified by column chromatography (Rf = 0.15, 5 % MeOH/CHCl3) to afford a 
colourless oil 4.4 obtained as a mixture of exo and endo isomers (7:3) that slowly 
transformed to the thermodynamically stable exo isomer over a period of several 
months (0.426 g, 77 %). 1H NMR (400 MHz, DMSO-d6) H (ppm): 1.57 (2H, quint. J = 
7.0 Hz, Hc), 2.88 (1H, d J = 6.5 Hz, Hf), 3.02 (1H, d J = 6.5 Hz, He), 3.36 (2H, t J = 
7.0 Hz, Hb), 3.39 (2H, m, Hd), 3.69 (1H, dd J = 6.0, 12.0 Hz, Hj), 4.03 (1H, dd J = 6.0, 
12.0 Hz, Hj’), 4.46 (1H, br. m, Ha), 4.97 (1H, br. m, Hk), 5.08 (1H, d, 1.0 Hz Hg), 6.52 
(1H, d J = 6.0 Hz, Hi), 6.53 (1H, dd J = 6.0, 1.0 Hz, Hh); 
13C NMR (100 MHz, 
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DMSO-d6) C (ppm): 30.5, 35.4, 47.7, 49.9, 58.3, 59.0, 80.2, 91.6, 136.4, 138.1, 174.9, 
176.4; FTIR (ATR)  cm-1): 3460 (O-H), 3112 (C-H), 2960 (C-H), 1683 (C=O), 1404 
(C-N), 1172 (C-O); ESIMS calculated mass (C12H15O5N+H)
+ 254.1023 found 
254.1025. 
Synthesis of Shell Wall Precursor 4.5 
 
Dihydroxy-functionalised Diels-Alder adduct 4.4 (0.393 g, 1.6 mmol) and toluene-2,4-
diisocyanate (TDI) (0.757 g, 4.4 mmol) were dissolved in tetrahydrofuran (15 mL) and 
maintained under reflux for a period of 18 hours under an atmosphere of argon. The 
solvent was removed in vacuo and excess TDI was removed by washing with 
cyclohexane (3 x 20 mL) at 80 °C to leave a yellow coloured solid 4.5 (0.926 g, 99%)  
(m.p. 125-129 °C). 1H NMR (400 MHz, THF-d8) H (ppm): 1.23 (2H, m, Hg), 2.55-2.60 
(6H, m, Ha), 2.93 (1H, m, Hi), 3.45 (2H, m, Hh), 3.73 (1H, m, Hj), 4.42 (2H, m, Hnn’), 
4.64 (2H, m, Hf), 5.05 (1H, m, Hk), 5.84-6.03 (2H, m, Hlm), 6.40-7.24 (2H, m, He), 6.40-
7.24 (6H, m, Hbcd); 
13C NMR (100 MHz, THF-d8) C (ppm): 16.6, 22.0, 25.6, 26.9, 50.1, 
61.9, 67.1, 67.7, 81.0, 89.8, 114.7, 115.7, 124.8, 125.9, 130.3, 132.4, 139.0, 152.0, 
175.4, 176.1; FTIR (ATR)  cm-1): 3340 (N-H), 3124 (C-H), 2947 (C-H), 2265 (NCO), 
1696 (C=O), 1537 (C-N), 1220 (C-O); ESIMS of 4.5 derivative from its reaction with 
MeOH, calculated mass (C32H35O11N5+Na)
+ 688.2225 found 688.2225. 
Synthesis of Microcapsules 4.6 
Gum arabic (9 g) was dispersed in H2O (60 mL) in a 150 mL beaker with the aid of 
mechanical agitation at a rate of 1000 rpm. Shell wall precursor 4.5 (0.100 g, 
0.17 mmol) and IPDI (0.09 g, 0.40 mmol) were dissolved in o-methoxyacetophenone 
(0.14 mL). This solution was added to the aqueous solution and the resultant emulsion 
heated to 70 °C at a rate of 10 °C/minute. When the temperature reached 50 °C, 
1,4-butanediol (5.2 g, 56.6 mmol) was added and agitated at the same rate for an 
additional 30 seconds. Agitation was reduced to a rate of 150 rpm for 45 minutes at 
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70 °C followed by a further 2 hours at room temperature. After this period, agitation 
was ceased, H2O (100 mL) was added and the generated microcapsules allowed to 
settle at the bottom of the beaker over a period of 1 hour at room temperature. The 
aqueous solution was decanted to leave polyurethane microcapsules 4.6 that were 
collected by vacuum filtration, washed with H2O and then air dried for a period of 48 
hours (0.149 g). 
Synthesis of Mechanically Robust Microcapsules 
Gum arabic (9 g) was dispersed in H2O (60 mL) in a 150 mL beaker with the aid of 
mechanical agitation at a rate of 1000 rpm. Shell wall precursor 4.5 (0.075 g, 
0.12 mmol), 3.2 (3.15 g, 0.72 mmol) and IPDI (0.550 g, 2.5 mmol) were dissolved in 
chlorobenzene (0.9 mL). This solution was added to the aqueous solution and the 
resultant emulsion heated to 70 °C at a rate of 10 °C/minute. When the temperature 
reached 50 °C, 1,4-butanediol (5.2 g, 56.6 mmol) was added and agitated at the same 
rate for an additional 30 seconds. Agitation was reduced to a rate of 150 rpm for 
45 minutes at 70 °C followed by a further 2 hours at room temperature. After this 
period, agitation was ceased, H2O (100 mL) was added and the generated 
microcapsules allowed to settle at the bottom of the beaker over a period of 1 hour at 
room temperature. The aqueous solution was decanted to leave polyurethane 
microcapsules that were collected by vacuum filtration, washed with H2O and then air 
dried for a period of 48 hours (1.50 g). 
4.5. References 
 
1 O. Diels, K. Alder, Justus Liebigs Ann. Chem., 1928, 460, 98-122. 
2 J. C. C. Atherton and S. Jones, Tetrahedron, 2003, 59, 9039-9057. 
3 B. Gacal, H. Durmaz, M. A. Tasdelen, G. Hizal, U. Tunca, Y. Yagci and A. L. 
Demirel, Macromolecules, 2006, 39, 5330-5336. 
4 V. Froidevaux, M. Borne, E. Laborbe, R. Auvergne, A. Gandini and B. Boutevin, 
RSC Adv., 2015, 5, 37742-37754. 
5 X. Chen, M. A. Dam, K. Ono, A. Mal, H. Shen, S. R. Nutt, K. Sheran and F. Wudl, 
Science, 2002, 295, 1698-1702. 
6 J.R. McElhanon, E.M. Russick, D.R. Wheeler, D.A. Loy and J.H. Aubert, J. Appl. 
Polym. Sci., 2002, 85, 1496-1502. 




8 W. H. Heath, F. Palmieri. J. R. Adams, B. K. Long, J. Chute, T. W. Holocombe, S. 
Zieren, M. J. Truitt, J. L. White and C. G. Wilson, Macromolecules, 2008, 41 719-
726. 
9 K. Eggers, D. Szopinski and G. A. Luinstra, Macromol. Symp., 2014, 346, 32-35. 
10 J. L. Yang, M. R. Kessler, J. S. Moore, S. R. White and N. R. Sottos, 
Macromolecules, 2008, 41, 9650-9655. 
11 M. Huang and J. Yang, J. Mater. Chem., 2011, 21, 11123-11130.   
12 L. T. T. Nguyen, X. K. D. Hillewaere, R. F. A. Teixeira, O. van den Berg and F. E. 
Du Prez, Polym. Chem., 2015, 6, 1159-1170. 




Delayed Quick-Cure of Hydroxy-Terminated Polybutadiene using Thermally-
Reversible Blocked Isocyanates 
The following chapter has, in part, been published by the author as a patent 
application in collaboration with BAE Systems plc. - M. E. Budd, W. C. Hayes, R. 
Stephens, Great British/European Patent Application, PBX Composition, 2015, 
GB1511869.8/ EP15275169.9. 
Abstract 
The manufacture of plastic/polymer bonded explosives (PBX) involves binding the 
energetic material within a polymer matrix. Typically, the matrix is formed by the 
crosslinking reaction of a hydroxy-functionalised aliphatic polymer with a diisocyanate. 
The current manufacturing procedure employed can lead to several detrimental 
processes that render the product unusable and thus it must be destroyed - a process 
that is both costly and hazardous. The following chapter demonstrates how reactive 
isocyanate functionality can be generated when desired by triggering the dissociation 
of thermally-labile oxime-urethanes using a thermal stimulus. In addition, control of the 
dissociation temperature can be achieved by modification of the steric and electronic 
properties around the thermally-labile bond. Finally, the potential of these oxime-
urethanes to cure hydroxy-functionalised aliphatic polymers has been demonstrated.  
5.1. Introduction 
Modern explosives typically consist of the energetic material bound within a rubbery 
polyurethane matrix formed from the polymerisation reaction of an isocyanate 
crosslinker with a hydroxy-functionalised polymer in the presence of a catalyst. Such 
composite materials are known as plastic or poplymer bonded explosives (PBX). The 
current manufacturing process of one such explosive formulation, Rowanex 1100 1A 
(Table 5.1), involves the addition of isophorone diisocyanate (IPDI) to a mixture of the 
explosive, hydroxy-terminated polybutadiene (HTPB) and the catalyst dibutyltin 
dilaurate (DBTDL), upon this addition an immediate crosslinking reaction occurs. As a 
result, the missiles or shells - designated herein as stores - must be filled with the 
rapidly curing mixture almost immediately. This can prevent the uniform delivery of the 
crosslinker and thus lead to the formation of an inhomogeneously crosslinked polymer 
matrix. In addition, consecutively filled stores often have varying degrees of 
131 
 
crosslinking consistency and can lead to the formation of voids. Upon firing, the 
explosive stores are subjected to an increased force of 13,000 G, sufficient to cause 
undesired detonation of the explosive thus posing a potentially fatal hazard to the gun 
operators. These detrimental properties mean that the defective explosive material 
must be disposed of in a safe manner, an expensive and dangerous process.  
Table 5.1. Rowanex 1100 1A explosive formulation. 
Constituent  Composition (wt %) 
RDX > 80 
HTPB R45HT  
Plasticiser  
Antioxidant   
Surfactant  < 20 
IPDI    
DBTDL  
Antifoaming Agent  
Polyurethanes are employed extensively in the adhesives and coatings industry. The 
high reactivity of isocyanates renders formulations containing free isocyanate 
unstable, polymerising readily under mild conditions.1 Blocking agents that react with 
the isocyanate moiety have thus been developed, 2  preventing undesired 
polymerisation. The blocking reaction is thermally-reversible, generating free 
isocyanate when desired by the application of heat (Scheme 5.1).  
 
Scheme 5.1 The reversible reaction of blocked isocyanates, regenerating isocyanate and 
blocking group. 
An extensive range of blocking agents have been developed 3  for polyurethane 
coatings and adhesives including - aromatic heterocycles, 4  sterically hindered 
secondary amines,5 phenols,6 amides7 and oximes.8 It is hoped that such systems can 
be used to control the curing process of polyurethane rubber composites used to bind 




5.2. Results and Discussion 
Explosive formulations that utilise blocked isocyanates must meet certain processing 
requirements - the blocked isocyanates must be soluble or uniformly dispersed within 
the HTPB binder, the released blocking groups must not be volatile at the curing 
temperature in order to avoid the formation of voids, the blocked isocyanate must be 
stable at the process mixing temperatures (55 - 70 °C) and curing temperature must 
not approach the ignition temperature of RDX (~220 °C), ideally it should be < 100 °C. 
Thus, it was important to investigate several different types of blocking groups - 
amines, amides, oximes, aromatic heterocycles and phenols - as potential candidates 
for the curing of hydroxy-functionalised polymers (Figure 5.1). 
 
Figure 5.1. Structures of blocking groups - amines, amides, oximes, aromatic heterocycles 
and phenols. 
5.2.1. Amine Blocking Groups 
The urea bond is stabilised by conjugation of the lone pair of the nitrogen and the 
-electrons of the carbonyl. However, literature investigations have revealed 9  the 
presence of steric groups prevent this conjugation and thus reduce the stability of 
ureas sufficiently to bring about its dissociation under mild conditions. Further to this, 
the temperature at which dissociation occurs can be controlled by modification of the 
degree of steric hindrance. 10  Literature studies, have reported 11  that such amine-
blocked diisocyanates can be used to cure HTPB at elevated temperatures. 
 
Scheme 5.2. Reaction of IPDI and diisopropylamine to from a urea 5.1. 
IPDI was reacted with an excess of diisopropylamine for a period of 1 hour 
(Scheme 5.2). Purification by washing with HCl (1M), afforded a white solid 5.1 which 
was analysed using FTIR spectroscopy. The absence of an absorption corresponding 
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to the isocyanate moiety and the presence of a urea carbonyl at 1620 cm-1 was 
observed (Figure 5.2). 
 
Figure 5.2. FTIR spectrum of urea 5.1, highlighting the absorption at 1620 cm-1 corresponding 
to the urea carbonyl moiety. 
5.2.2. Amide Blocking Groups 
The lone pair of the nitrogen of amides typically exhibits poor reactivity resulting from 
its delocalisation into the carbonyl bonding system. However, the lone pair has 
demonstrated to possess sufficient reactivity with certain electrophilic carbons 
including isocyanates.7 A short study investigated12 the synthesis and dissociation of 
isocyanates blocked with amides. It was found dissociation of such compounds to 
regenerate isocyanate could be achieved within the temperature range 100 - 157 °C. 
Further studies have demonstrated 13 , 14  how amide-blocked isocyanates can be 
employed to cure hydroxy-functionalised polymers at high temperatures. 
IPDI was reacted with an excess of -caprolactam in order to yield an amide-blocked 
diisocyanate 5.2 able to regenerate the reactive isocyanate moiety when exposed to 
heat (Scheme 5.3).  
 









The amide-blocked diisocyanate 5.2 was characterised using a range of analytical 
techniques including 13C NMR spectroscopy. Resonances at 154.0 and 155.2 ppm 
were observed corresponding to the newly formed urea carbonyl functionality. 
Furthermore, resonances at 179.3 and 179.6 corresponding to the amide carbonyl 
verify the synthesis of an amide-blocked diisocyanate (Figure 5.3). In addition, FTIR 
spectroscopic analysis revealed absorbances at 1694 and 1651 cm-1 confirming the 
presence of amide and urea carbonyl functionalities, respectively. 
 
Figure 5.3. 13C NMR spectrum of -caprolactam-blocked IPDI highlighting resonances 
corresponding to the urea and amide carbonyl moieties. 
5.2.3. Oxime Blocking Groups 
Oximes react readily with isocyanates to form oxime-urethanes. The thermally-
reversible nature of this bond has led to its extensive employment as a blocking agent 
in the adhesives industry. 15 , 16  Studies have revealed 17  that increasing the steric 
hindrance around the oxime increases the rate at which dissociation occurs. 
Chapter 2 describes the synthesis of thermally-labile oxime-urethanes and 
demonstrates how they can be used to generate isocyanates upon the application of a 
thermal stimulus.  
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IPDI blocked with an oxime, often referred to as an oxime-urethane was synthesised in 
a similar approach described in Chapter 2 and first involved the generation of 
3,3-dimethyl-2-butanone oxime 5.3. The reaction involved heating of 3,3-dimethyl-2-
butanone with hydroxylamine hydrochloride in the presence of triethylamine. 
Subsequent reaction of the afforded oxime with isophorone diisocyanate in a 2:1 ratio 
afforded the oxime-urethane 5.4 without the need for further purification (Scheme 5.4).  
 
Scheme 5.4.  Thermally reversible reaction of IPDI and 3,3-dimethyl-2-butanone oxime to 
yield oxime-urethane 5.4. 
The oxime-urethane was analysed using a range of analytical techniques including 
1H NMR spectroscopy. The chemical shift values of the methyl and tbutyl protons were 
subject to a downfield shift from 1.07 and 1.81 ppm on the oxime to 1.19 and 2.99 
respectively on the oxime-urethane, verifying the reaction of the oxime and isocyanate. 
Further resonances that reinforce the observed reaction at 6.13 and 6.57 ppm 
correspond to the urethane nitrogen protons (Figure 5.4). 
 
Figure 5.4. 1H NMR spectra of 3,3-dimethyl-2-butanone oxime 5.3 and oxime-urethane 5.4. 
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5.2.4. Aromatic Heterocycle Blocking Groups 
Aromatic heterocyclic compounds including pyrazoles, imidazoles and triazoles that 
possess a nucleophillic heteroatom have been demonstrated to exhibit reversible 
reactions with isocyanates.18,19,20 Heterocycle-blocked isocyanates have indeed been 
used to cure hydroxy and amine-functionalised pre-polymers that are employed in 
adhesives and coatings.21 
Imidazole-blocked IPDI 5.5 was afforded by the reaction of imidazole and IPDI in a 2:1 
ratio to give white crystals that did not require further purification (Scheme 5.5). 
 
Scheme 5.5. Reaction of IPDI and imidazole to yield imidazole-blocked IPDI 5.5. 
The blocked isocyanate 5.5 thus produced was analysed using a variety of techniques 
including mass spectrometry. Mass spectrometry utilising electrospray ionisation was 
employed and a mass of 359.2190 was observed corresponding to the proton ionised 
imidazole-blocked IPDI with a molecular ion formula of C18H27O2N6
+. A further mass 
ion at 381.2010 was also observed corresponding to the Na+ ionised imidazole-
blocked IPDI with a molecular ion formula of C18H26O2N6Na
+ (Figure 5.5). 
 




+ at 359.2190 and 381.2010, respectively. 
5.2.5. Phenol Blocking Groups 
The reversible nature of urethanes synthesised from phenol compounds has been well 
documented.22 The temperature at which phenol-blocked isocyanates dissociate can 
be controlled to some extent by conjugating the aromatic ring with electron donating 
groups. Polyisocyanates blocked with salicylate esters and other phenolic groups have 




A phenol-blocked isocyanate 5.6 was obtained by reaction of 2,6-dimethylphenol and 
IPDI in the presence of a catalytic quantity of  DBTDL. The removal of the catalyst was 
achieved by washing with hexane to leave the pure compound obtained as a white 
powder (Scheme 5.6).  
 
Scheme 5.6. Reaction of IPDI and 2,6-dimethylphenol to afford a thermally-labile urethane. 
The phenol-blocked IPDI 5.6 was characterised with a range of analytical techniques 
including FTIR spectroscopy. Characteristic absorptions at 3314 and 1706 cm-1 typical 
of vibrations corresponding to urethane N-H and C=O functionalities (Figure 5.6) were 
observed. 
 
Figure 5.6. FTIR spectrum of phenol-blocked IPDI 5.6 highlighting the key absorption at 
1706 cm-1 corresponding to the urethane carbonyl moiety. 
5.2.6. Dissociation of Blocked-IPDI 
It was important to measure the dissociation temperature of the generated blocked 
isocyanates 5.1-6 in order to ascertain the conditions that will be required in order to 
achieve the cure of HTPB. Chapter 2 describes how variable temperature infra-red 










The blocked isocyanates 5.1-6 were dissolved in dried tetraethylene glycol dimethyl 
ether in a ratio of 1:0.25 wt. %. This solution was injected into a variable temperature 
cell and an IR spectrum recorded at 10 °C increments. In accordance with literature 
studies, the dissociation temperature was recorded as the onset at which an 
absorption characteristic of the isocyanate stretching vibration ~ 2250 cm-1 was 
observed (Table 5.2).  
Table 5.2. Dissociation temperatures of blocked-isocyanates 5.1-6 measured using VTIR 
spectroscopy 
 Blocking group 
Dissociation 
Temperature (°C) 
5.1 diisopropylamine 90-110 
5.2 -caprolactam 120-130 
5.4 3,3-dimethyl-2-butanone oxime 110-120 
5.5 imidazole 65-70 
5.6 2,6-dimethylphenol 150-160 
Ideally, the dissociation temperature should be < 100 °C but not below 70 °C - the 
current mixing conditions for Rowanex 1100 1A. Imidazole-blocked IPDI 5.5 began to 
dissociate at 70 °C, well within the desired temperature range. Diisopropylamine-
blocked IPDI 5.1 exhibited dissociation at 100 °C and it is expected that increasing the 
steric hindrance around the bond will lead to a reduction in the dissociation 
temperature and can be easily achieved by blocking with more sterically hindered 
amines.11 3,3-Dimethyl-2-butanone oxime-blocked IPDI 5.4 began to dissociate at 
120 °C, although this is above the desired temperature, literature studies17 and results 
obtained in Chapter 2 suggest the dissociation temperature of oxime-urethanes can 
also be reduced by increasing the steric hindrance around the oxime. -Caprolactam-
blocked IPDI 5.2 dissociated at 130 °C, above the desired temperature. The 
dissociation of these blocked isocyanates cannot be controlled easily by modification 
of the blocking group structure. Literature studies report22 the dissociation of 
2,6-dimethylphenol-blocked isocyanates occurred at 125 °C, however, the dissociation 




5.2.7. Cure of HTPB using Blocked-IPDI 
The potential of these blocked-isocyanates to cure hydroxy-functionalised polymers at 
elevated temperatures was investigated. The blocked isocyanates 5.1-6 (8.01 mmol) 
were dispersed in a mixture of HTPB (18.22 g) and DBTDL (0.044 g) in accordance 
with the Rowanex 1100 1A formulation using an overhead stirrer at 70 °C. In order to 
achieve uniform curing of HTPB, complete dispersion of the blocked isocyanates 
within HTPB was desired and indeed 5.1 5.2 and 5.4 exhibited excellent solubility at 
70 °C. In contrast, imidazole-blocked IPDI 5.5 and 2,6-dimethylphenol-blocked IPDI 
5.6 exhibited poor solubility in HTPB and thus efficient dispersion was not achieved.  
The mixtures were heated for a period of 72 hours at 120 °C in an evacuated 
atmosphere. Curing of HTPB was achieved using diisopropylamine-blocked IPDI 5.1 - 
however, as a result of the evolution of volatile diisopropylamine, bubbles were formed 
within the polyurethane rubber. The high dissociation temperature of -caprolactam-
blocked IPDI 5.2 (130 °C) prevented the cure of HTPB. The cure of HTPB was 
successfully achieved using oxime-urethane 5.4. The poor solubility of 5.5 in HTPB 
prevented the formation of a homogeneously crosslinked polyurethane, thus the 
formation of a uniformly crosslinked matrix was not achieved. The high temperatures 
required for the dissociation of 2,6-dimethylphenol-blocked IPDI 5.6 and its poor 
solubility in HTPB prevented the formation of a polyurethane matrix (Table 5.3). 
Table 5.3. Solubility and curing capability of blocked isocyanates 5.1-6 in HTPB 
 Blocking group 
Soluble in HTPB 
(70 °C) 
Cure of HTPB 
(120 °C) 
5.1 diisopropylamine yes yes 




5.5 imidazole no no 
5.6 2,6-dimethylphenol no no 
These results identify that oxime-urethanes possess the ideal properties required for 
their potential employment in explosive formulations - soluble in HTPB, low volatility of 
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released oxime and relatively low dissociation temperature that could be decreased by 
modification of the steric and electronic properties of the oxime. 
5.2.8. Effect of Steric Hindrance on the Dissociation of Oxime-Urethanes 
Literature investigations have reported17 that the dissociation of oxime-urethanes is 
accelerated by increasing the steric hindrance of the oxime. In addition, results 
reported in Chapter 2 describe how the increased steric hindrance of a benzophenone 
oxime analogue led to a reduction in the dissociation temperature. IPDI was reacted 
with a range of oximes in order to generate a library of IPDI-based oxime-urethanes 
that possess varying degrees of steric hindrance. All oximes with the exception of 
benzophenone oxime were afforded by the reaction of the corresponding ketones with 
hydroxylamine hydrochloride and triethylamine. The high steric hindrance of 
benzophenone prevented efficient reaction using triethylamine, thus the smaller base 
NaOH was employed. 2-Butanone oxime and 3-methyl-2-butanone oxime were 
obtained as a mixture of E and Z isomers, all other oximes were afforded isomerically 
pure. The dissociation temperature of the oxime-urethanes 5.12-16 was measured 
using VTIR spectroscopy and the results are listed in Table 5.4. 
The least sterically encumbered oxime-urethane 5.12 dissociated at 135 °C. It was 
expected the dissociation of 5.13 would occur at the next highest temperature followed 
by 5.4. However, the dissociation of 5.13 was observed 20 °C below that of 5.4. This 
result suggests that sterically encumbered Z-oximes have a greater effect on the 
dissociation temperature than the corresponding E-isomer. Furthermore, the 
dissociation of 5.14 was observed at the same temperature as 5.13. This steric effect 
was also observed in aromatic oximes, benzophenone-based oxime-urethane 5.16 









Table 5.4. Dissociation temperatures of IPDI blocked with a range of oximes possessing 
varying degrees of steric hindrance. 




 E:Z = 3:1 
135-140 
5.13 














5.2.9. Electronic Effects on the Dissociation of Oxime-Urethanes 
Alongside the effects of steric hindrance on the dissociation temperature of oxime-
urethanes, the electronic effects were also investigated. A range of oxime-urethanes 
using acetophenone oxime analogues were generated that contain electron-
withdrawing and electron donating moieties at the ortho, meta, and para-positions. The 
dissociation temperatures of the generated oxime-urethanes 5.23-28 were measured 






Table 5.5. Dissociation temperatures of IPDI blocked with a range of acetophenone oxime 
analogues that possess electron withdrawing or electron donating groups at the ortho, meta or 
para positions. 
























The dissociation temperature appeared to be significantly reduced by the presence of 
an electron donating group at the ortho-position 5.23. The dissociation mechanism of 
oxime-urethanes proposed8 by Levine et al. occurs via a five-membered tranisition 
state, the close proximity of the polar methoxy moiety may have assisted the 
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dissociation (Scheme 5.7). However, the presence of an ortho nitro-substituent did not 
reduce the dissociation temperature. 
 
Scheme 5.7. Dissociation mechanism of an oxime-urethane, showing the close proximity of 
the methoxy moiety. 
The dissociation temperature was also decreased by the presence of an electron 
donating group at the meta-position and in turn increased by an electron withdrawing 
moiety - this trend is in agreement with literature studies.26 The formation of the five-
membered transition state proposed by Levine et al. may be stabilised by conjugation 
of the electrons within the aromatic system and thus forming an electron deficient 
centre at the ortho-position (Scheme 5.8). The electron withdrawing nitro moiety 
located meta on the aromatic ring further increases this electron deficiency and thus 
destabilises the system. In contrast, electron donating groups stabilise this transition 
state by providing electron density at the electron deficient centre.  
 
Scheme 5.8. Conjugation of the dissociation transition state into the aromatic system. 
The presence of para-substituents did not have any effect on the dissociation 
temperature, both 5.28 and 5.25 dissociating at 120 °C. Conjugation of these moieties 
did not contribute any stabilising or destabilising effect and were not in close proximity 
to the oxime-urethane bond to assist the dissociation. 
5.2.10. Curing Studies of HTPB Using Oxime-Urethanes 
The potential of the generated oxime-urethanes 5.12-28 to cure HTPB was 
investigated. Each oxime-urethane (8.01 mmol) was mixed with HTPB (18.22 g) and 
DBTDL (0.044 g) in ratios according to the Rowanex 1100 1A formulation using an 
overhead stirrer at 70 °C. All aliphatic oxime-urethanes exhibited excellent solubility in 
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HTPB at 70 °C, thus complete dispersion was achieved. In contrast, all of the aromatic 
oxime-urethanes exhibited poor solubility at 70 °C and uniform dispersion of 5.15,16 
and 23 could only be achieved at high temperatures (> 100 °C) with vigorous mixing. 
Uniform dispersion of all of the other aromatic oxime-urethanes was not achieved. 
The mixtures were heated to 120 °C for a period of 72 hours in an evacuated 
atmosphere. Cured HTPB was produced successfully using sterically encumbered 
aliphatic oxime-urethanes 5.13 and 5.14. The generation of a polyurethane matrix was 
achieved using 5.15, 16 and 23, however, the poor solubility of these oxime-urethanes 
led to separation from the polymer and the formation of crystallised regions was 
observed. The poor solubility of aromatic oximes 5.24-28 prevented the formation of a 
polyurethane matrix and only curing small regions of HTPB. 
Table 5.6. Solubility and curing capability of oxime-urethanes 5.12-28 in HTPB. 
 Blocking group 
Soluble in HTPB 
(70 °C) 
Cure of HTPB  
(120 °C) 













5.15 Acetophenone oxime no yes 




























5.2.11. Monitoring the Curing of HTPB  
A variety of techniques can be employed to monitor the reaction of curing 
polyurethanes.27 These include 1H NMR spectroscopy,28 IR spectroscopy,29 differential 
scanning analysis (DSC),30 swelling behaviour31 and tensile testing.27  
As a result of the high molecular weight and restricted mobility of the polymer chains in 
curing HTPB, traditional methods for observing chemical reaction using 1H NMR 
spectroscopy is restricted. In addition, the elastomeric nature of the cured material 
prevented the preparation of a fine powder required for solid state NMR techniques.  
In an IR spectrum, isocyanates exhibit a stretching vibration that appears as an 
absorption at 2250 cm-1, thus observing the appearance of this characteristic 
absorption upon dissociation of the blocked isocyanate followed by its disappearance 
as the crosslinking reaction reaches completion could be an effective method for 
monitoring the curing reaction.29 However, no absorption corresponding to the 
isocyanate was observed during curing, suggesting the reaction occurred immediately 
upon the dissociation of the blocked isocyanates.  
As the curing reaction ensues, the crosslinking density in turn also increases, this may 
be observed by an increase in the glass transition temperature Tg as the mobility of the 
polymer chains decreases.30 However, the glass transition of the fully cured 
polyurethane was below the detectable limits of DSC or indeed the high crosslinking 
density prevented the observation of a defined transition. 
Tensile testing offers a route to monitor the curing reaction, as the curing reaction 
ensues and the crosslinking density increases, the elastic modulus (=stress/strain) 
is expected to increase.4 Tensile testing of the curing mixture of HTPB and 5.4 was 
measured at 24, 48 and 72 hours at 120 °C. In addition, tensile testing was performed 
on a control polyurethane generated from IPDI, HTPB and DBTDL cured for 72 hours 
at 60 °C in accordance with current processing conditions used for manufacture of 
Rowanex 1100 1A. An increase in the elastic modulus was observed after 48 hours 
and a small increase was observed after 72 hours, suggesting the majority of the 
curing had occurred within 48 hours at 120 °C. The elastic modulus of cured control 
polyurethane was significantly higher than the 5.4 mixture. A plasticising effect of the 




Figure 5.7. Stress-strain curves of curing HTPB using 5.4 at 24, 48 and 72 hours at 120 °C 
and control polyurethane. 
A further technique that can be employed for monitoring the curing reaction is to 
measure the swelling behaviour of the polyurethane. Crosslinked polymers readily 
absorb organic solvents and as the crosslinking density of the polyurethane increases 
the permeation of solvent into the polymer in turn decreases.30 Segments (~ 50 mg) of 
the polyurethane cured using 5.4 after 24, 48 and 72 hours were immersed in toluene 
(5 mL) and weighed after a period of 15 minutes. The swelling behaviour of the control 
polyurethane was also measured. Employing Equation 5.1 allows the calculation of 





Where Ms = mass of solvent absorbed (mg), Mrs = molecular weight of solvent and Mp = initial 
mass of polymer (mg). 
As the curing time increases the amount of toluene absorbed by the polymer 
decreases, suggesting the crosslinking density increases. A large decrease is 
observed after 48 hours and only a small change is observed after this time, implying 
that the majority of the curing has occurred within 48 hours supporting tensile testing 
results. In addition, there is only a small difference between the swelling behaviour of 
the polyurethane cured using 5.4 and the control polyurethane, further implying that 
almost complete crosslinking can be achieved using blocked isocyanates after 72 


























reproducibility with only a small range of error (< 0.6%) demonstrating how this simple 
reproducible test can be effectively employed to monitor the curing reaction. 
 
Figure 5.8. Swelling behaviour of polyurethane cured using 5.4 at 24, 48 and 72 hours at 
120 °C and control polyurethane. 
5.2.12. Synthesis of Blocked Isocyanate Prepolymer 
Although most of the oxime-urethanes exhibited good solubility in HTPB at 70 °C, 
some oxime-urethanes, particularly 5.16 could not be easily dispersed, requiring 
temperatures up to 100 °C. This poor solubility caused a small quantity of the oxime-
urethane to separate from the polymer and can be observed as dark crystallised 
regions in the cured polyurethane (Figure 5.9). The formation of a uniformly 
crosslinked polyurethane is desired, thus it was necessary to explore an alternative 
route to employ blocked isocyanates. 
 
Figure 5.9. Image of a cured polyurethane using 5.4 observing dark crystallised regions in the 
cured polyurethane. 
Benzophenone oxime and IPDI were reacted in a ratio of 1:2, this ensured a mixture of 
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and DBTDL were added in order to afford an oligomeric mixture that contains 
benzophenone oxime-blocked HTPB based prepolymer 5.29 (Figure 5.10).  
 
Figure 5.10. Structure of benzophenone oxime-blocked HTPB based prepolymer 5.29. 
The oligomeric mixture 5.29 was cured at 120 °C for a period of 72 hours and a 
uniformly crosslinked polyurethane was generated successfully. Swelling tests 
revealed that complete crosslinking was achieved after 72 hours (Figure 5.11).  
       
Figure 5.11. a) Swelling behaviour of polyurethane cured using 5.29 at 120 °C for 24, 48, 72 
hours and control polyurethane at 72 hours. b) Image of cured 5.29 after 72 hours at 120 °C. 
5.3. Conclusion 
The synthesis of isocyanate crosslinkers blocked with amines, amides, oximes, 
aromatic heterocycles and phenols that can be cleaved using an application of heat 
has been achieved and this thermal reversibility has been confirmed using VTIR 
spectroscopy. The potential of these blocked isocyanates to cure hydroxy-
functionalised polymers was investigated and oxime-urethanes were revealed to 
possess the ideal solubility and curing properties required for potential employment in 
exploisive formulations. Increasing the steric hindrance on the oxime significantly 
reduced the dissociation temperature of the thermally-labile bond. In addition, the 
dissociation temperature can be reduced by the close proximity of electron donating 
groups to the oxime-urethane. The effect of electron donating and electron 




















moieties reducing the dissociation temperature and electron withdrawing nitro 
functionality increasing the dissociation temperature. Methods to monitor the curing of 
polyurethane rubbers were investigated - tensile testing and swelling behaviour tests 
proved efficient methods of analysis. The poor solubility of certain aromatic oxime-
urethanes led to the formation of an inhomogeneously crosslinked rubber. The 
formation of blocked HTPB-based prepolymer was demonstrated to eliminate this 
problem and allowed the successful formation of a uniform polyurethane matrix. 
5.4. Experimental 
All chemical purification and experimental techniques employed in this chapter are 
identical to those described in Chapter 2 and 3 with the exception of the following. 
Gel permeation chromatography (GPC) was carried out using an Agilent Technologies 
1260 Infinity Series Chromatograph employing an Agilent Technologies PLgel 5m 
MIXED-D column (300 x 7.5 mm) eluting tetrahydrofuran (THF) at 40 °C calibrated 
with polystyrene standards. Tensile stress tests were carried out using a Stable 
Microsystems TA.XT Plus Texture Analyser.  
Synthesis of diisopropylamine-blocked IPDI 5.1 
 
Diisopropylamine (5.06 g, 50.0 mmol) and isophorone diisocyanate (IPDI) (5.30 g, 
24.0 mmol) were dissolved in dichloromethane (100 mL) and stirred at room 
temperature for a period of 1 hour in an atmosphere of argon. The excess amine was 
removed by washing with HCl (1M) (3 x 50 mL) followed by NaHCO3 (2 x 20 mL). The 
solution was dried over MgSO4, filtered and solvent removed in vacuo to leave a white 
solid 5.1 (9.95 g, 99 %) (m.p. 72-75 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.87 
(3H, m, He), 0.90 (1H, m, Ha), 0.93 (3H, s, Hg), 1.08 (1H, m, Hd), 1.09 (1H, m, Hb), 1.10 
(3H, m, He’), 1.22 (1H, m, Ha’), 1.23 (24H, m, Hj), 1.74 (1H, m, Hd’), 1.80 (1H, m, Hb’), 
3.05 (2H, m, Hf), 3.87 (4H, m, Hi), 4.03 (1H, m, Hc), 4.30 (1H, m, Hh’), 4.67 (1H, m, Hh);
 
13C NMR (100 MHz, CDCl3) C (ppm): 21.5, 23.4, 27.7, 32.1, 35.3, 36.4, 42.9, 43.7 
44.8, 47.3, 48.1, 54.7, 156.6, 157.5; FTIR (ATR)  (cm-1): 3361 (N-H), 2960 (C-H), 
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1620 (C=O), 1514 (N-H), 1327 (C-N); ESIMS calculated mass (C24H48O2N4+H)
+ 
425.3850 found 425.3841. 
Synthesis of -caprolactam-blocked IPDI 5.2 
 
IPDI (4.96 g, 22.3 mmol) and -caprolactam (7.57 g, 66.9 mmol) were dissolved in 
THF (100 mL) and maintained under reflux for a period of 18 hours in an atmosphere 
of argon. The solution was poured into water (500 mL) and decanted to leave a 
viscous colourless oil that was dissolved in THF (50 mL), dried over MgSO4, filtered 
and the solvent removed in vacuo to yield a white solid 5.2 (9.79 g, 98 %) (m.p. 
58-60 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.93 (3H, s, He), 1.00 (2H, m, Hbd), 
1.03 (3H, s, Hg), 1.08 (3H, s, He’), 1.08 (1H, m, Ha), 1.26 (1H, m, Ha’), 1.72 (2H, m, Hk), 
1.76 (2H, m, Hj), 1.78 (2H, m, Hl), 1.78 (2H, m, Hb’d’), 2.71 (2H, m, Hi), 3.07 (2H, m, Hf), 
3.98 (2H, m, Hm), 4.04 (1H, m, Hc), 9.13 (1H, m, Hh’), 9.44 (1H, m, Hh); 
13C NMR (100 
MHz, CDCl3) C (ppm): 23.4, 23.4, 27.6, 28.3, 29.1, 31.8, 35.1 36.1, 39.8, 41.8, 43.8, 
44.3, 46.0, 47.4, 54.7, 154.0, 155.2, 179.3; FTIR (ATR)  (cm-1): 3260 (N-H), 1694 
(C=O amide), 1651 (C=O urea), 1163 (C-N); ESIMS calculated mass 
(C24H40O4N4+Na)
+ 471.2942 found 471.2935. 
Synthesis of 3,3-dimethyl-2-butanone oxime 5.332 
 
Hydroxylamine hydrochloride (10.15 g, 146.0 mmol), triethylamine (14.77 g, 
146.0 mmol) and 3,3-dimethyl-2-butanone (13.28 g, 133.0 mmol) were dissolved in 
EtOH (100 mL) and maintained under reflux for a period of 4 hours. The solvent was 
removed in vacuo and the product extracted with Et2O to afford a white solid 5.3 
(12.73 g, 83 %) (m.p. 73-76 °C, lit. 75-76°C). 1H NMR (400 MHz, CDCl3) H (ppm): 
1.07 (9H, s, Hb), 1.81 (3H, s, Ha), 9.70 (1H, br., Hc); 
13C NMR (100 MHz, CDCl3) C 
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(ppm): 10.1, 27.5, 37.2, 164.2; FTIR (ATR)  (cm-1): 3236 (O-H), 1661 (C=N), 929 
(N-O); ESIMS calculated mass (C6H13ON+H)
+ 116.1070 found 116.1067. 
Synthesis of 3,3-dimethyl-2-butanone oxime-blocked IPDI 5.4 
 
3,3-Dimethyl-2-butanone oxime 5.3 (12.73 g, 110.5 mmol) and IPDI (12.28 g, 
55.3 mmol) were dissolved in THF (150 mL) and maintained under reflux for a period 
of 18 hours in an atmosphere of argon. The solvent was removed in vacuo to leave a 
white solid 5.4 (24.90 g, 99 %) (m.p. 57-61 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 
0.96 (6H, s, Heg), 0.99 (2H, m, Hbd), 1.10 (1H, m, Ha), 1.13 (3H, s, He’), 1.18 (18H, m, 
Hj) 1.25 (1H, m, Ha’), 1.83 (2H, m, Hb’d’), 2.00 (6H, m, Hi), 3.07 (2H, m, Hf), 3.96 (1H, 
m, Hc), 6.13 (1H, m, Hh’), 6.58 (1H, m, Hh); 
13C NMR (100 MHz, CDCl3) C (ppm): 12.1, 
23.4, 27.3, 30.0, 31.9, 35.1, 36.4, 37.9, 42.8, 44.6, 46.9, 47.2, 54.7, 155.1, 156.3, 
169.0; FTIR (ATR)  (cm-1): 3408 (N-H), 1726 (C=O), 1638 (C=N), 1495 (C-N), 997 
(C-O), 904 (N-O); ESIMS calculated mass (C24H44O4N4+H)
+ 453.3435 found 453.3435. 
Synthesis of imidazole-blocked IPDI 5.5 
 
Imidazole (3.80 g, 55.8 mmol) and IPDI (6.2 g, 27.9 mmol) were dissolved in 
tetrahydrofuran (THF) (100 mL) and stirred for a period of 2 hours at room temperature 
in an atmosphere of argon. The solvent was removed in vacuo to leave a white solid 
5.5 (9.8 g, 98 %) (m.p. 85-89 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.97 (3H, s, 
He), 1.13 (3H, s, Hg), 1.19 (3H, s, He’), 1.19 (2H, m, Hbd), 1.25 (1H, m, Ha), 1.32 (1H, m, 
Ha’), 1.80 (2H, m, Hb’d’), 3.20 (2H, m, Hf), 4.18 (1H, m, Hc), 7.01 (2H, m, Hj), 7.60 (1H, 
m, Hh’) 7.65 (2H, m, Hi), 7.86 (1H, m, Hh), 8.22 (2H, m, Hk); 
13C NMR (100 MHz, 
CDCl3) C (ppm): 23.8, 28.0, 29.7, 35.5, 37.9, 41.7, 45.7, 46.0, 47.7, 54.8, 117.1, 
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130.6, 136.7, 149.2, 150.6; FTIR (ATR)  (cm-1): 3223 (N-H), 1698 (C=O), 1282 (C-N); 
ESIMS calculated mass (C18H26O2N6+H)
+ 359.2190 found 359.2190. 
Synthesis of 2,6-dimethylphenol-blocked IPDI 5.6 
 
2,6-Dimethylphenol (5.0 g, 40.9 mmol), IPDI (4.55 g, 20.46 mmol) and dibutyltin 
dilaurate (DBTDL) (0.387 g, 0.6 mmol) were dissolved in THF (100 ml) and maintained 
under refluxed for a period of 24 hours under an atmosphere of argon. The product 
was precipitated in hexane (300 mL), filtered, washed with a further portion of hexane 
(200 mL) and dried under high vacuum to leave a white solid 5.6 (8.95, 94 %) 
(m.p. 80-84 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.96 (3H, s, He), 1.01 (2H, m, 
Hbd), 1.09 (3H, s, Hg), 1.12 (3H, s, He’), 1.12 (1H, m, Ha), 1.25 (1H, m, Ha’), 1.83 (2H, 
m, Hb’d’), 2.20 (12H, m, Hi), 3.03 (2H, m, Hf), 3.90 (1H, m, Hc), 6.74 (1H, m, Hh’), 6.95 
(1H, m, Hh), 7.04 (6H, m, Hjk); 
13C NMR (100 MHz, CDCl3) C (ppm): 15.9, 23.2, 27.6, 
31.9, 35.1, 36.6, 41.7, 45.0, 46.2, 47.1, 55.1, 120.1, 125.6, 128.5, 130.9, 153.3, 154.5; 
FTIR (ATR)  (cm-1): 3314 (N-H), 1706 (C=O), 1241 (C-N), 1174 (C-O); ESIMS 
calculated mass (C28H38O4N2+Na)
+ 489.2724 found 489.2711. 
Synthesis of 2-butanone oxime 5.732 
 
2-Butanone (14.4 g, 200 mmol), hydroxylamine hydrochloride (15.3 g, 220 mmol) and 
triethylamine (22.26 g, 220 mmol) were dissolved in MeOH (200 mL) and maintained 
under reflux for a period of 4 hours. The solvent was removed in vacuo and the 
product extracted with Et2O to give a colourless oil 5.7 (16.8 g, 96 %) (E:Z, 3:1). (E)-2-
butanone oxime: 1H NMR (400 MHz, CDCl3) H (ppm): 1.01 (3H, t J = 7.5 Hz, Hc), 1.81 
(3H, s, Ha), 2.15 (2H, q J = 7.5 Hz, Hb), 9.79 (1H, br., Hd); 
13C NMR (100 MHz, CDCl3) 
C (ppm): 10.7, 13.2, 29.1, 159.4; (Z)-2-butanone oxime:
 1H NMR (400 MHz, CDCl3) H 
(ppm): 1.00 (3H, t J = 8.0 Hz, Ha’), 1.80 (3H, s, Hc’), 2.33 (2H, q J = 8.0 Hz, Hb’), 9.79 
(1H, br., Hd’); 
13C NMR (100 MHz, CDCl3) C (ppm): 9.8, 19.1, 21.8, 159.9; FTIR (ATR) 
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 (cm-1): 3232 (O-H), 1664 (C=N), 929 (N-O); ESIMS calculated mass (C4H9ON+H)
+ 
88.0757 found 88.0753.  
Synthesis of 3-methyl-2-butanone oxime 5.832 
 
Hydroxylamine hydrochloride (9.00 g, 129.0 mmol), triethylamine (13.1 g, 129.0 mmol) 
and 3-methyl-2-butanone (10.16 g, 118 mmol) were dissolved in EtOH (50 mL) and 
maintained under reflux for a period of 4 hours. The solvent was removed in vacuo 
and the product extracted with Et2O to yield a colourless oil 5.8 (11.63 g, 97 %) (E:Z, 
4:1). (E)-3-methyl-2-butanone oxime: 1H NMR (400 MHz, CDCl3) H (ppm): 1.10 (6H, d 
J = 7.0 Hz, Hc), 1.86 (3H, s, Ha), 2.51 (1H, hept. J = 7.0 Hz, Hb)  9.79 (1H, br., Hd); 
13C NMR (100 MHz, CDCl3) C (ppm): 11.1, 19.6, 34.4, 162.4; (Z)-3-methyl-2-butanone 
oxime: 1H NMR (400 MHz, CDCl3) H (ppm): 1.05 (6H, d J = 7.0 Hz, Hc’), 1.79 (3H, s, 
Ha’), 3.48 (1H, hept. J = 7.0 Hz, Hb’), 9.79 (1H, br., Hd’); 
13C NMR (100 MHz, CDCl3) C 
(ppm): 15.3, 18.8, 25.7, 162.9; FTIR (ATR)  (cm-1): 3252 (O-H), 1657 (C=N), 937 (N-
O); ESIMS calculated mass (C5H11ON+H)
+ 102.0913 found 102.0909. 
Synthesis of 2,4-dimethyl-3-pentanone oxime 5.932 
 
Hydroxylamine hydrochloride (3.20 g, 46.0 mmol), triethylamine (4.65 g, 46.0 mmol) 
and 2,4-dimethyl-3-pentanone (4.80 g, 42.0 mmol) were dissolved in EtOH (50 mL) 
and maintained under reflux for a period of 4 hours. The solvent was removed in 
vacuo and the product extracted with Et2O to yield a white solid 5.9 (4.50 g, 83 %) 
(m.p. 33-34 °C, lit. 33-34 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 1.06 (6H, d J = 
7.0 Hz, Hb), 1.10 (6H, d J = 7.5 Hz, Hb’), 2.49 (1H, hept. J = 7.0 Hz, Ha), 3.14 (1H, 
hept. J = 7.5 Hz, Ha’), 9.75 (1H, br., Hc); 
13C NMR (100 MHz, CDCl3) C (ppm): 18.8, 
21.3, 27.5, 30.7, 168.5; FTIR (ATR)  (cm-1): 3266 (O-H), 1651 (C=N), 941 (N-O); 
ESIMS calculated mass (C7H15ON+H)




Synthesis of acetophenone oxime 5.1032 
 
Hydroxylamine hydrochloride (3.89 g, 56.0 mmol), triethylamine (5.66 g, 56.0 mmol) 
and acetophenone (6.13 g, 51.0 mmol) were dissolved in EtOH (100 mL) and 
maintained under reflux for a period of 18 hours. The solvent was removed in vacuo 
and the product extracted with Et2O to yield a white solid 5.10 (5.75 g, 94 %) 
(m.p. 54-55 °C, lit. 55-60 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 2.31 (3H, s, Ha), 
7.39 (3H, m, Hbd), 7.63 (2H, m, Hc), 9.43 (1H, br., He); 
13C NMR (100 MHz, CDCl3) C 
(ppm): 12.4, 126.1, 128.6, 129.3, 136.5, 156.0; FTIR (ATR)  (cm-1): 3235 (O-H), 1599 
(C=N), 923 (N-O); ESIMS calculated mass (C8H9ON+H)
+ 136.0757 found 136.0754. 
Synthesis of benzophenone oxime 5.1133 
 
Benzophenone (5.00 g, 27.4 mmol), hydroxylamine hydrochloride (3.82 g, 54.8 mmol) 
and sodium hydroxide (2.02 g, 54.8 mmol) were dissolved in MeOH (40 ml) for 18 
hours. The solution was precipitated into H2O, filtered and dried under high vacuum to 
give a white solid 5.11 (5.38 g, 99 %) (m.p. 136-140 °C, lit. 139-141 °C). 1H NMR 
(400 MHz, CDCl3) H (ppm): 7.30-7.47 (10H, m, Habc), 9.08 (1H, br., Hd); 
13C NMR 
(100 MHz, CDCl3) C (ppm): 127.9, 128.2, 128.3, 121.9, 129.2, 129.5, 132.7, 136.2, 
158.0; FTIR (ATR)  (cm-1): 3222 (O-H), 3056 (C-H), 1444 (C=N), 918 (N-O); ESIMS 
calculated mass (C13H11ON+H)
+ 198.0913 found 198.0910. 
Synthesis of 2-butanone oxime-blocked IPDI 5.12 
 
Isophorone diisocyanate (11.21 g, 50.0 mmol) and 2-butanone oxime 5.7 (8.79 g, 
100.0 mmol) were dissolved in THF (100 mL) and maintained under reflux for a period 
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of 18 hours. The solvent was removed in vacuo to give a white solid 5.12 (19.38 g, 
98 %), (m.p. 65-69 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.96 (6H, s, Heg), 1.01 
(2H, m, Hdb), 1.10 (1H, m, Ha), 1.12 (3H, s, He’), 1.17 (6H, m, Hk), 1.27 (1H, m, Ha’), 
1.82 (2H, m, Hb’d’), 1.96-2.01 (6H, m, Hi), 2.30-2.49 (4H, m, Hj), 3.06 (2H, m, Hf), 3.96 
(1H, m, Hc), 6.12 (1H, m, Hh’), 6.47 (1H, m, Hh);
 13C NMR (100 MHz, CDCl3) C (ppm): 
10.4, 15.2, 19.4, 23.7, 27.7, 29.2, 35.1, 41.6, 44.7, 46.2, 47.2, 54.7, 154.9, 156.2, 
164.4; FTIR (ATR)  (cm-1): 3404 (N-H), 2952 (C-H), 1714 (C=O), 1651 (C=N), 1504 
(C-N), 1001 (C-O), 905 (N-O); ESIMS calculated mass (C20H36O4N4+Na)
+ 419.2629 
found 419.2627. 
Synthesis of 3-methyl-2-butanone oxime-blocked IPDI 5.13 
 
Isophorone diisocyanate (12.78 g, 57.5 mmol) and 3-methyl-2-butanone oxime 5.8 
(11.63 g, 115.0 mmol) were dissolved in THF (60 ml) and maintained under reflux for 
18 hours in an atmosphere of argon. The solvent was removed in vacuo to leave a 
white solid 5.13 (15.0 g, 63 %) (m.p. 45-49 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 
0.96 (6H, s, Heg), 1.01 (2H, m, Hbd), 1.05 (3H, s, He’), 1.05 (1H, m, Ha), 1.12 (12H, m, 
Hk), 1.27 (1H, m, Ha’), 1.79 (2H, m, Hb’d’), 1.98-2.00 (6H, m, Hi), 2.30-2.49 (2H, m, Hj), 
3.06 (2H, m, Hf), 3.95 (1H, m, Hc), 6.12 (1H, m, Hh’), 6.47 (1H, m, Hh); 
13C NMR 
(100 MHz, CDCl3) C (ppm): 10.4, 15.1, 19.4, 23.7, 27.7, 29.2, 31.8, 35.1, 36.5, 41.6, 
44.7, 46.2, 47.2, 54.7, 154.9, 156.2, 164.3; FTIR (ATR)  (cm-1): 3411 (N-H), 2962 
(C-H), 1723 (C=O), 1644 (C=N), 1498 (C-N), 999 (C-O), 911 (N-O); ESIMS calculated 
mass (C22H40O4N4+H)








Synthesis of 2,4-dimethylpentanone oxime-blocked IPDI 5.14 
 
Isophorone diisocyanate (4.00 g, 18.0 mmol) and 2,4-dimethyl-3-pentanone oxime 5.9 
(4.65 g, 36.0 mmol) were dissolved in THF (100 ml) and maintained under reflux for 
18 hours. The solvent was removed in vacuo to leave a white solid 5.14 (8.50 g, 98 %) 
(m.p. 56-62 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.96 (6H, s, Heg), 0.96 (3H, s, 
He’), 1.01 (1H, m, Hd), 1.04 (1H, m, Hb), 1.10 (1H, m, Ha), 1.15 (12H, m, Hj), 1.17 (12H, 
m, Hj’), 1.28 (1H, m, Ha’), 1.84 (2H, m, Hb’d’), 2.64 (2H, m, Hi), 3.06 (2H, m, Hf), 3.23 
(2H, m, Hi’), 3.96 (1H, m, Hc), 6.12 (1H, m, Hh’), 6.54 (1H, m, Hh); 
13C NMR (100 MHz, 
CDCl3) C (ppm): 19.0, 21.0, 21.2, 29.2, 29.2, 31.4, 35.1, 36.4, 41.7, 44.6, 46.2, 47.3, 
54.7, 155.0, 156.3, 173.8; FTIR (ATR)  (cm-1): 3408 (N-H), 1728 (C=O), 1635 (C=N), 
1496 (C-N), 991 (C-O), 898 (N-O); ESIMS calculated mass (C26H48O4N4+H)
+ 481.3748 
found 481.3745. 
Synthesis of acetophenone oxime-blocked IPDI 5.15 
 
Isophorone diisocyanate (4.73 g, 21.3 mmol) and acetophenone oxime 5.10 (5.75 g, 
42.5 mmol) were dissolved in THF (100 ml) and maintained under reflux for 18 hours. 
The solvent was removed in vacuo to leave a white solid 5.15 (10.43 g, 99 %), (m.p. 
72-74 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.97 (6H, s, Heg), 1.05 (2H, m, Hbd), 
1.12 (3H, s, He’), 1.17 (1H, m, Ha), 1.27 (1H, m, Ha’), 1.85 (2H, m, Hb’d’), 2.43 (6H, s, 
Hi), 3.14 (2H, m, Hf), 4.02 (1H, m, Hc), 6.25 (1H, m, Hh’), 6.60 (1H, m, Hh), 7.45 (4H, m, 
Hk), 7.45 (2H, m, Hl), 7.66 (4H, m, Hk);
 13C NMR (100 MHz, CDCl3) C (ppm): 14.6, 
23.3, 27.7, 32.0, 35.1, 36.6, 41.7, 44.9, 46.2, 47.2, 54.9, 126.8, 128.8, 130.5, 134.9, 
154.6, 156.0, 160.1; FTIR (ATR)  (cm-1): 3319 (N-H), 1722 (C=O), 1622 (C=N), 1495 
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(C-N), 989 (C-O), 912 (N-O); ESIMS calculated mass (C28H36O4N4+Na)
+ 515.2629 
found 515.2622 
Synthesis of benzophenone oxime-blocked IPDI 5.16 
 
Isophorone diisocyanate (3.01 g, 13.5 mmol) and benzophenone oxime 5.11 (5.34 g, 
27.1 mmol) were dissolved in THF (40 ml) and refluxed for 18 hours under an 
atmosphere of argon. The solvent was removed to give a white solid 5.16 (8.14 g, 
97 %), (m.p. 93-96 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.98 (6H, s,  Heg), 0.99 
(3H, s, He’), 1.06 (2H, m, Hbd), 1.16 (1H, m, Ha), 1.28 (1H, m, Ha’), 1.86 (2H, m, Hb’d’), 
3.10 (2H, m, Hf), 4.01 (1H, m, Hc), 6.14 (1H, m, Hh’), 6.53 (1H, m, Hh), 7.38 (8H, m, Hil), 
7.45 (4H, m, Hnk), 7.50 (8H, m, Hjm); 
13C NMR (100 MHz, CDCl3) C (ppm): 29.8, 32.0, 
35.1, 35.1, 36.5, 41.7, 45.7, 46.2, 47.2, 54.9, 128.3, 128.9, 129.9, 129.4, 130.8, 132.0, 
135.1, 154.4, 155.8, 161.4; FTIR (ATR)  (cm-1): 3408 (N-H), 1728 (C=O), 1638 
(C=N), 1493 (C-N), 959 (C-O), 910 (N-O); ESIMS calculated mass (C38H40O4N4+Na)
+ 
639.2942 found 639.2936. 
Synthesis of o-methoxyacetophenone oxime 5.1734 
 
Hydroxylamine hydrochloride (5.53 g, 79.6 mmol), o-methoxyacetophenone (10.87 g, 
72.4 mmol) and triethylamine (8.05 g, 79.6 mmol) were dissolved in EtOH (100 mL) 
and maintained under reflux for a period of 18 hours. The solvent was removed in 
vacuo and the product extracted with EtOAc. The organic phase was washed with H2O 
(3 x 50 mL), dried over MgSO4 and then filtered. The solvent was removed in vacuo to 
leave a white solid 5.17 (11.80 g, 99 %) (m.p. 83-86 °C, lit. 96-97 °C) (E:Z, 9:1). (E)-o-
methoxyacetophenone oxime:  1H NMR (400 MHz, CDCl3) H (ppm): 2.24 (3H, s, He), 
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3.83 (3H, s, Hf), 6.92 (1H, d J = 8.0 Hz, Ha), 6.96 (1H, td J = 7.5, 1.0 Hz, Hc), 7.30 (1H, 
m, Hb), 7.32 (1H, m, Hd), 9.43 (1H, br., Hg);
 13C NMR (100 MHz, CDCl3) C (ppm): 15.2, 
55.4, 111.1, 120.6, 126.8, 129.4, 130.2, 156.8, 157.4; (Z)-o-methoxyacetophenone 
oxime: 1H NMR (400 MHz, CDCl3) H (ppm): 2.18 (3H, s, He’), 3.82 (3H, s, Hf’), 6.96 
(1H, d J = 8.0 Hz, Ha’), 6.99 (1H, td J = 7.5, 1.0 Hz, Hc’), 7.30 (1H, m, Hb’), 7.35 (1H, m, 
Hd’), 8.52 (1H, br., Hg);
 13C NMR (100 MHz, CDCl3) C (ppm): 21.4, 55.6, 111.2, 120.5, 
124.2, 128.4, 129.9, 156.8, 157.4; FTIR (ATR)  (cm-1): 3210 (O-H), 2962 (C-H), 1460 
(C=N), 1023 (C-O), 915 (N-O); ESIMS calculated mass (C9H11O2N+H)
+ 166.0863 
found 166.0860. 
Synthesis of m-methoxyacetophenone oxime 5.1834 
 
Hydroxylamine hydrochloride (5.53 g, 79.6 mmol), m-methoxyacetophenone (10.87 g, 
72.4 mmol) and triethylamine (8.05 g, 79.6 mmol) were dissolved in EtOH (100 mL) 
and maintained under reflux for a period of 18 hours. The solvent was removed in 
vacuo and the product extracted with EtOAc. The organic phase was washed with H2O 
(3 x 50 mL), dried over MgSO4 and then filtered. The solvent was removed in vacuo to 
leave a white solid 5.18 (11.59 g, 99 %) (m.p. 44-45 °C, lit. 44-45 °C). 1H NMR 
(400 MHz, CDCl3) H (ppm): 2.29 (3H, s, He), 3.82 (3H, s, Hf), 6.92 (1H, ddd J = 8.0, 
3.0, 1.0 Hz Hc), 7.20 (2H, m, Hab), 7.29 (1H, d J = 8.0 Hz, Hd), 9.76 (1H, br., Hg);
 
13C NMR (100 MHz, CDCl3) C (ppm): 12.5, 55.3, 111.14, 115.1, 118.7, 129.6, 137.9, 
156.0, 159.7; FTIR (ATR)  (cm-1): 3234 (O-H), 2938 (C-H), 1578 (C=N), 1038 (C-O), 
939 (N-O); ESIMS calculated mass (C9H11O2N+H)
+ 166.0863 found 166.0859. 
Synthesis of p-methoxyacetophenone oxime 5.1934 
 
Hydroxylamine hydrochloride (5.53 g, 79.6 mmol), p-methoxyacetophenone (10.87 g, 
72.4 mmol) and triethylamine (8.05 g, 79.6 mmol) were dissolved in EtOH (100 mL) 
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and maintained under reflux for a period of 18 hours. The solvent was removed in 
vacuo and the product extracted with EtOAc. The organic phase was washed with H2O 
(3 x 50 mL), dried over MgSO4 and then filtered. The solvent was removed in vacuo to 
leave a white solid 5.19 (11.48 g, 96 %) (m.p. 82-84 °C, lit. 85-86 °C). 1H NMR 
(400 MHz, CDCl3) H (ppm): 2.28 (3H, s, Hd), 3.82 (3H, s, Hc), 6.90 (2H, d J = 9.0 Hz, 
Hb), 7.57 (2H, d J = 9.0 Hz, Ha), 9.61 (1H, br., He); 
13C NMR (100 MHz, CDCl3) C 
(ppm): 12.3, 55.3, 113.9, 127.4, 129.0, 155.5, 160.5; FTIR (ATR)  (cm-1): 3212 (O-H), 
2936 (C-H), 1514 (C=N), 1023 (C-O), 920 (N-O); ESIMS calculated mass 
(C9H11O2N+H)
+ 166.0863 found 166.0859. 
Synthesis of o-nitroacetophenone oxime 5.2034 
 
Hydroxylamine hydrochloride (5.27 g, 75.9 mmol), o-nitroacetophenone (11.34 g, 
69.0 mmol) and triethylamine (7.68 g, 75.9 mmol) were dissolved in EtOH (100 mL) 
and maintained under reflux for a period of 18 hours. The solvent was removed in 
vacuo and the product extracted with EtOAc. The organic phase was washed with H2O 
(3 x 50 mL), dried over MgSO4 and then filtered. The solvent was removed in vacuo to 
leave a white solid 5.20 (11.60 g, 93 %) (m.p. 83-86 °C, lit. 118-119 °C) (E:Z, 1:2). 
(E)-o-nitroacetophenone oxime: 1H NMR (400 MHz, Acetone-d6) H (ppm): 2.21 (3H, s, 
He), 7.65 (1H, dd J = 8.0, 1.5 Hz, Hd), 7.63 (1H, td J = 8.0, 1.5 Hz, Hb), 7.76 (1H, td J = 
8.0, 1.5 Hz, Hc), 7.95 (1H, dd J = 8.0, 1.5 Hz, Ha), 10.55 (1H, s, Hf); 
13C NMR 
(100 MHz, Acetone-d6) C (ppm): 14.8, 125.0, 130.3, 131.2, 133.7, 132.2, 133.9, 
153.5; (Z)-o-nitroacetophenone oxime: 1H NMR (400 MHz, Acetone-d6) H (ppm): 2.26 
(3H, s, He’), 7.47 (1H, dd J = 8.0, 1.5 Hz, Hd’), 7.61 (1H, td J = 8.0, 1.0 Hz, Hb’), 7.82 
(1H, td J = 8.0, 1.5 Hz, Hc)’, 8.08 (1H, dd J = 8.0, 1.5 Hz, Ha’), 9.87 (1H, s, Hf’); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 21.0, 124.6, 129.5, 130.2, 132.2, 133.9, 
134.6, 153.5; FTIR (ATR)  (cm-1): 3194(O-H), 2873 (C-H), 1521 (C=N), 1348 (N-O), 
930 (N-O); ESIMS calculated mass (C8H8O3N2+H)




Synthesis of m-nitroacetophenone oxime 5.2134 
 
Hydroxylamine hydrochloride (5.27 g, 75.9 mmol), m-nitroacetophenone (11.34 g, 
69 mmol) and triethylamine (7.68 g, 75.9 mmol) were dissolved in EtOH (100 mL) and 
maintained under reflux for a period of 18 hours. The solvent was removed in vacuo 
and the product extracted with EtOAc. The organic phase was washed with H2O (3 x 
50 mL), dried over MgSO4 and then filtered. The solvent was removed in vacuo to 
leave a white solid 5.21 (11.55 g, 93 %) (m.p. 131-134 °C, lit. 131-132 °C). 1H NMR 
(400 MHz, Acetone-d6) H (ppm): 2.23 (3H, s, He), 7.70 (1H, t J = 8.0 Hz, Hc), 8.13 
(1H, dd J = 8.0, 2.0 Hz, Hb), 8.23 (1H, dd J = 8.0, 2.0 Hz, Hd), 8.54 (1H, t J = 2.0 Hz, 
Ha), 10.76 (1H, s, Hf); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 11.4, 121.0, 123.9, 
130.6, 132.6, 139.8, 149.4, 152.9; FTIR (ATR)  (cm-1): 3222 (O-H), 3081 (C-H), 1521 
(C=N), 1351 (N-O), 947 (N-O); ESIMS calculated mass (C8H8O3N2+H)
+ 181.0608 
found181.0605. 
Synthesis of p-nitroacetophenone oxime 5.2234 
 
Hydroxylamine hydrochloride (5.27 g, 75.9 mmol), p-nitroacetophenone (11.34 g, 
69 mmol) and triethylamine (7.68 g, 75.9 mmol) were dissolved in EtOH (100 mL) and 
maintained under reflux for a period of 18 hours. The solvent was removed in vacuo 
and the product extracted with EtOAc. The organic phase was washed with H2O (3 x 
50 mL), dried over MgSO4 and then filtered. The solvent was removed in vacuo to 
leave a white solid 5.22 (12.04 g, 97 %) (m.p. 171-175 °C, lit. 174-175 °C). 1H NMR 
(400 MHz, Acetone-d6) H (ppm): 2.31 (3H, s, Hc), 7.98 (2H, d J = 8.0 Hz, Ha), 8.25 
(2H, d J = 8.0 Hz, Hb), 10.90 (1H, s, Hd); 
13C NMR (100 MHz, Acetone-d6) C (ppm): 
11.4, 124.3, 127.5, 144.3, 148.8, 153.3; FTIR (ATR)  (cm-1): 3216 (O-H), 3078 (C-H), 





Synthesis of o-methoxyacetophenone oxime-blocked IPDI 5.23 
 
Isophorone diisocyanate (7.62 g, 34.3 mmol) and o-methoxyacetophenone oxime 5.17 
(11.32 g, 68.5 mmol) were dissolved in THF (100 mL) and maintained under reflux for 
18 hours under an atmosphere of argon. The solvent was removed to leave a white 
solid 5.23 (18.94 g, 100 %) (m.p. 58-62 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.93 
(3H, s, He), 1.00 (2H, m, Hbd), 1.09 (1H, m, Ha), 1.09 (3H, s, Hg), 1.11 (3H, s, He’), 1.23 
(1H, m, Ha’), 1.80 (2H, m, Hb’d’), 2.37 (6H, s, Hi), 3.05 (2H, m, Hf), 3.86 (6H, s, Hn), 3.98 
(1H, m, Hc), 6.21 (1H, m, Hh’), 6.55 (1H, m, Hh), 6.96 (2H, td J = 7.0, 2.0 Hz, Hj), 
7.00 (2H, td J = 7.0, 2.0 Hz, Hl), 7.31 (2H, td J = 7.0, 2.0 Hz, Hk), 7.43 (2H, td J = 7.0, 
2.0 Hz, Hm); 
13C NMR (100 MHz, CDCl3) C (ppm): 17.2, 23.3, 27.4, 31.9, 35.0, 36.6, 
41.8, 44.3, 46.2, 47.2, 54.8, 55.4, 111.1, 120.5, 125.3, 129.6, 131.2, 154.8, 156.1, 
157.6, 161.9; FTIR (ATR)  (cm-1): 3411 (N-H), 2952 (C-H), 1724 (C=O), 1600 (C=N), 
1491 (C-N), 1021 (C-O), 996 (C-O), 904 (N-O); ESIMS calculated mass 
(C30H40O6N4+Na)
+ 575.2840 found 575.2843. 
Synthesis of m-methoxyacetophenone oxime-blocked IPDI 5.24 
 
Isophorone diisocyanate (7.61 g, 34.2 mmol) and m-methoxyacetophenone oxime 
5.18 (11.31 g, 68.5 mmol) were dissolved in THF (100 mL) and maintained under 
reflux for 18 hours under an atmosphere of argon. The solvent was removed to leave a 
white solid 5.24 (18.05 g, 95 %) (m.p. 59-63 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 
0.96 (3H, s, He), 1.05 (1H, m, Hb), 1.05 (1H, m, Hd), 1.11 (3H, s, Hg), 1.14 (1H, m, Ha), 
1.15 (3H, s, He’), 1.29 (1H, m, Ha’), 1.83 (1H, m, Hb’), 1.85 (1H, m, Hd’), 2.41 (6H, s, Hi), 
3.11 (2H, m, Hf), 3.85 (6H, s, Hn), 4.00 (1H, m, Hc), 6.21 (1H, m, Hh’), 6.60 (1H, m, Hh), 
7.00 (2H, dd J = 8.0, 2.0 Hz, Hl), 7.19 (2H, m, Hj), 7.24 (2H, m, Hk), 7.35 (2H, m, Hm); 
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13C NMR (100 MHz, CDCl3) C (ppm): 14.6, 23.1, 27.3, 31.9, 35.1, 36.6, 41.8, 44.7, 
46.2, 47.3, 55.0, 55.2, 112.3, 115.9, 119.0, 129.7, 136.6, 154.6, 155.9, 159.7, 160.1; 
FTIR (ATR)  (cm-1): 3409 (N-H), 2951 (C-H), 1725 (C=O), 1599 (C=N), 1495 (C-N), 
1041 (C-O), 993 (C-O), 923 (N-O); ESIMS calculated mass (C30H40O6N4+Na)
+ 
575.2840 found 575.2843. 
Synthesis of p-methoxyacetophenone oxime-blocked IPDI 5.25 
 
Isophorone diisocyanate (7.54 g, 33.9 mmol) and p-methoxyacetophenone oxime 5.19 
(11.20 g, 67.8 mmol) were dissolved in THF (100 mL) and maintained under reflux for 
18 hours under an atmosphere of argon. The solvent was removed to leave a white 
solid 5.25 (18.29 g, 97 %) (m.p. 59-64 °C). 1H NMR (400 MHz, CDCl3) H (ppm): 0.97 
(3H, s, He), 1.05 (1H, m, Hb), 1.08 (1H, m, Hd), 1.13 (3H, s, Hg), 1.16 (3H, s, He’), 1.16 
(1H, m, Ha), 1.30 (1H, m, Ha’), 1.84 (1H, m, Hb’), 1.86 (1H, m, Hd’), 2.39 (6H, s, Hi), 
3.12 (2H, m, Hf), 3.85 (6H, s, Hl), 4.01 (1H, m, Hc), 6.24 (1H, m, Hh’), 6.62 (1H, m, Hh), 
6.94 (4H, d J = 8.0 Hz, Hk), 7.64 (4H, d J = 8.0 Hz, Hj);
 13C NMR (100 MHz, CDCl3) C 
(ppm): 14.4, 23.2, 27.6, 31.9, 35.1, 36.6, 41.7, 44.8, 46.3, 47.2, 54.8, 55.2, 114.0, 
127.0, 128.3, 154.8, 156.1, 159.6, 161.5; FTIR (ATR)  (cm-1): 3406 (N-H), 2953 
(C-H), 1722 (C=O), 1605 (C=N), 1496 (C-N), 1028 (C-O), 996 (C-O), 912 (N-O); 
ESIMS calculated mass (C30H40O6N4+Na)
+ 575.2840 found 575.2832. 
Synthesis of o-nitroacetophenone oxime blocked-IPDI 5.26 
 
Isophorone diisocyanate (7.13 g, 32.1 mmol) and o-nitroacetophenone oxime 5.20 
(11.55 g, 64.1 mmol) were dissolved in THF (100 mL) and maintained under reflux for 
18 hours under an atmosphere of argon. The solvent was removed to leave a pale 
yellow coloured solid 5.26 (18.65 g, 100 %) (m.p. 78-80 °C). 1H NMR (400 MHz, 
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CDCl3) H (ppm): 0.94 (3H, s, He), 1.00 (2H, m, Hbd), 1.06 (1H, m, Ha), 1.08 (3H, s, Hg), 
1.09 (3H, s, He’), 1.22 (1H, m, Ha’), 1.75 (1H, m, Hd’), 1.79 (1H, m, Hb’), 2.38 (6H, s, Hi), 
3.03 (2H, m, Hf), 3.92 (1H, m, Hc), 5.95 (1H, m, Hh’), 6.20 (1H, m, Hh), 7.47-7.74 (6H, 
m, Hjlm), 8.01-8.22 (2H, m, Hk); 
13C NMR (100 MHz, CDCl3) C (ppm): 17.4, 21.6, 23.1, 
27.4, 31.9, 34.8, 36.5, 41.3, 45.0, 46.2, 46.9, 54.8, 124.7, 128.1, 130.1, 130.6, 131.3, 
131.7, 133.6, 133.7, 134.4, 145.6, 147.7, 154.0, 155.3, 160.0; FTIR (ATR)  (cm-1): 
3411 (N-H), 2954 (C-H), 1731 (C=O), 1612 (C=N), 1525 (N-O), 1499 (C-N), 1028 
(C-O), 993 (C-O), 913 (N-O); ESIMS calculated mass (C28H34O8N6+Na)
+ 605.2330 
found 605.2328. 
Synthesis of m-nitroacetophenone oxime blocked-IPDI 5.27 
 
Isophorone diisocyanate (7.05 g, 31.7 mmol) and m-nitroacetophenone oxime 5.21 
(11.43 g, 63.4 mmol) were dissolved in THF (100 mL) and maintained under reflux for 
18 hours under an atmosphere of argon. The solvent was removed to leave a pale 
yellow coloured solid 5.27 (18.65 g, 100 %) (m.p. 78-80 °C). 1H NMR (400 MHz, 
CDCl3) H (ppm): 1.00 (3H, s, He), 1.10 (2H, m, Hbd), 1.13 (3H, s, Hg), 1.15 (1H, m, Ha), 
1.17 (3H, s, He’), 1.30 (1H, m, Ha’), 1.85 (1H, m, Hb’), 1.89 (1H, m, Hd’), 2.50 (6H, s, Hi), 
3.14 (2H, m, Hf), 4.03 (1H, m, Hc), 6.07 (1H, m, Hh’), 6.45 (1H, m, Hh), 7.65 (2H, br. m, 
Hl), 8.03 (2H, br. m, Hm), 8.32 (2H, td J = 2.0, 1.0 Hz, Hj), 8.54 (2H, br. m, Hk); 
13C NMR (100 MHz, CDCl3) C (ppm): 14.5, 23.11, 27.7, 32.0, 34.7, 36.8, 41.5, 45.1, 
46.0, 47.2, 54.8, 121.7, 124.9, 129.9, 132.5, 136.6, 148.4, 154.0, 155.3, 158.2; FTIR 
(ATR)  (cm-1): 3408 (N-H), 2953 (C-H), 1727 (C=O), 1623 (C=N), 1528 (N-O), 1498 









Synthesis of p-nitroacetophenone oxime blocked-IPDI 5.28 
 
Isophorone diisocyanate (7.33 g, 32.0 mmol) and p-nitroacetophenone oxime 5.22 
(11.88 g, 65.9 mmol) were dissolved in THF (100 mL) and maintained under reflux for 
18 hours under an atmosphere of argon. The solvent was removed to leave a pale 
yellow coloured solid 5.28 (19.21 g, 99 %) (m.p. 81-85 °C). 1H NMR (400 MHz, CDCl3) 
H (ppm): 0.99 (3H, s, He), 1.08 (1H, m, Hd), 1.09 (1H, m, Hb), 1.12 (3H, s, Hg), 1.14 
(1H, m, Ha), 1.15 (3H, s, He’), 1.29 (1H, m, Ha’), 1.83 (1H, m, Hd’), 1.90 (1H, m, Hb’), 
2.49 (6H, s, Hi), 3.13 (2H, m, Hf), 4.01 (1H, m, Hc), 6.04 (1H, m, Hh’), 6.40 (1H, m, Hh), 
7.86 (4H, d J = 9.0 Hz, Hj), 8.29 (4H, d J = 9.0 Hz, Hk); 
13C NMR (100 MHz, CDCl3) C 
(ppm): 14.4, 22.8, 27.6, 32.0, 35.0, 36.7, 41.6, 45.1, 45.8, 47.3, 54.8, 123.9, 127.8, 
140.8, 148.9, 153.9, 155.3, 158.7; FTIR (ATR)  (cm-1): 3405 (N-H), 2953 (C-H), 1727 
(C=O), 1594 (C=N), 1516 (N-O), 1497 (C-N), 993 (C-O), 921 (N-O); ESIMS calculated 
mass (C28H34O8N6+Na)
+ 605.2330 found 605.2329. 
Synthesis of benzophenone-blocked HTPB prepolymer 5.29 
 
IPDI (17.8 g, 8.0 mmol) and benzophenone oxime (0.808 g, 4.1 mmol) were dissolved 
in THF (100 mL) and maintained under reflux for a period of 18 hours under an 
atmosphere of argon. The solution was added to a mixture of hydroxy-terminated 
polybutadiene (HTPB) (18.22 g) and DBTDL (0.044 g, 0.07 mmol) and maintained 
under reflux for a further period of 18 hours. The solvent was removed in vacuo to give 
a pale yellow coloured viscous oil 5.29 (21.03 g, 100 %). FTIR (ATR)  (cm-1): 3007 
(C-H), 2915 (C-H), 2844 (C-H), 1714 (C=O), 1639 (C=N), 1511 (C-N), 1216 (C-N), 965 
(C-O), 911 (N-O), 754 (C=C); GPC (THF, BHT 250 ppm): Mn = 12718 Da, Mw = 76566 
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The limitations and complications associated with the current procedure used for the 
manufacture of plastic or polymer bonded explosives (PBX) have been recognised. 
Two approaches to eliminate these issues using thermally-reversible bonds have been 
identified. The first approach encompasses the encapsulation of the reactive 
crosslinker in polyurethane microcapsules that are able to release their core contents 
upon the application of heat. The second approach utilises thermally-reversible 
blocked-isocyanates to regenerate the active isocyanate moiety when desired using 
an application of heat. 
Initial studies involved the synthesis of isocyanate-terminated shell wall precursors 
capable of further chain extension in order to afford polyurethane microcapsules using 
an interfacial polymerisation technique. The synthesis involved the protection of a 
hydroxy-functionalised aromatic ketone in the form of a silyl ether followed by 
conversion of the ketone to an oxime using hydroxylamine hydrochloride. This 
approach then allowed reaction with a diisocyanate to form the thermally-labile oxime-
urethane. Subsequent deprotection to afford the hydroxyl moiety followed by reaction 
with excess toluene-2,4-diisocyanate (TDI) yielded the shell wall precursor. It was 
important to investigate the effect of steric hindrance around the thermally-labile bond 
on the dissociation temperature. Thus a library of shell wall precursors possessing 
varying degrees of steric hindrance was generated by employing two oximes - 
benzophenone oxime and an acetophenone oxime analogue and four diisocyanates - 
HDI, XDI, IPDI and TMXDI. Methods to observe the dissociation of the oxime-
urethanes were investigated. Variable temperature infrared spectroscopy proved to be 
an effective analytical tool for measuring the dissociation, revealing increasing steric 
hindrance around the oxime-urethane decreases the temperature at which dissociation 
occurs. This dissociation did not generate any volatile products and thus 
thermogravimetric analysis was demonstrated to be unsuitable analytical tool for 
observing the desired bond dissociation. In addition, differential scanning calorimetry 




The generated shell wall precursors were employed in an interfacial polymerisation 
technique to successfully yield polyurethane microcapsules. Spectroscopic analysis of 
the released microcapsule core revealed the successful encapsulation of active 
isophorone diisocyanate (IPDI). Increasing the steric hindrance of the shell wall 
precursors led to the formation of structurally weaker microcapsules. The release of 
these microcapsules using the application of heat was confirmed and was used to 
successfully cure hydroxy-terminated polybutandiene (HTPB) demonstrating the 
potential for such microencapsulated systems for large scale deployment in the 
manufacture of PBX. Control of the physical properties of microcapsules was achieved 
by manipulation of the reaction parameters of the microcapsule synthesis. 
Microcapsule diameter can be controlled by agitation rate, surfactant concentration 
and selection of the hydrophobic solvent. The shell wall thickness is dependent on 
concentration of the shell wall precursor and reaction time. In addition, the maximum 
loading of IPDI in the microencapsulated core was investigated. The permeability of 
the microcapsule core can be controlled by increasing the concentration of the chain 
extender. Furthermore, the successful encapsulation of a dye, -carotene, 
demonstrated how UV spectroscopy could be employed to observe and quantify the 
release of microencapsulated core. 
The thermally-reversible nature of the maleimide-furan Diels-Alder adduct was 
exploited in order to generate microcapsules that released IPDI from the core upon 
exposure to heat. This study initially involved the synthesis of an isocyanate-
terminated shell wall precursor that contained the Diels-Alder adduct. This was 
achieved by protection of maleic anhydride with furan followed by conversion to the 
maleimide to form a hydroxy-functionalised Diels-Alder adduct. Deprotection followed 
by reaction with furfuryl alcohol generated a dihydroxy-functionalised Diels-Alder 
adduct that was reacted with an excess of TDI to afford the desired shell wall 
precursor. The synthesis of microcapsules containing IPDI was achieved using an 
interfacial polymerisation technique that employed this shell wall precursor to form the 
microcapsule shell wall. The release of the microcapsule core using a heat stimulus 
was demonstrated. The mechanical strength of the microcapsules was improved by 
using a synthesis that employed a mixture of a shell wall precursor containing the 
Diels-Alder adduct and a shell wall precursor not containing the thermally-reversible 
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bond. Although mechanical strength was improved, the capability of the microcapsules 
to release the core was reduced. 
The final part of this thesis investigated the potential of thermally-reversible blocked 
isocyanates to cure HTPB using an application of heat. Studies involved the synthesis 
of IPDI blocked with a range of groups - amines, amides, oximes, aromatic 
heterocycles and phenols. Crosslinking studies of HTPB using these generated 
blocked isocyanates revealed oxime blocking groups referred to as oxime-urethanes 
demonstrated ideal solubility and curing properties for potential employment in the 
manufacture of PBX. Attempts to reduce the dissociation of oxime-urethanes were 
successfully achieved by increasing the steric hindrance of the oxime. In addition, the 
presence of electron donating groups at the ortho and meta position of aromatic 
oximes led to a reduction of the dissociation temperature. Methods to measure the 
curing of HTPB were investigated - tensile testing and observing the swelling 
behaviour of the curing material were identified as reliable methods of analysis. The 
poor solubility of aromatic oxime-urethanes in HTPB was remedied by generation of 
an oxime-blocked HTPB-based prepolymer. The cure of HTPB using such blocked-
isocyanates revealed promising results, however, further development is still required 






Chapter 4 has described how the presence of an electron donating methoxy moiety at 
the meta-position of acetophenone oximes has significantly reduced the dissociation 
temperature of oxime-urethanes, thus it is expected that increasing this electron 
density will further reduce the dissociation temperature. This could be achieved by 
generating analogues of acetophenone oxime that possesses electron donating 
substituents at both the available meta-positions. Further electron density could be 
imparted into the system by employing more strongly donating substituents - tertiary 
amines in particular exhibit strong electron donating nature. The effect of electron 
donating substituents could be fully exploited by the synthesis of 3,3’,5,5’-substituted 
benzophenone oxime analogues (Figure 7.1). 
 
Figure 7.1. The structures of analogues of acetophenone oxime and benzophenone oxime 
possessing methoxy and dimethylamine electron donating groups (EDG). 
Another approach that can be employed to reduce the dissociation temperature of 
oxime-urethanes is to position polar functional groups in close proximity to the labile-
bond. Acetophenone oxime functionalised with an ortho-methoxy moiety has reduced 
the dissociation temperature of oxime-urethanes - therefore the presence of an 
additional methoxy group is expected to enhance this effect and could be further 
enhanced by the addition of an acetyl moiety (Figure 7.2). 
 
Figure 7.2. The structures of analogues of acetophenone oxime that possess polar methoxy 
and acetyl groups in close proximity to the oxime functional group. 
In addition, the dissociation temperature of oxime-urethanes is dependent on the steric 
hindrance around the thermally-labile bond and this effect has been demonstrated in 
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Chapter 2 and 4. Reduction of the dissociation temperature could be achieved by 
employing sterically hindered aliphatic oximes such as - 2,2,4-trimethyl-3-pentanone 
oxime and 2,2,4,4-tetramethyl-3-pentanone oxime. A combination of the steric and 
electronic effects could also significantly lead to a reduction in the dissociation 
temperature of oxime-urethanes (Figure 7.3). 
 
Figure 7.3. Structures of sterically encumbered aliphatic oximes and an analogue of sterically 
encumbered acetophenone oxime that possesses electron donating groups at the meta-
positions. 
The future investigative work outlined in this chapter can be used in the development 
of microcapsules that release their core contents with an application of heat. Shell wall 
precursors can be designed in order to exploit the steric and electronic effects that 
reduce the dissociation temperature of the oxime-urethane bond. 
Although microencapsulation technology has demonstrated the potential for 
employment in PBX formulations, further development is required. Firstly the scale of 
the microcapsule synthesis will need to be increased in order to meet scale 
requirements of explosive formulations. Release of the microcapsule core using a 
range of temperatures and exposure times will need to be performed. Microcapsules 
will be required to possess sufficient mechanical strength in order to survive the mixing 
process of the explosive formulation thus a method to measure the mechanical 
strength of microcapsules will be required. This has been the subject of many literature 
studies and methods include - crushing between two plates,1 shear breakage in a 
turbine reactor2,3 and compression using micromanipulation.4,5 Of these methods 
measuring the shear breakage in a turbine reactor may be suitable, since it most 
closely represents the forces microcapsules will experience in the mixing process 
employed in the manufacture of PBX. Alongside this, controlling the mechanical 
strength of the microcapsules will be important. Studies have shown1 that the 
mechanical strength is dependent on the microcapsule diameter and the thickness of 
the shell wall. Although control of these properties has been described in Chapter 3, 
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further studies may be required in order to tailor microcapsules that possess a desired 
mechanical strength for employment in PBX formulations. 
Microcapsules that utilise Diels-Alder adducts within the shell wall also require 
development. The mechanical strength of these microcapsules may be improved by 
the addition of a short polymer chain to the Diels-Alder adduct and thus facilitate in 
formation of a stronger polymer shell (Figure 7.4). 
 
Figure 7.4. Modified Diels-Alder adduct with a short PEG chain. 
The potential to synthesise microcapsules that contain alternative Diels-Alder adducts 
within the shell wall also need to be investigated. Tricyanoacrylate-fulvene adducts 
have demonstrated6 excellent reversibility at 25-50 °C. In addition, Diels-Alder adducts 
have been developed7 that are formed by reaction of a thio-thiocarbonyl RAFT agent 
with cyclopentadiene (Figure 7.5). 
 
Figure 7.5. Reversible reactions of Diels-Alder adducts formed from tricyanoacrylate with 
fulvene and thio-thiocarbonyl RAFT agent with cyclopentadiene. 
It may be necessary to investigate other thermally-labile bonds that can be 
incorporated into the shell wall of microcapsules. Results described in Chapter 4 
demonstrate the potential of other thermally-labile linkers that could be incorporated 
into the shell wall of microcapsules. Amines and aromatic heterocycles in particular 
show promising dissociation character. 
In addition to release of microcapsule core using an application of direct heat, the 
release using ultrasound could also be explored. Ultrasound cavitation brings about 
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localised regions of short lived high temperature environments8 that could be sufficient 
to bring about the dissociation of thermally-labile bonds. 
The development of thermally-labile bonds described in this thesis have been 
designed specifically for the purpose of controlling the crosslinking of polyurethane 
matrices. The release of the core from microcapsules using heat is not restricted to 
isocyanate crosslinkers and potential for the release of other chemicals is recognised. 
In recent years there has been demand for recyclable and degradable materials9 and 
the thermally-labile bonds developed herein could be employed as degradable 
crosslinks in thermoset plastics. The reversible nature of the oxime-urethane bonds 
described in this thesis also needs to be investigated as such thermally-reversible 
systems are used in healable materials.10 
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VTIR spectra of 2.3a 
 
 



























VTIR spectra of 2.3c 
 
 



























VTIR spectra of 2.3e 
 
 



























VTIR spectra of 2.3g 
 
 





























VTIR spectra of 5.2 
 
 























VTIR spectra of 5.5 
 
 




















VTIR spectra of 5.12 
 

























VTIR spectra of 5.14 
 
 
























VTIR spectra of 5.16 
 
 
























VTIR spectra of 5.24 
 
 






















VTIR spectra of 5.26 
 
 





















VTIR spectra of 5.28 
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